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Many countries in the world have experienced increases in life expectancy and the
accompanying population ageing over the past century. Saving sufficiently for retire-
ment, being able to face higher pension expenses, efficiently allocating health care re-
sources are significant challenges for individuals, public and private pension funds, in-
surance companies, and government (see, e.g., Bloom, Canning, Mansfield, and Moore,
2007; Hári, De Waegenaere, Melenberg, and Nijman, 2008; Pitacco, Denuit, Haberman,
and Olivieri, 2009b). Like many other countries, the United States is facing a shift in
the demographic structure of the population. The percentage of the population aged 65
and over has increased from 9.2% in 19601 to 13.1% in 20102. To reduce the accompany-
ing increased public pension expenditure, the U.S. 1983 Social Security Amendments
has raised the full retirement age for cohorts born after 1937 gradually from 65 years
in 2002 to 67 years in 2026. A concern associated with such policies is that even if an
increase in retirement age effectively relieves the increased pension liability, possible
spillover effects, such as increases in spending of disability insurance and social secu-
rity insurance, and health expenditure may offset the reduced pension expenditure if
people are not healthy enough to work (see,e.g., Munnell, Meme, Jivan, and Cahill,
2004; Munnell and Libby, 2007; Cutler, Meara, and Richards-Shubik, 2011; Unger and
Schulze, 2013). This means that the complexity of changes in public finance associ-
1Population estimates provided by the U.S. Census Bureau. See http://www.census.gov/popest/
data/national/asrh/pre-1980/PE-11.html.




ated with ageing is not only caused by people’s longer lifetimes, but also by the future
development of people’s health. Therefore, an effective and efficient policy making
process requires not only quantifying the increase in life expectancy, which measures
the expected remaining years of life at a given age and time, but also considering the
development of healthy life expectancy, which measures the expected remaining life-
time in good health.
Another important concern relating to a large part of government expenditure in
the United States is the fast growing healthcare expenditure over the past 50 years.
The healthcare spending in the United States as a share of GDP (gross domestic prod-
uct) has increased from 5.2% in 1960 to 17.9% in 20113. The rising healthcare cost
continuously takes up a larger proportion of the annual government budget, and ag-
gravates the government burden considerably. There is a growing stream of literature
that investigates whether, and to what extent, various factors determine the growth
of healthcare expenditure. For instance, Hansen and King (1996), Manton, Lamb, and
Gu (2007), Moscone and Tosetti (2010), Xu, Saksena, and Holly (2011), Solakoglu and
Civan (2012), and many others suggest that national income, the price of healthcare,
public financing, age structure, and population health are important factors affecting
the growth of health expenditure. As one might assume, the use of healthcare services
depends on people’s health condition. Solakoglu and Civan (2012) adopt population
health as an indicator of healthcare need, and find that the rising share of healthcare ex-
penditure in GDP can be explained by the growing healthcare need. Therefore, better
understanding of the development of population health provides relevant information
for policy makers to improve decisions when allocating scarce healthcare resources.
In light of these concerns, the primary motivation of this dissertation is to provide
insights into the future developments of mortality and population health, and the as-
sociated effects on public finance in the United States. Chapter 2 models the future
developments of population health and quantifies the degree of uncertainty in the fu-
ture developments. Chapter 3 jointly models the future developments of mortality and
health, using a similar approach as for health in Chapter 2. This allows us to further in-
vestigate the association between the developments of life expectancy and healthy life
expectancy, taking into account dependence between developments of mortality and
health. Chapter 4 extends the forecast model developed in Chapter 3 by taking into
account the dependence between male and female mortality and health. The model is
used to estimate the effects on (healthy) life expectancy of a policy that links the retire-
ment age to life expectancy. Finally, Chapter 5 studies another important part of public
finance, the growth of healthcare expenditure. In this chapter, we investigate the dy-
namic relationship between the growth of healthcare cost and a relatively large set of
its determinants, with special attention on the effect of people’s health on the growing
3Data Source: “NHE summary including share of GDP, CY 1960-2011" provided by National Health
Expenditure Data from Center of Medicare and Medicaid.
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healthcare cost. The rest of the introduction will address each chapter in detail.
There is an extensive literature on modeling trends in population health. However,
forecasting future health developments is not a trivial task. Several factors may af-
fect population health in different directions and complicate the prediction of health
changes. For example, Ruhm (2000) and Erdil and Yetkiner (2009) suggest that eco-
nomic growth has a positive effect on the people’s health. Michaud, Goldman, Lak-
dawalla, Zheng, and Gailey (2009) find that, on the one hand, increased obesity re-
duces life expectancy and increases morbidity; on the other hand, reduced smoking
shows an opposite effect. The net effect remains unclear, and is surrounded by a lot
of uncertainty. Much of the literature on forecasting health uses a deterministic ap-
proach (see, e.g., Singer and Manton, 1998; Jacobzone, 2000; Jagger, Matthews, Spiers,
Brayne, Comas-Herrera, Robinson, Lindesay, and Croft, 2006; Manton, Gu, and Lamb,
2006a; Manton, Lamb, and Gu, 2007). Commonly used deterministic approaches are
to assume population health improves with a certain speed annually, or to consider a
number of deterministic scenarios for the development of health. One shortcoming of
such deterministic approaches is that they do not provide information regarding the
likelihood of changes in population health. Exceptions are Majer, Stevens, Nusselder,
Mackenbach, and van Baal (2012) and van Baal, Peters, Mackenbach, and Nusselder
(2013). These studies develop Lee and Carter (1992) type approaches to model health
transition probabilities and disability rates for the Dutch population. A major advan-
tage of a Lee and Carter type approach is that it provides not only the forecasts of the
future health changes, but also the corresponding uncertainties. Chapter 2 of this dis-
sertation, which is based on the working paper, Yang, De Waegenaere, and Melenberg
(2013b), extends the Lee and Carter (1992) approach by including observed variables,
namely GDP per capita and the unemployment rate to model and forecast the health
changes of the U.S. population. An important advantage of including observed vari-
ables is that future forecasts not only depend on estimated latent time trend but also on
the (future) developments of GDP and unemployment rate. Moreover, because of tak-
ing into account additional information besides the latent time trend as in the original
Lee-Carter model, this model might generate more precise model-based forecasts.
In Chapter 3, the future development of (healthy) life expectancy is examined, dis-
tinguished by genders. This chapter is based on the working paper, Yang, De Waege-
naere, and Melenberg (2013a). Healthy life expectancy now is often used to measure
the quality of life (van de Water, Perenboom, and Boshuizen (1996)) and measures
changes in population health (Laditka and Laditka (2002)). In many studies, forecasts
of healthy (or disability free) life expectancy allow changes in future mortality rates,
but assume that future health remains constant or has multiple deterministic scenarios
(see for example, Jagger, Matthews, Spiers, Brayne, Comas-Herrera, Robinson, Linde-
say, and Croft (2006), Jacobzone (2000), and Manton, Gu, and Lamb (2006a)). As a
consequence, the uncertainty of future healthy life expectancy generated by the uncer-
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tainty of future health changes, which is possibly larger than the uncertainty of future
mortality, cannot be sufficiently quantified. Moreover, separately treating mortality
and health may result in biased estimation of life expectancy due to the possible high
dependence of mortality on health. Applying the methodology proposed in Chapter 2,
and extending it to jointly model mortality and health, Chapter 3 forecasts the devel-
opment of future (healthy) life expectancy by taking into account the joint dynamics
of mortality, health, and macroeconomic variables, quantifying its future uncertainties
derived from both mortality and health. Moreover, it is well-documented that pat-
terns of mortality and health are not the same for males and females (see, for example,
Van Oyen, Cox, Jagger, Cambois, Nusselder, Gilles, and Robine (2010) and Van Oyen,
Nusselder, Jagger, Kolip, Cambois, and Robine (2013)). Therefore, we also briefly dis-
cuss the gender disparities in (healthy) life expectancy in Chapter 3.
As discussed earlier in this introduction, one possible policy to deal with conse-
quences of continuing increases in life expectancy is to raise the retirement age. Includ-
ing the United States, several countries have already implemented such policies (see
OECD (2013) and Schwan and Sail (2013)). One drawback of deterministically raising
the retirement age for some period in advance is that there is a considerable degree of
uncertainty regarding the development of future life expectancy. For this reason, coun-
tries such as Italy, Denmark, Greece, the Netherlands, Slovakia, and Cyprus have im-
plemented policies in which the development of retirement age is directly linked to the
development of life expectancy (see, e.g., Schwan and Sail, 2013). However, whether
trends in health of the elderly support the raise in retirement age is a question that
is not addressed in many studies. In addition to keeping people’s remaining lifetime
after retirement stable over time in order to avoid further increases in pension liabili-
ties, two aspects related to retirees’ health deserve attention. First, the number of years
that retirees can enjoy retirement in good health might be significantly impacted by the
policy if healthy life expectancy does not grow at the same pace as life expectancy (see,
e.g., Cutler, Meara, and Richards-Shubik, 2011). Second, if the fraction of individuals
that is sufficiently healthy to work until retirement would decrease significantly due
to the policy, increases in unemployment or other social security benefits might off-
set the benefits of the policy in terms of reduced pension payments (see, e.g., Munnell,
Meme, Jivan, and Cahill, 2004). Whether people will be healthy enough to work longer
is a concern for the policy makers (see, e.g., Munnell, Meme, Jivan, and Cahill, 2004;
Munnell and Libby, 2007; Unger and Schulze, 2013). Therefore, Chapter 4 of this dis-
sertation, which is based on the working paper De Waegenaere, Melenberg, and Yang
(2014), estimates the effects of a retirement age policy in which, roughly speaking, an
increase in life expectancy of one month is accompanied by an increase in retirement
age of one month. We investigate the effects of such a policy on life expectancy and
healthy life expectancy before and after retirement, as well as the likelihood of being in
good health at retirement age. To do so, the model developed in Chapter 3 is extended
CHAPTER 1 5
to jointly model trends in mortality and health of both genders.
In Chapter 5, which is based on the working paper, Yang and Melenberg (2014), we
investigate the development of the U.S. healthcare costs. The U.S. healthcare costs rep-
resent a significant part of the country’s GDP, it is 17.9% in 20114. As suggested by the
literature, important factors affecting healthcare costs include national income (Chris-
tiansen, Bech, and Lauridsen (2007) and Amiri and Ventelou (2012)), demographic
structure (Xu, Saksena, and Holly (2011)), healthcare price (Murthy and Ukpolo (1994)),
public financing (Gerdtham and Jonsson (2000) and Murthy and Okunade (2000)), and
technological progress (Berndt, Cutler, Frank, Griliches, Newhouse, and Triplett (2000)
and van Elk, Mot, and Franses (2009)). Moreover, the ageing of the population and
people’s health play a major role in the future development of healthcare costs (See
Solakoglu and Civan (2012), Dreger and Reimers (2005), and Murthy and Okunade
(2000)). As the demand for healthcare is ultimately derived from the demand for bet-
ter health, we examine in this chapter the health status of the elderly together with
macroeconomic determinants and the age structure of the population as drivers of the
healthcare spending growth. There are several complications to be dealt with when
analyzing the relationship between health expenditure and its determinants. First,
most of the studies only include a few factors, omitting important determinants, pos-
sibly resulting in an omitted variable bias when quantifying, for example, the income
elasticity (Roberts (1999) and Gerdtham and Jonsson (2000)), or the effect of popula-
tion ageing (Zweifel, Felder, and Meiers (1999) and Yang, Norton, and Stearns (2003)).
Second, there may exist simultaneous relationships between healthcare spending and
its determinants. For example, possibly a bilateral relationship exists between health
expenditure and the elderly’s health condition. On the one hand, an increase in the
population fraction of the elderly in good health may reduce the need for healthcare
services, which in turn might slow down the growth in healthcare cost; on the other
hand, part of the increased healthcare expenditure may be attributed to better medical
treatments and provisions of services to maintain life quality, which may improve peo-
ple’s health. Moreover, a reverse effect may exist from increased health expenditure on
the growth of national income, through the enhancement of education, improvement
in labor participation, and higher productivity due to health improvement brought by
higher health expenditure (Erdil and Yetkiner (2009)). As a result, failure to take into
account possible simultaneous relationships may under- or overestimate the effects of
the variables of interest. Finally, an application of the appropriate methodology in
this study turns out to be challenging. Trends in health expenditure and its deter-
minants indicate non-stationarity. We find different forms of nonstationarity. Such
different forms of nonstationarity complicate the econometric analysis considerably.
The literature also documents conflicting conclusions regarding the stationarity/non-
4Data source: “NHE summary including share of GDP, CY 1960-2011" provided by National Health
Expenditure Data from Center of Medicare and Medicaid.
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stationarity of health expenditure and its determinants, and possible cointegration re-
lationships between them (see reviews provided by Gerdtham and Lothgren (2000)
and Moscone and Tosetti (2010)). Chapter 5 proceeds as follows. First, a relatively
large number of factors are considered when investigating the changes in health ex-
penditure. Second, we apply variable-specific transformations so that after applying
these transformations the transformed variables are (close to) stationary. Third, we ap-
ply a Vector Auto Regression (VAR) model to capture the joint dynamic relationships
between these stationarized variables. In the VAR framework, we allow the other vari-
ables to influence health expenditure and also the other way around. In this way, we
try to reduce potential biases due to omitted variables, and avoid ignoring mutual rela-
tionships. We further evaluate forecasts of the healthcare spending based on an out-of-
sample analysis. In particular, we compare the forecasts derived from the VAR model
including the elderly’s health status, with forecasts ignoring the elderly’s health status,
and with "official forecasts" published by Center of Medicare and Medicaid (CMS). We
find that forecasts in the VAR model by taking into account the elderly’s health status
are superior than forecasts from the other two compared methods.
CHAPTER 2
STOCHASTIC MODELING AND FORECASTING OF HEALTH
CHANGES IN THE U.S. POPULATION
This Chapter is based on Yang, De Waegenaere, and Melenberg (2013b)
This chapter proposes a model for self-assessed health at an aggregate level that
allows to generate age- and gender-specific stochastic forecasts of future health. We
decompose health status into a time effect and an age effect. We then further decom-
pose the time effect into observed macroeconomic quantities (GDP and unemploy-
ment rate) and an unobserved latent time factor. We use data on the U.S. population’s
self-assessed health for both males and females to estimate the model. The estima-
tion results show that trends in health can be largely captured by trends in the ob-
served macroeconomic quantities. Next, based on forecasts of the observed and the
unobserved time effects, using a vector auto regression (VAR) model, we present fore-
casts for future health together with the corresponding forecasting uncertainty, show-
ing that there is no clear future trend upward or downward. A backtesting analysis
suggests that our approach with macroeconomic quantities significantly improves the
forecasting accuracy for future health development compared with a simple extrap-
olation based approach. It also outperforms the model without taking into account
observed variables.
2.1 Introduction
Over the past century, understanding and predicting health changes in the United
States has gained growing interest, not only from demographers and health economists,
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but also from institutions, such as insurance companies, pension funds, social security,
and government. For example, the United States’ total spending for health care as a
share of GDP (gross domestic product) is the highest among the OECD (Organisation
for Economic Co-operation and Development) countries. It is almost double the OECD
average and still growing. As health care expenditure generally increases with age and
bad health status, it is important for institutions, such as health service providers, to
assess to what extent health will change in the future. Moreover, better understand-
ing health changes might be helpful for policy makers to improve labor participation
decisions. For instance, many countries currently start increasing the retirement age
gradually in order to reduce the rising pension costs because of an increase in life ex-
pectancy. However, such a policy decision might be inconsiderate if it only relies on
the information of life expectancy, and ignoring people’s future health changes. Since
a rise in the retirement age may have an adverse effect if people are not healthy enough
to work longer, it may lead to higher government spending on healthcare or disabil-
ity benefits, possibly offsetting the reduced pension costs. A basic ingredient here is a
good understanding of the development in health, now and in the future.
Future health changes in the U.S., however, are not trivial to predict. Costa (2002)
states that functional limitations of the older U.S. men has reduced annually from the
early twentieth century to the early 1990s. Moreover, the health of adults aged 50-
64 has improved on average from 1984 to 2001, examined by Duggan and Imberman
(2006) using self-assessed health from the National Health Interview Survey (NHIS).
However, the future development of health is quite uncertain. Health might be affected
by many factors, such as the economic situation, technological advances, strengthen-
ing of primary healthcare, and people’s lifestyle choices. These factors may have large
and offsetting effects. For instance, Michaud, Goldman, Lakdawalla, Zheng, and Gai-
ley (2009) find that, on the one hand, increased obesity reduces life expectancy and
increases morbidity for a number of years before death and, on the other hand, re-
duced smoking lowers morbidity and increases life expectancy. The net effect remains
unclear, and is surrounded by a lot of uncertainty.
Our aim in this paper is to model and predict the future development of health in the
United States, as well as the degree of uncertainty regarding the future development.
We first apply the stochastic approach proposed by Lee and Carter (1992). This is a
parsimonious modeling approach that consists of decomposing (in its original form)
mortality into an age and a time effect. Such an approach seems to be relevant for
modeling health as well, since health as a function of time and age shows similarities
to mortality as a function of time and age. Importantly, the Lee and Carter (1992) model
explicitly allows for quantifying the uncertainty surrounding the health development
and its forecasts.
There are many studies forecasting health using a deterministic approach (e.g., Singer
and Manton (1998), Jacobzone (2000), Jagger, Matthews, Spiers, Brayne, Comas-Herrera,
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Robinson, Lindesay, and Croft (2006), Manton, Gu, and Lamb (2006a), and Manton,
Lamb, and Gu (2007), to name just a few). Forecasting health using a determinis-
tic approach has a main disadvantage that the forecast uncertainty is not quantified.
The deterministic forecast might over- or underestimate the future development, even
to large extent, and does not provide any information on such forecast errors. As a
consequence, policy measures based on deterministic forecasts might turn out to be
misguided, if the forecast error turns out to be substantial and the possibility of such
a forecast error is not taken into account. See, for example, also Lee and Miller (2002)
for a discussion of the drawbacks associated with deterministic forecasts. In response
to these concerns, there is a growing body of literature on stochastic methods for de-
mographic and health forecasting. Since the seminal work by Lee and Carter (1992),
the stochastic approach to mortality forecasting has gained considerable attention, but
is still less common for health modeling. Notable recent exceptions are Majer, Stevens,
Nusselder, Mackenbach, and van Baal (2012) and van Baal, Peters, Mackenbach, and
Nusselder (2013). Majer, Stevens, Nusselder, Mackenbach, and van Baal (2012) ap-
ply the Lee-Carter model to model and project transition probabilities between health
states and death for the Dutch population at a disaggregated level. van Baal, Peters,
Mackenbach, and Nusselder (2013) apply the Lee-Carter model to quantify the healthy
life expectancy of different educational groups at an aggregated level. Our approach
differs from theirs in the following way. We extend the Lee and Carter (1992) approach
by including observed variables (GDP per capita and the unemployment rate), which
turn out to capture most of the time variation in health. This has some advantages
compared to the traditional Lee and Carter (1992) model. First, the model allows for a
direct link to (economic) models that generate (future) scenarios of GDP and the unem-
ployment rate. Second, it implies similar time variations in terms of health in countries
with similar time variations in the development of GDP and unemployment. Finally,
the model might generate more precise model-based forecasts, see also Niu and Me-
lenberg (2014). The reason is that in the traditional Lee and Carter (1992) model, a
latent variable is estimated that is assumed to capture the time variation. This esti-
mated latent trend variable might result in some in-sample overfitting, when trying to
capture the time variation as good as possible. Compared to GDP and unemployment,
the latent estimated variable might be more volatile. This extra volatility is then trans-
lated into a wider forecast interval. In our extended Lee and Carter (1992) model, the
included latent time variable will only capture the residual time variation, not yet cap-
tured by GDP and unemployment. If GDP and unemployment indeed capture most
of the time variation, as we do find, then the possible overfitting by the included latent
time variable likely will only be of minor importance. Another difference between our
approach and that in Majer, Stevens, Nusselder, Mackenbach, and van Baal (2012) is
that we focus on modeling the time variation in aggregate health (using a time series of
cross-sectional health status data), whereas they model the time variation in individ-
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ual transitions in health status. While our approach has the disadvantage that it yields
less detailed information regarding health and its relation to mortality, an important
advantage is that we can use a much longer dataset. Whereas their time period covers
19 years (1989–2007), our study uses aggregated U.S. data over the period 1972-2010.
The longer dataset might help to better capture long-term trends in health status at
population level.
The remainder of the paper is organized as follows. In the next section, we for-
mally define the health status index, and introduce the theoretical framework to esti-
mate health changes stochastically. Next, in Section 5.3, we describe the health data
and macroeconomic variables included in the study. Section 2.4 presents the estima-
tion results on modeling the health dynamics for the United States from 1972 to 2010,
distinguishing males and females. We then discuss the forecast of health changes in
Section 2.5. Section 2.6 provides a sensitivity analysis. We conclude in Section 5.5.
2.2 Health modeling
In this section, we first present the health measurement used in this paper, focusing
on the construction of the Health Status Index (HSI). Next, a latent framework is il-
lustrated to model dynamic changes in the health process. We then extend the latent
model by including observed macroeconomic information.
2.2.1 Health measurement
The analysis in this paper uses self-assessed health. Although there are some well-
known drawbacks to using self-assessed health (such as, e.g., its subjective nature,
possible biases, and heterogeneity), self-assessed health is a commonly used measure
of health. While it is indeed subjective in nature, it can incorporate a variety of fea-
tures of health, including not only physical aspects, but also cognitive and emotional
health. Several studies show that it might provide useful information regarding an
individual’s working eligibility, health service demand, and long-term care needs, see,
for instance, Branch, Jette, Evashwick, Polansky, Rowe, and Diehr (1981), Peng, Ling,
and He (2010), and McGarry (2004).
In line with the health definition introduced by Imai and Soneji (2007a), we define
the Health Status Index (HSI), πx,t, to represent the proportion of the population of
group x at time t with a certain health condition, for example, “good” or “bad.” This
Health Status Index, reflects the overall health level of the population of a certain age
and at a certain time. In our application, the population consists of all males or all
females in the U.S., and a group x consists of all individuals in this population at age
x, with x ∈ {0, 1, · · · , 85+}.
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2.2.2 Health modeling in a latent framework
In this section, we model the development of the Health Status Index (HSI) over spe-
cific groups and time employing the original Lee and Carter (1992) framework, which
is a parsimonious and latent modeling approach. The Lee-Carter model and its numer-
ous extensions belong to the commonly used methods in mortality analysis. See, for
instance, recent books by Girosi and King (2008) and Pitacco, Denuit, Haberman, and
Olivieri (2009a), and references included in these works. Quantitative comparisons of
the Lee-Carter model and its extensions can be found in, for example, Cairns, Blake,
Dowd, Coughlan, Epstein, Ong, and Balevich (2007), Dowd, Cairns, Blake, Coughlan,
Epstein, and Khalaf-Allah (2010), and Cairns, Blake, Dowd, Coughlan, Epstein, and
Khalaf-Allah (2011). They conclude that no single model dominates all other models.
Since our study is one of the first attempts to model health dynamics under a latent
stochastic framework in the current literature, there is no reason to assume at this stage
that a more complicated extension will outperform the original Lee-Carter framework.
Let πx,t denotes the health status index (HSI) of group x at time t. The Lee-Carter
model assumes that some transformation F of πx,t satisfies the following relationship,
F (πx,t) = αx + βxκt + εx,t, (2.1)
where αx describes the time-independent level of health as a function of x, κt is a time-
dependent univariate latent variable, which represents the change in the overall level
of F (πx,t) over time, βx describes the group-specific sensitivity to the overall level
when κt varies, and εx,t is the error term, reflecting idiosyncratic time- and group-
specific influences, with mean 0 and (possibly group-specific) variance σ2ε,x.
In this model specification, αx, βx and κt are not uniquely identified. For instance,
multiplying all βx-s by a non-zero constant and dividing all κt-s by the same constant c,
or adding a non-zero constant d to κt and subtracting d× βx from αx does not alter the




κt = 0 and ∑
x
βx = 1. (2.2)
The first constraint implies that for each x an estimate for αx will be the average of the
F (πx,t) over time. The second one implies that βx represents which fraction (over all
groups) of the change in κt is captured by group x.1 These normalizations identify the
αx-s and κt-s. The βx-s are identified if the κt-process is not identically equal to zero.
Thus, if we set βx = 0 (all x) if κt = 0 (all t), then also the βx-s are identified.
1As argued by Cairns, Blake, Dowd, Coughlan, Epstein, Ong, and Balevich (2007) and Pitacco, De-
nuit, Haberman, and Olivieri (2009a), the first constraint is a natural choice, whereas other choices of
the second constraint have no impact on the quality of the fit, nor the model forecasts. Other constraints
can be found in the literature, for instance, Wilmoth (1993) employs ∑x β2x = 1.
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Originally, Lee and Carter (1992) use F (z) = log z when the dependent variable of
interest is mx,t, the central mortality death rate of group x at time t. As a benchmark,
we also adopt the log-transformation of the HSI, though in case of πx,t other transfor-
mations might work better. In Section 2.6.1, we consider alternatives and show that
the log-transformation seems to be a reasonable choice.
2.2.3 Lee-Carter model with observed variables
In the original Lee and Carter (1992) model, the latent κt captures the time trend. In this
section, we introduce an extension of the Lee and Carter (1992) model, by including
observed economic variables. Such an extension might help to better understand a
possible trend in health, since the observed variables might capture some or even all
of the trend instead of κt. Let Zt be an m-dimensional vector containing as components
of observed variables. Examples of Zt can be macroeconomic variables (in our case
logarithm of GDP and unemployment rate), or, alternatively, life-style related factors,
such as alcohol and tobacco consumption (see Section 2.6.3 on the sensitivity analysis).
The health curve is then modeled as
log (πx,t) = αx + βxκt + ρ′xZt + εx,t, (2.3)
where ρx =
(
ρ1x, · · · , ρmx
)′ is an m-dimensional group specific parameter vector, con-
taining the coefficients corresponding to Zt. We normalize the components of the vec-
tor Zt such that they have mean zero and variance one. However, adding some com-
ponent of Zt to κt and subtracting βx from the corresponding component of ρx does
not alter the systematic part of the model. Therefore, for identification purposes, we
impose a constraint on ρx,
∑
x
ρix = 1, for each i = 1, . . . , m. (2.4)
Suppose we observe πx,t and Zt for t ∈ {t1, · · · , tn}. If κ = (κt1 , · · · , κtn)
′ is not linearly
dependent of the columns of Z = (Zt1 , · · · , Ztn)
′, then the βx-s and ρx-s are identified.
Thus, if we set βx = 0 (all x), in case κ is linearly dependent of the columns of Z, then
also the βx-s and ρx-s are identified. See the appendix for a proof.
We estimate the model using the Newton-Raphson procedure, generalizing Ren-
shaw and Haberman (2006), see the Appendix for details. Following Lee and Carter
(1992), the estimated κt are adjusted by finding the value of κt for which the actual and
expected total number of people who are in a certain health condition in each year are
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Nx,t exp(α̂x + β̂xκ̂t + ρ̂′xZt). (2.5)
In addition, as we usually do not expect an irregular pattern of people’s health changes
with respect to group x, the age dependent estimates are smoothed using a spline
method, proposed by Currie, Durban, and Eilers (2004), to fit the health surface.
Finally, to quantify the real trend in health captured by Zt, we shall consider replac-
ing the estimated κ̂t by κ̃t and the estimated ρx by ρ̃x, where κ̃t is constructed such that
it is orthogonal to Zt, i.e,
κ̃t = κ̂t − Z′t(Z′Z)−1(Z′κ̂), (2.6)
ρ̃x = ρ̂x + (Z′Z)−1(Z′κ̂)βx, (2.7)
β̃x = β̂x. (2.8)
Since κ̃t by construction is orthogonal to Zt, the resulting ρ̃x can be interpreted as cap-
turing the “full” effect of Zt on health. Moreover, ρ̃x = 0 if Zt would not have any
effect and κ̃t = 0, if there would be no remaining time effect next to Zt.3
2.3 Data description
In this section, we describe the U.S. self-assessed health data and the macroeconomic
variables used in this study.
2.3.1 Health data
The empirical analysis in this paper is based on consecutive annual cross-sectional
self-assessed health data over the period 1972-2010 in the United States. The health
data is obtained from the Integrated Health Interview Series (IHIS).4 The IHIS doc-
uments the integrated self-assessed health of the civilian, non-institutionalized U.S.
population, surveyed by the National Health Interview Survey (NHIS). The NHIS is a
cross-sectional household face-to-face interview survey. It is conducted by the National
2The identification constraints will be satisfied by replacing κ̂t with κ̂t − κ̂t and α̂x by α̂x + β̂xκ̂t.
3Niu and Melenberg (2014) use this way of estimating their model for mortality, similar to (3.4), but
then for mortality instead of health and with only GDP per capita as observed variable included. Their
normalization is that κ is orthogonal to the space spanned by Z, instead of our normalization that κ is
linearly independent of the columns of Z. Moreover, if κ = 0 then they set βx = 0 (all x), while we
set βx = 0 (all x) if κ is linearly dependent of the columns of Z. These two ways of identifying the
parameters are equivalent.
4Minnesota Population Center and State Health Access Data Assistance Center, Integrated Health
Interview Series: Version 4.0. Minneapolis: University of Minnesota 2011. For general information, see
http://www.ihis.us/ihis/.
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Center for Health Statistics (NCHS) and Centers for Disease Control and Prevention
(CDC). On average, around 42,000 households are interviewed annually since 1972.
These households contain on average around 100,000 people. The annual response rate
of the eligible households is close to 93%.5 All household members are interviewed,
with information of household members under age 18 provided by a knowledgeable
adult member of the household. The annual average conditional persons’ response rate
on the self-assessed health variable is 99.5%.6 Non-respond persons are people who re-
fused, reported not ascertained or unknown. Detailed information on the household
response rates and the conditional persons’ response rates each year from 1972 to 2010
is provided in Table 2.3 in the appendix. In addition, the IHIS constructs a variable,
person weight, representing the inverse probability of persons selected into the sam-
ple. The person weight is based on the Final Annual Weight in the original NHIS
public use files and adjusted for non-response with post-stratification adjustments for
age, race/ethnicity, and sex using the Census Bureau’s population control totals.7
The NHIS survey rates an individual’s health on a four-point scale (excellent, good,
fair, or poor) for 1972-81 and a five-point scale (excellent, very good, good, fair, or
poor) from 1982 until now. We define the health status index in the way that people
are classified to be healthy unless they report “poor” or “fair.” Accordingly, we define
Hj,x,t = 1 when respondent j belonging to age group x in year t reports a “bad” health
condition (“poor” or “fair”), and Hj,x,t = 0 otherwise. The Health Status Index of
age class x in year t (πx,t) is estimated as follows, using the IHIS constructed variable










where Nx,t denotes the number of persons in age class x in year t.
In our analysis, we use data over the period 1972-2010 on males and females sepa-
rately, where the groups are age classes ranging from age 0 to age 85+, where the age
class 85+ consists of the individuals of age 85 and higher.8 We exclude individuals
with response “unknown”, which is only a very small proportion of the entire sur-
5The NHIS reports that non-response households are those were not interviewed due to reasons
including refusal, no one is home after repeated contact attempts, unacceptable partial interviews, or
other reasons for no interview.
6The conditional persons’ response rate is the ratio of the number of interviewed persons who pro-
vide health information to the number of interviewed persons.
7See https://www.ihis.us/ihis/userNotes_weights.shtml
8The variable “Health status,” downloaded from the website https://www.ihis.us/ihis-action/
variables/group/health_general, presents aggregated information from 1996 onwards (1996: 90+,
1997 and later: 85+. For this reason we also aggregate the data over the ages 85+ for the years 1972–
1995.
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vey sample.9 The IHIS reports that the relative frequency of responses more favorable
than “fair,” i.e., combining “excellent,” “very good,” and “good” versus combining
“excellent” and “good,” is similar before and after 1982. This motivates our choice of
constructing the health status index, with the aim to avoid a systematic shock because
of the change of reported health categories.10
Figure 2.1 – Description of the Health Status Index in the U.S.
Data Source: Minnesota Population Center and State Health Access Data Assistance
Center, Integrated Health Interview Series: Version 4.0. Minneapolis: University of
Minnesota, 2011.
Note: The left graph shows the average bad health condition as a function of age aver-
aged over time. The right graph shows the average bad health condition as a function
of time averaged over age.
Figure 3.3 describes the average health status index over age (left graph) and over
time (right graph) for both males and females.11 As our health status index represents
people’s “bad” health, its growing patterns over age are expected. This indicates that,
in general, people’s health condition is getting worse as people age. Over time, we first
see a decreasing and then a slightly increasing trend, implying that health changes are
not just trended in one direction as time goes on.
2.3.2 Observed variables
It is well documented that population health is associated with the macroeconomic
condition (see, e.g., Toffolutti and Suhrcke (2014), García-Muñoz, Neuman, and Neu-
man (2014), Baird, Friedman, and Schady (2011), Ruhm (2000), and Harvey Brenner
(1979), to name a few). For instance, García-Muñoz, Neuman, and Neuman (2014)
9For males 0.53% and for females 0.54% are unknown.
10As part of the sensitivity analysis, we investigate whether there are systematic differences when
using the whole sample, or only the subsample 1982–2010.
11The average health status index over age is calculated based on the total number of respondents
among all the survey years. Similarly, the average health status index over time is calculated based on
the total number of respondents at all ages.
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find that self-reported health is largely affected by GDP per-capita. Ruhm (2004) and
Ruhm (2003) suggest that higher income reduces the risk of morbidity and functional
limitations. As for the effect of unemployment on health, the literature presents mixed
evidence. On the one hand, a higher unemployment rate may result in reduced income
and the loss of health insurance (see Cawley, Moriya, and Simon (2011)). This happens
particularly in a country like the United States, in which workers receive health in-
surance coverage as employee benefits. The U.S. Census Bureau report Employment-
Based Health Insurance: 201012 states that 56.5% of the U.S. population in 2010 relied
on employment-based health insurance. This means that many working adults will
lose health insurance once unemployed, and hence, will have limited access to health-
care (see Quinn, Catalano, and Felber (2009) and Catalano and Satariano (1998)). Con-
sistent with that, Tefft and Kageleiry (2014) find that preventive healthcare decreases
when unemployment increases. On the other hand, as argued by e.g., Ruhm (2000),
unemployment might also positively affect people’s health. This could occur, for ex-
ample, when unemployment reduces job stress, or allows for more leisure and healthy
behavior. Given this empirical evidence, we investigate whether GDP and unemploy-
ment rate can capture part of the trend in health.
We obtain these two macroeconomic variables from the Organisation for Economic
Cooperation and Development (OECD) Statistics Extracts (the Country Statistical Pro-
files, 2010). The sample period is 1972-2010. GDP per capita is in real terms corrected
by the inflation based on the year 2000. The in-sample evolutions of these two vari-
ables’ are presented in Figure 3.5. Over the past 39 years, GDP per capita has a gener-
ally increasing trend, while the unemployment rate clearly fluctuates over time, with
clear upward peaks around 1975, around 1982-1983, around 1992, around 2003, and
around 2010. We shall examine whether these macroeconomic quantities will help to
capture the trend in health, in addition to the latent time variable in the Lee-Carter
model.13
12Report is available from the website http://www.census.gov/prod/2013pubs/p70-134.pdf
13In the sensitivity analysis in Section 2.6.3, we also investigate the performance of two life-style re-
lated variables, alcohol and tobacco consumption.
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Figure 2.2 – Description of macroeconomic variables.
Note: The left graph describes the real GDP per capita in dollars, corrected by inflation.
The right graph describes the total unemployment rate, as a fraction of the total labor
force.
2.4 Model estimation
In this section, we present first the estimation results of the original Lee-Carter model
(subsection 2.4.1), and then the results of its extended version with GDP and unem-
ployment rate included (subsection 2.4.2).
2.4.1 Modeling health using the Lee-Carter model
In this subsection, we present the estimation results of the original Lee-Carter model
for health, see equation (2.1). Figures 2.3 and 2.4 show the estimates for males and
females, respectively. Each figure contains four panels. The upper left panel shows the
estimated α̂x, the upper right panel the estimated β̂x, the lower left panel the estimated
κ̂t adjusted according to (2.5), and the lower right panel the estimated residuals. As
irregular shapes of the estimated α̂x and β̂x across age groups are usually not expected,
we in addition show the smoothed estimates using B-splines, see Currie, Durban, and
Eilers (2004).
For both males and females, besides the first 15 years in life, the increasing shape
of estimated α̂x (upper left panels) indicates that on average people’s health is getting
worse as people age. The estimated κ̂t-s (left lower panels) are first declining, but then
slightly trending up, indicating that the proportion of people in bad health has a de-
creasing trend over time, except for the last 10 years. Furthermore, the estimated β̂x-s
(upper right panels) show that the young are more sensitive to the time trend than the
elderly. A simple and quick visual check of the model validity is to see whether the
estimated residuals follow more or less a random pattern. In the lower right panels,
the estimated residuals for both males and females indeed do not show a clear system-
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atic structure, looking reasonably random. Nevertheless, for both males and females
there seems to be a “line” separating the 1972–1981 period from the 1982–2010 period,
suggesting a break between these subperiods. This likely corresponds to the survey
design changes from the four-point to the five-point scale of individual health report
since 1982. In Section 2.6.2, we present the estimation results for the subperiod 1982–
2010, and show that there are no systematic differences between the whole sample
period and this subperiod.
Figure 2.3 – Estimates of the Lee-Carter model for males.
Note: The upper left panel shows the non-smoothed and smoothed α̂x. The upper right
panel shows the non-smoothed and smoothed β̂x. The lower left panel shows κ̂t. The
lower right panel shows the estimated residuals.
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Figure 2.4 – Estimates of the Lee-Carter model for females.
Note: The upper left panel shows the non-smoothed and smoothed α̂x. The upper right
panel shows the non-smoothed and smoothed β̂x. The lower left panel shows κ̂t. The
lower right panel shows the estimated residuals.
2.4.2 Modeling health with macroeconomic variables
In this section, we present the estimation results of the Lee-Carter model including the
two macroeconomic variables, namely, GDP per capita in logarithmic form and the
unemployment rate. The estimates of αx and βx are quite similar to the original Lee
and Carter model, as presented in subsection 2.4.1, and therefore not reported. The
plots of the residuals (also not reported) again do not reveal systematic patterns (other
than the line separating the pre-1981 from the post-1982 period). Figure 2.5 presents
the estimated ρ̃x. For both males and females, the estimated ρ̃x-s of log GDP (see left
panels) show a negative correlation between people’s bad health condition and GDP,
where this negative correlation is strongest for the young. Thus, GDP and good health
are positively correlated. The estimated ρ̃x corresponding to the unemployment rate
(see right panels) show a positive correlation between the bad health condition and
unemployment for most age classes, except for the very young and the very old. Thus,
unemployment correlates negatively with good health.
The estimated κ̃t-s, shown in Figure 2.6, seem to be stationary. The Augmented
Dickey-Fuller test suggests that κ̃t-s do not have unit roots for both genders. If κ̃t-s are
indeed stationary, this would imply that the trend in health is fully captured by the
20
STOCHASTIC MODELING AND FORECASTING OF HEALTH CHANGES IN THE U.S.
POPULATION
macroeconomic fluctuations.
Figure 2.5 – Transformed ρx (i.e., ρ̃x) in the extended Lee-Carter model.
Note: ρ̃x-s of log GDP (left panels) and unemployment rate (right panels). The upper
panels are for males. The lower panels are for females.
Figure 2.6 – Transformed κt (i.e., κ̃t) in the extended Lee-Carter model.
Note: The left graph is for males. The right graph is for females.
Furthermore, to quantify the estimation inaccuracy, we use the bootstrap method,
see the Appendix. Figure 2.7 shows the 95% confidence intervals for the smoothed
ρ̃x-s of log GDP (left panels) and unemployment rate (right panels) for both genders,
calculated using 2000 bootstraps and allowing for age-specific σ̂2ε,x. For both males
and females, at most of the ages, the GDP has a significant effect on health, since the
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confidence intervals do not include zero, except at very high ages. However, the unem-
ployment rate does not play a significant effect for many ages. On the other hand, the
test results of the null hypothesis H0 : ρ̃ = 0 show that the included variables jointly
have a significant effect on people’s bad health.14
Figure 2.7 – Confidence intervals for smoothed ρ̃x in the extended Lee-Carter
model.
Note: Left panels: log GDP. Right panels: unemployment rate. Upper panels: males.
Lower panels: females.
We then compare the model fit for the two models of interest based on the Mean
Square Errors (MSE). Results are presented in Table 2.1. We find that, compared with
the original Lee-Carter model, the extended Lee-Carter model reduces the MSE-s by
18.0% for males, and by 19.9% for females. This leads to the conclusion that the Lee-
Carter model with GDP and unemployment rate included yields a significant improve-
ment in the model fit. Moreover, we also compare the values of the Bayes Information
Criterion (BIC). In general, a smaller BIC value is preferred. This means that extra
parameters are only included when there is a significant quality improvement of fit.
14Indeed, for males, we find for GDP as test statistic 85073 and for unemployment 274. For females,
we find for GDP as test statistic 78779 and for unemployment 128. These are all significant at the con-
ventional significance levels.
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We see that the Lee-Carter model with GDP and unemployment rate also provides the
smallest BIC values.
Table 2.1 – Comparison of model fit
Male Female
MSE(10−4) BIC MSE(10−4) BIC
Original Lee-Carter model 5.158 -6.945 4.193 -7.153
Lee-Carter model with observed variables 4.228 -7.144 3.358 -7.375
2.5 Forecasting Health
Having developed and estimated the health model, we are now ready to consider fore-
casting health. The forecasting performance of a model is an important model evalu-
ation criterion. In this section, we first address the method to forecast κt (for males
and females) and observed variables (log GDP and unemployment rate). Based on the
forecasts of these “independent” variables, the health status index is then forecasted
using both the original Lee-Carter model and the Lee-Carter model extended with the
macroeconomic variables.
In the traditional Lee-Carter approach applied to mortality data, the estimated κt
is modeled and forecasted assuming an ARIMA(p,d,q) time series method. Lee and
Carter (1992), and also many later applications, see Tuljapurkar, Li, and Boe (2000),
conclude that the dynamics of κt in the mortality context can be described as a random
walk with drift µ. This ARIMA(0,1,0) time series model is given by
κt = µ + κt−1 + et, (2.10)
where the innovation et is assumed to follow a normal distribution with mean 0 and
variance σ2e . However, in the Lee-Carter model with observed variables for health,
we propose to apply models to describe the joint dynamic evolutions of κt (or κ̃t) for
males and females, and the observed variables. We consider three models, one using
κt (males and females) and two using κ̃t (males and females). The latter two include
one assuming κ̃t is stationary and one assuming κ̃t is nonstationary. We first describe
the method of projecting κt. To indicate gender dependence we shall add a superscript
g ∈ {m, f }. For example, κgt is the κt for males if g = m and the κt for females if g = f .
To undertake an out-of-sample analysis, we subdivide the dataset into an estima-
tion period 1972-2000, and a forecasting period 2001-2010. Applying the Augmented
Dickey-Fuller test, we find evidence that κmt , κ
f
t , log GDP, and unemployment rate
are all I(1) processes, while their first differences are stationary over the estimation
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period 1972-2000.15 Therefore, we model the first differences ∆Kt ≡ Kt − Kt−1 and










= C + ΘYt−1 + νt, (2.11)
where C is a (4 × 1) parameter vector, Θ is a 4 × 4 coefficient matrix, and νt is a 4-
dimensional vector of white noise terms with means zero and covariance matrix Σν.
Results of the VAR model estimation are shown in Table 2.4 in the Appendix. Using
the VAR model, we are able to predict Yt+h, conditional on Yt at time t. That is
Ŷt+h = (I − Θ̂)−1(I − Θ̂h)Ĉ + Θ̂hYt,
where Ŷt+h = (K̂t+h, Ẑt+h)′ denotes the h-period ahead forecast. Next, the forecast of











where the superscripts g ∈ {m, f } indicate the gender dependence.
Following the same principle, we employ two models to forecast health status index
using K̃t = (κ̃mt , κ̃
f
t )
′. Assuming K̃t is nonstationary, we construct a VAR model, just
like (4.12), but with ∆K̃t instead of ∆Kt. As the final model, assuming K̃t is stationary,
we use a first order Auto Regression (AR(1)) model for K̃t and a VAR model for Zt, i.e.
(4.12), but then restricted to ∆Zt.
Due to the randomness of νt in equation (4.12), process risk arises. We quantify this
process risk using simulation method as follows. Under the assumption νt ∼ N (0, Σν),
we simulate 2000 future innovations and sample paths from the multidimensional VAR
model (4.12), then construct the corresponding forecasting intervals for the indepen-
dent variables Ŷt+h (using (4.12)) and the dependent variable π̂x,t+h (using (3.10)). Be-
sides the process risk, due to the uncertainty caused by the inaccuracy of the estimated
parameters Ĉ, Θ̂, and Σ̂ν in (4.12), as well as the uncertainty in the parameters α̂x, β̂x,
ρ̂x, κ̂t, and σ̂2ε,x in (3.4), parameter risk arises. We further quantify the parameter risk
by the bootstrap method, see the Appendix for further details.
15The Augmented Dickey-Fuller test statistics are (with p-values in brackets): log GDP in levels,
−0.03(0.63), and log GDP in first differences, −2.88(0.01); unemployment in levels, −1.60(0.10), and
unemployment in first differences, −4.17(0.001); κmt in levels, −0.64(0.41), and κmt in first differences,
−4.97(0.001); κ ft in levels, −0.44(0.48), and κ
f
t in first differences, −4.41(0.001).
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Figure 2.8 – Forecasts based on the VAR model.
Note: The upper panels show forecasts for κmt (left panel) and κ
f
t (right panel). The
lower panels show forecasts for GDP (left panel) and unemployment rate (right panel).
Two confidence intervals are presented: narrower dotted curves present the uncer-
tainty with process risk, wider dashed curves present the uncertainty with both process
and parameter risks.
Figure 2.8 shows the forecasts of κmt and κ
f
t (upper panels), and log GDP and un-
employment rate (lower panels), together with their realized values (solid lines). The
realized values of κt-s are constructed from the estimated κt-s for the whole sample
1972-2010. We rescale the estimated κt series for the sample 1972-2010 such that its
value in the year 2000 is equal to the last estimated κt for the sample 1972-2000, and
its summation from 1972 to 2000 is equal to 1. The rescaled κt series (1972-2010) is
compared to the realized values. Indeed, in the upper panels, the dots, presenting the
rescaled κt-s over the period 1972-2000, are very close to the estimated κt-s for the sam-
ple 1972-2000. 95% confidence intervals from process risk only, or both process and
parameter risks in the VAR model during the out-of-sample period are shown.
Next, Figure 2.9 shows forecasts of the average health status index over time and
age for males (upper panels) and females (lower panels), together with their realized
values. In this figure, we also present forecasts with a jump-off bias correction, i.e.,
rescaling the forecast such that it starts off from the end-of-sample value without jump,
see Lee and Miller (2001) for further details. In addition, the 95% confidence intervals
from process risk only, or both process and parameter risks are presented in both fig-
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ures. When quantifying the uncertainty in the parameters from (3.4), see left panels
in Figure 2.9, we investigate two options, which either include or ignore the uncer-
tainty in σ̂2ε,x. The results show that, on average, the out-of-sample observations in the
forecasting period almost all fall into the constructed forecasted intervals.
Figure 2.9 – Health forecasts based on the extended Lee-Carter model.
Note: Average forecasts of the bad health condition over age (left panels), and over time
(right panels). The upper panels are for males. The lower panels are for females. Three
confidence intervals are presented: narrowest dotted curves present the uncertainty
with process risk, middle dashed curves present the uncertainty with both process and
parameter risks, but excluding the uncertainty in σ̂2ε,x, and the largest intervals are for
both process and parameter risks including the uncertainty in σ̂2ε,x.
To evaluate the forecasting performance of the models of interest, we use the mean
squared forecasting error (MSFE), the mean absolute forecasting error (MAFE), and
the mean forecast error (MFE), where we average the differences between the observa-
tions and the forecasts over both the age and the time dimensions. Table 2.2 presents
the forecasting accuracy for males (the first panel) and females (the second panel). The
first four rows of each panel show the forecast accuracy based on the Lee-Carter model,
and the Lee-Carter models with the two macroeconomic variables employing three dif-
ferent variants, namely, the one with a VAR-model for ∆Zt and an AR-process for K̃t
(“K̃t, AR”), the one with a VAR-model for both ∆Zt and ∆K̃t (“∆K̃t”), and the one with
a VAR-model for both ∆Zt and ∆Kt (“∆Kt”). The results show that, by including the
observed variables, the MSFE and the MAFE are clearly improved compared with the
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original Lee-Carter model, in particular for the VAR-model with Kt included (“∆Kt”).
In this case, the MSFE improves by 18.74% and 20.52% for males and females, respec-
tively. Negative signs of the MFE indicate that on average we overforecast in all cases
people’s health improvement.
Table 2.2 – Comparison of forecast accuracy
MSFE (10−4) MAFE (10−2) MFE (10−3)
Male
Original Lee-Carter 7.016 1.789 -3.191
K̃t, AR 7.000 1.842 -9.860
∆K̃t 5.721 1.613 -6.644
∆Kt 5.701 1.613 -6.646
∆Kt, Zt+h 6.347 1.650 -2.371
Female
Original Lee-Carter 7.179 1.914 -5.591
K̃t, AR 6.595 1.871 -9.478
∆K̃t 5.707 1.713 -7.503
∆Kt 5.706 1.713 -7.503
∆Kt, Zt+h 6.542 1.775 -3.949
Note: The first and the second panels are for males and females sepa-
rately.
In the Lee-Carter model with GDP and unemployment rate (collected
in Zt),
“K̃t AR”: predict with a VAR-model for ∆Zt and an AR-process for K̃t,
“∆K̃t”: predict with a VAR-model for both ∆Zt and ∆K̃t,
“∆Kt”: predict with a VAR-model for both ∆Zt and ∆Kt,
“∆Kt, Zt+h”: predict with the forecasted Kt (using the VAR model with
∆Zt and ∆Kt) and the actually observed Zt+h.
We examine an additional comparison with forecasts of the health status index us-
ing the realized values of the observed variables, i.e., we use equation (4.12) to forecast
∆Kt (untransformed), but in equation (3.10) we use the observed Zt+h, instead of the
forecasted Ẑt+h (“∆Kt, Zt+h”). In this way, we eliminate the possible error due to es-
timating Zt. However, we do not see an improvement of the forecasted π based on
the realized values of the observed variables compared with the forecasts based on the
forecasted values of the observed variables. What is noticeable is that our forecasting
period includes the years of economic crisis. The large volatilities in changes of GDP
and unemployment might be reduced if the forecasts are based on our VAR model.
As a consequence, our VAR-forecasts for K̂t+h and Ẑt+h lead to better health forecasts,
likely because health itself is a smooth process as well.
Finally, we construct a rolling window forecast to further test the forecasting power
of the original Lee-Cater model and the Lee-Cater model with the macroeconomic vari-
ables, focusing on the untransformed κt. Based on the first fitting period, 1972-2000, we
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compute 1 to 5 years ahead forecasts, 2001-2005, and determine the forecast errors by
comparing the forecasts with the actual out-of-sample data. We then move the fitting
period one year ahead, and compute again 1 to 5 years ahead forecasts, and the fore-
cast errors. This procedure is repeated 6 times, until the last forecasting year is 2010.
The lag order of the VAR model is chosen based on the AIC value in each rolling win-
dow estimation. According to the MSFE, we find quite a significant improvement of
the forecasting performance from the Lee-Carter model with the two macroeconomic
variables included compared with the original Lee-Carter model. Over the 6 rolling
window forecasts, for males, the MSFE decreases on average 23.31%, with values be-
tween at most 28.19% and at least 20.13%, and for females, the MSFE decreases on
average 21.45%, with values between at most 24.76% and at least 15.20%.
2.6 Sensitivity Analysis
This section presents a sensitivity analysis. We first examine whether a transformation
of πx,t other than the log-transformation yields an improvement in the model fit. Next,
we consider the subperiod 1982-2010, corresponding to the five-point scale of individ-
ual health report, instead of the whole period 1972–2010. Finally, we investigate two
alternative life-style related factors, namely, alcohol and tobacco consumption, instead
of, but also next to, the macroeconomic variables GDP per capita and the unemploy-
ment rate. We summarize most of the results.16
2.6.1 Different transformations of the health status index
Other transformations of πx,t than the log-transformation in equations (2.1) and (3.4)
are possible. We experiment with alternative transformations F(πx,t) to investigate
whether these could increase the quality of the model fit. We consider the logit trans-
formation (F(πx,t) = log(
πx,t
1−πx,t )), the Box-Cox transformation (F(πx,t) =
πax,t−1
a , given
a certain parameter a, see Box and Cox (1964)), and the MacKinnon and Magee trans-
formation (F(πx,t) =
H(aπx,t)
a , given a certain parameter a and with H the inverse hy-
perbolic sine transformation, see MacKinnon and Magee (1990)). We find that com-
pared with the log-transformation, these alternative choices of F(πx,t) do not result in
a significant improvement of the mean square errors. Furthermore, they provide very
similar estimates. Therefore, F(πx,t) = log(πx,t) seems to be a good choice.
2.6.2 Analysis for subperiod 1982–2010
As reported in Section 2.4, Figures 2.3–2.4, for both males and females, there seems to
be a “line” separating the 1972–1981 period from the 1982–2010 period, suggesting a
16Detailed results are available upon request from the corresponding author.
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break between these two subperiods. This break subdivides the four-point scale data
from the five-point scale data.
Therefore, we re-estimate the models, using the data of the subperiod 1982–2010 and
further compare the estimates of the models using the whole sample period 1972-2010.
Figure 2.10 shows some selected results. The left panels present both the estimated κt
for the whole period 1972-2010 (κ̂orgt ) and the estimated κt for the subperiod 1982–2010













with t′1 = 1982, the starting year of the subsample. For males (upper left panel) the
estimated κt in both the whole and the subsample are quite close, whereas for females
(lower left panel) the estimated κt in the subsample 1982–2010 seems to be somewhat
more volatile than in the whole sample. The right panels show the estimated β̂x and its
smoothed patterns for both males (upper right panel) and females (lower right panel).
The results show that besides some increasing deviation between the subsample es-
timates and the whole sample estimates at the very young age groups, estimates in
other age groups seem to be more or less similar. This deviation might be somewhat
overemphasized by the smoothing method employed.
Figure 2.10 – Selected estimates of the Lee-Carter model for health, comparing
1982–2010 with 1972-2010.
Note: Upper panels: males. Lower panels: females. Left panels: κt. Right panels: βx.
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2.6.3 The choice of other observed variables
Population health is determined by many factors interactively. Besides the macroeco-
nomic environment, there is extant evidence that health is affected by lifestyle choices.
In our sensitivity analysis, we focus on alcohol consumption and smoking. According
to Mokdad, Marks, Stroup, and Gerberding (2004) and McGinnis and Foege (1993),
these lifestyle related factors are among the most important health risk factors in the
United States. It is well-documented that smoking increases the risk of heart disease
and lung cancer (the Center for Disease Control and Prevention (CDC).17 Similarly,
there is evidence of the health risks associated with alcohol consumption. It is argued
that excessive alcohol use in the long term increases the risk of neurological, cardiovas-
cular, and psychiatric problems, and can lead to lead to cancer and liver diseases18 (see
Corrao, Bagnardi, Zambon, and Vecchia (2004) and Rehm, Gmel, Sempos, and Trevisan
(2003)). The World Health Organization (WHO (2011)) reports that almost 4% of the to-
tal deaths worldwide are caused by alcohol. This might be particularly relevant for the
United States, because the average consumption of alcohol per person aged 15 years or
older in the United States is higher than the average consumption worldwide (WHO
(2011)). Therefore, we further investigate whether tobacco and alcohol consumption
can capture trends in health. These two variables are obtained from the OECD Health
Data (2010). Alcohol consumption is the annual consumption of pure alcohol in liters
per person aged 15 years and over. Tobacco consumption is the annual consumption of
tobacco items (for example, cigarettes, cigars) in grams per person aged 15 years and
over. In the sample period 1972 to 2010, tobacco consumption has a steady decreas-
ing trend, while alcohol consumption is increasing for the first 10 years, significantly
decreasing in the following 10 years to a large extent, but then increasing again in the
latest 15 years, although with a relatively small amount.
We estimate the Lee-Cater model with alcohol and tobacco consumption, instead
of GDP and unemployment rate. We find that alcohol and tobacco consumption both
have positive effects on people’s “bad” health, reflected by the estimated transformed
ρ̃x. In addition, the estimated ρ̃x are jointly significantly different from 0. In terms of the
mean square errors, the improvements compared with the original Lee-Carter model
are 14.8% and 15.0% for males and females, respectively. However, these do not exceed
the improvements when instead including GDP and unemployment rate (18.0% and
19.9%). This means that the two macroeconomic variables capture the health trend
better than the two life-style related factors. The BIC values confirm this conclusion.19




19The BIC values are now −7.089 for males and −7.300 for females, to be compared to −7.144 and
−7.375, respectively.
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rors considerably, but the corresponding BIC values are also much higher. Therefore,
we consider the model with the two macroeconomic variables, GDP and unemploy-
ment rate included as the preferred one.
2.7 Conclusion
This paper develops a stochastic model to estimate and forecast health changes taking
uncertainty into account. A better understanding of health dynamics is important for
government policy decisions, such as the increase of the retirement age, or changes of
the health expenditure. This article makes two main contributions. First, we consider
the health dynamics as a stochastic process, and model it using the framework of Lee
and Carter (1992). We find that the Lee-Carter model fits the self-assessed health data
well for the United States. Second, we incorporate macroeconomic variables into the
Lee-Carter model to better capture the health development in addition to the latent
time factor. In this way, the health dynamics can be forecasted not only based on its
historical pattern, but also on the basis of economy changes.
To summarize our key findings, first, a latent Lee-Carter framework works well to
model health changes. Second, the Lee-Carter model with the macroeconomic vari-
ables leads to a significant improvement in the model fit. A large part of the time trend
in health can be attributed to economic trends. Moreover, as suggested by the backtest-
ing analysis, the Lee-Carter model with the macroeconomic variables significantly im-
proves the accuracy for health forecasts compared with the original Lee-Carter model.
We also conducted a sensitivity analysis. We first investigate various transformations
of the health status index other than the log-transformation. We then experiment a
subperiod analysis. Finally, alternative factors are also considered to capture the trend
in health.
As alternative factors in our sensitivity analysis, we examined smoking and alcohol
consumption. There are also other interesting factors, such as obesity. As reported
by the CDC (Fryar, Carroll, and Ogden (2012)), the percentage of adults in the United
States aged 20 years and over who are obese20 increased from around 15% to 35%
over the past 50 years. The National Institutes of Health (NIH (1998))21 and Stanford
Hospital & Clinics22 report various potential obesity related health risks, including
heart disease, diabetes, cancers, hypertension, stroke, liver and gallbladder diseases,
etc. Thus, obesity is a serious risk factor, even becoming a more serious risk factor
than tobacco (see Sturm (2002) and Mokdad, Marks, Stroup, and Gerberding (2004)).






We leave the investigation of the correlation between obesity and health for future
research.
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Appendix
Identification Lee-Carter model with observed variables
Let time t = t1, . . . , tn, age x = x1, . . . , xk, and dim(Zt) = dim(ρx) = m, where tn ≥
m + 2. We write
θa = (αx, x = x1, . . . , xk, κt, t = t1, . . . , tn) ,
θb = (βx, x = x1, . . . , xk, ρx, x = x1 . . . , xk) ,
θ = (θa, θb) ,
and
`πx,t = log(πx,t), x = x1, . . . , xk, t = t1, . . . , tn,
`π = (`πx,t, x = x1, . . . , xk, t = t1, . . . , tn) .
Theorem
• If ∑t κt = 0, ∑x βx = 1, and ∑x ρix = 1, for each i = 1, . . . , m, then
θ1a 6= θ2a ⇒ `π1 6= `π2.
• Moreover, if
A ≡ A(t̃1, t̃′1, . . . , t̃m+1, t̃′m+1)
≡

κt̃1 − κt̃′1 Zt̃1 − Zt̃′1
...
...
κt̃m+1 − κt̃′m+1 Zt̃m+1 − Zt̃′m+1
 ∈ R(m+1)×(m+1).
is having a non-zero determinant, then
θ1 6= θ2 ⇒ `π1 6= `π2.
Thus, given the imposed normalizations, the αx-s and κt-s are identified. Moreover,
if κ = (κt1 , · · · , κtn)
′ is not linearly dependent of the columns of Z = (Zt1 , · · · , Ztn)
′,
then the matrix [κ Z] will have a (m + 2) × (m + 1) sub-matrix of rank m + 1. Pre-
multiplying this sub-matrix by a (m+ 1)× (m+ 2) differencing-operator of rank m+ 1


























































































We estimate the parameters α, β, ρ, and κ in (3.4) by solving iteratively the first order
conditions resulting from minimizing







(πx,t − αx − βxκt − ρ′xZt)2.
The system of equations to be solved iteratively is obtained by setting the partial










βx(πx,t − αx − βxκt − ρ′xZt), t = t1, · · · , tn,
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Zt(πx,t − αx − βxκt − ρ′xZt), x = x1, · · · , xk.
We solve this system by using iteratively the following univariate Newton-Raphson












































































After each update, these parameters are adjusted by the normalization constraints (3.5)
and (2.4). After convergence, κ̂(r+1)t are further adjusted by fitting the total observed



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Quantifying parameter risk by the bootstrap method
To quantify the accuracy of the estimates, we apply the bootstrap method. For details
about bootstrapping in the Lee-Carter framework, we refer to Pitacco, Denuit, Haber-
man, and Olivieri (2009a), in particular pages 229-232. First, we create a matrix R of
residuals with components ε̂x,t, given by
ε̂x,t = log(πx,t)− log(π̂x,t),
where log(π̂x,t) = α̂x + β̂xκ̂t + ρ̂′xZt. From these, we generate B = 2000 replications
Rb with components ε̂bx,t, b = 1, 2, ..., B, by sampling with replacement the components
in the matrix R. We assume the residuals are independently distributed and we al-
low for heteroskedasticity by means of age-specific variances σ2ε,x. We then create the
corresponding bootstrapped logarithm of the health status index log(π̂bx,t),





Using the bootstrapped dependent variables, we re-estimate for each b the parameters,
yielding the estimates α̂bx, β̂bx, κ̂bt , and ρ̂
b
x. The confidence intervals for the estimates are
derived from the corresponding bootstrapped percentiles.
To quantify the forecasting uncertainty in the parameters from both the Lee-Carter
model with observed variables (3.4) and the VAR model (4.12), we again apply the
bootstrap method and construct the bootstrap percentile intervals for the forecasts.
The procedure is carried out as follows:
1. First, for each bootstrap b = 1, 2, ..., B, with B = 2000, we follow the same







and residuals ε̂b,gx,t from the Lee-Carter model with observed variables (3.4). g ∈
{m, f }, where g = m for males, and g = f for females.









′. In turn, we estimate ˆ̃Cb and ˆ̃Θb, and the residuals ˆ̃νbt = Yt − ˆ̃Ybt ,
where ˆ̃Ybt = (
ˆ̃Cb + ˆ̃ΘbYt−1). This also results in the variance covariance matrix
ˆ̃Σbν = Ĉov( ˆ̃νbt ).
3. To ensure that the bootstrapped residuals ν̂bt have the same variance covariance
matrix ˆ̃Σbν, the next procedure is followed. We first decompose
ˆ̃Σbν = AbDb Ab
′
,
where Db is a unique diagonal matrix with positive entries along the principal
diagonal and Ab is a unique lower triangular matrix with 1-s along the principal
diagonal. We then construct ˆ̃ubt = A
b−1 ˆ̃νbt . Next, û
b
t are generated by sampling
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t . We estimate parameters
Ĉb and Θ̂b for Ybt in the VAR model.
5. Then we generate projections Ŷbt+h, based on bootstrapped estimates Ĉ
b and Θ̂b.
The future errors ν̂bt+h are sampled from a multivariate normal distribution with
mean 0 and variance covariance matrix Σ̂bν.




x , projected κ̂
b,g
t+h, and
Ẑbt+h, we can generate the projection π̂
b,g
x,t+h based on these bootstrapped estimates
for both males and females. The future errors ε̂b,gx,t+h are sampled from ε̂
b,g
x,t .
7. Finally, the confidence intervals of forecasted Ŷt+h are constructed based on the
bootstrapped values Ŷbt+h. Similarly, the confidence intervals of forecasted π̂
g
x,t+h














































































































































































































































































































































































































































DO AMERICANS LIVE LONGER AND HEALTHIER?
FORECASTING HEALTHY LIFE EXPECTANCY BY
INCLUDING DYNAMIC EVOLUTIONS OF MORTALITY,
HEALTH, AND MACROECONOMIC VARIABLES
This Chapter is based on Yang, De Waegenaere, and Melenberg (2013a)
We study the evolution in remaining life expectancy and healthy life expectancy
of the U.S. population from 1972 to 2020, distinguished by genders. We propose a
methodology to forecast life expectancy and healthy life expectancy by incorporating
the joint future developments of age-specific mortality and health prevalence rates,
GDP, and the unemployment rate. We also quantify the uncertainties of (healthy) life
expectancy taking into account the joint evolution of mortality, health, and macroe-
conomic variables. Finally, we make a comparison with the corresponding models
without GDP and the unemployment rate or without taking into account the joint de-
velopment of mortality and health.
3.1 Introduction
One of the remarkable changes in the United States over the past century is the popu-
lation aging due to the baby boom and the unprecedented declines in mortality rates
(Robine, Romieu, and Michel (2003)). The U.S. National Vital Statistics Report, 2010 pub-
lish U.S. life expectancy for the total population by different age groups, using a period
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life table. It reports that U.S. life expectancy at birth increases from 49.24 years in 1900
to 68.07 years by 1950, and to 77.7 in the second half of the century. The continuation
of this pattern leads to a rapidly aging population. The accompanied increasing pen-
sion payment and health care spending attracts considerable attention from scholars,
policymakers, and insurers. In addition to these growing concerns in the demography
of aging, a question that is of great interest is how likely Americans are living longer
with higher quality lives. Therefore, besides life expectancy, which measures the aver-
age remaining years of life a person can expect to live, healthy life expectancy (HLE)
is increasingly recognized by researchers as a measure of the quality of life. It mea-
sures the expected remaining years of life in good health for persons at a given age
and time. Estimates of healthy life expectancy (HLE) are available in many developed
and developing countries (Jagger, Barberger-Gateau, and Robine (2005)) and focus on
multiple dimensions of health, such as disability, physical functioning, disease preva-
lence, and self-assessed health (Crimmins, Hayward, Saito, and Kenkyūjo (1996) and
Laditka and Laditka (2002)). Combined with life expectancy, healthy life expectancy
has been used to study issues related to living longer and improving the quality of life
(van de Water, Perenboom, and Boshuizen (1996)). Moreover, it is particularly impor-
tant to distinguish gender differences in the progress of (healthy) life expectancy, as
patterns of mortality and health are not exactly the same for males and females (see,
for example, Van Oyen, Cox, Jagger, Cambois, Nusselder, Gilles, and Robine (2010)
and Van Oyen, Nusselder, Jagger, Kolip, Cambois, and Robine (2013)).
Sullivan (1971) proposed a method to estimate healthy life expectancy. He devel-
oped the concept of combining health prevalence data with mortality data in a period
life table to measure healthy life expectancy. To apply Sullivan’s method, one needs
data from cross-sectional surveys or population censuses. Such data set is typically
easy to obtain. Due to the often large sample sizes of these health surveys, they gener-
ally produce highly reliable estimates of age-specific prevalence. In addition, Sullivan’s
method is straightforward to apply, having many extensions, see, for example, Molla,
Wagener, and Madans (2001), Manton, Gu, and Lamb (2006b), and Imai and Soneji
(2007a). A detailed manual for applying Sullivan’s approach is available in Jagger,
Cox, Le Roy, and the EHEMU team (2006).
In this paper, we study the future (healthy) life expectancy, employing the approach
by Sullivan (1971), by taking into account the joint development of mortality, health,
and two macroeconomic variables, namely real GDP per capita and the unemploy-
ment rate. Moreover, uncertainties of future developments in (healthy) life expectancy
are quantified. In particular, the paper not only quantifies the uncertain development
of mortality, like most of the other literature does, but also quantifies the joint un-
certain evolutions of mortality and health, in combination with real GDP per capita
and the unemployment rate. We consider macroeconomic variables in this study be-
cause those factors may help to predict the development of health and mortality, see
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for instance, Van Oyen, Cox, Jagger, Cambois, Nusselder, Gilles, and Robine (2010),
Thorslund, Wastesson, Agahi, Lagergren, and Parker (2013), Yang, De Waegenaere,
and Melenberg (2013b), Niu and Melenberg (2014), and Liu, Arai, Kanda, Lee, Glasser,
and Tamashiro (2013). In our study we use U.S. data from 1972 to 2010. We model
mortality and health adopting the method introduced by Yang, De Waegenaere, and
Melenberg (2013b), who include observed variables in the Lee and Carter (1992) frame-
work to model health. We predict the joint future dynamics of the variables of interest
using a vector autocorrelation (VAR) model.
Another method commonly adopted to derive healthy life expectancy is the mul-
tistate life table method, which is proposed by Schoen and Woodrow (1980). Differ-
ently from Sullivan’s approach, a multistate life table method allows for recovery from
certain health conditions (for example, from unhealthy to healthy). However, such a
method requires a longitudinal data set, which is typically difficult to get. Further-
more, many researchers including Hayward and Grady (1990), Crimmins, Hayward,
and Saito (1994), Crimmins, Hayward, Saito, and Kenkyūjo (1996), and Laditka (1998)
pointed out that because the longitudinal data set is often collected every one, two, or
even four to five years, health transitions may happen over relatively long time inter-
vals only (for example, the National Long Term Care Survey in the United States). For
these reasons, many researchers apply Sullivan’s method. Comprehensive reviews on
healthy life expectancy studies are provided by Laditka and Laditka (2002), Robine,
Romieu, and Michel (2003), and Laditka and Laditka (2009).
In many studies, forecasts of healthy (or disability free) life expectancy allow changes
in future mortality rates, but assume that future health remains constant or has differ-
ent deterministic scenarios, see, for example, Jagger, Matthews, Spiers, Brayne, Comas-
Herrera, Robinson, Lindesay, and Croft (2006), Jacobzone (2000), and Manton, Gu, and
Lamb (2006a). A disadvantage of such deterministic forecast methods is that they do
not provide any information regarding the likelihood of future health changes (Jag-
ger, Cox, Le Roy, and the EHEMU team (2006) and Van Baal, Peters, Mackenbach, and
Nusselder (2013)). Papers that apply a stochastic approach include Majer, Stevens,
Nusselder, Mackenbach, and van Baal (2012) and Van Baal, Peters, Mackenbach, and
Nusselder (2013) who use Lee and Carter (1992) framework for the Dutch population
and also provide corresponding prediction intervals. Majer, Stevens, Nusselder, Mack-
enbach, and van Baal (2012) derive projections of disability-free life expectancy and
Van Baal, Peters, Mackenbach, and Nusselder (2013) model differences in (healthy) life
expectancy due to differences in educational levels. Our approach differs from these
approaches in that we model the developments of aggregated health and mortality, in
combination with important macroeconomic determinants.
As discussed by Yang, De Waegenaere, and Melenberg (2013b), extending the Lee
and Carter (1992) by including observed macroeconomic quantities has some advan-
tages. In particular, capturing the time variation by macroeconomic variables might
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result in more precise model-based forecasts, if these macroeconomic variables are
able to capture most of the time variation. Without such macroeconomic variables
the trend in the Lee and Carter (1992) model is fully captured by a latent time vari-
able. This might result in some overfitting in order to capture the trend as good as
possible. The latent time variable will then be more volatile than the macroeconomic
variables, potentially resulting in wider model-based forecast intervals. See also Niu
and Melenberg (2014). In addition to these advantages, in our model the time varia-
tion in mortality and health are both captured to a large extent by the macroeconomic
variables. This implies that we do not only capture the correlation between the time
variation in mortality and health via the residuals, as in, for example, Majer, Stevens,
Nusselder, Mackenbach, and van Baal (2012), but also directly via the common time
varation in the macroeconomic variables. This will avoid deviating trends.
The remainder of this paper is organized as follows. The methodology applied in
this paper will be introduced in the next section. The data used will be presented in
Section 5.3. Next, Section 3.4 shows the empirical results of our study on (healthy) life
expectancy, focusing on newborns and 65 years old using data from 1972 to 2010 and
presenting forecasts to 2020 in the United States, distinguished by genders. Finally, the
paper concludes in Section 5.5.
3.2 Methodology
This section illustrates the methodology we use to estimate and forecast life expectancy
and healthy life expectancy.
3.2.1 Life Expectancy and Healthy Life Expectancy
Our starting point is the (raw) central death rate mx,t for a cohort born in year t − x
over a one year age interval [x, x + 1). Next, let qx,t be the one year death probability
of age class x at time t (i.e., the time t conditional probability of death within an age
interval of length one, given that an individual at age x survived up to age x. We can
approximate qx,t on the basis of mx,t as (see Molla, Wagener, and Madans (2001)),
qx,t =
mx,t
1 + (1− ax,t)mx,t
, (3.1)
where ax,t is the average proportion of years lived in the age interval [x, x + 1) among
those who are alive at age x but die within 1 year. Using the one year death probabili-
ties qx,t, we define the τ year survival probabilities τ px,t as







, τ ≥ 1.
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Life expectancy is then given by
LEx,t = ∑
τ≥0
(τ+1px,t + τ px,tqx+τ,t+τax+τ,t+τ) . (3.2)
If, in this equation, we set qx+τ,t+τ = qx+τ,t, for all τ ≥ 0, then we use the one year
death probabilities that can be obtained from the period life table at time t. If, on the
other hand, each qx+τ,t+τ is the one year death probability applying to age class x + τ
at year t + τ, then the life expectancy is based on a cohort life table. In this paper, we
calculate life expectancy on the basis of cohort life tables.
Next, let πx,t ∈ [0, 1] represent the health status index of age class x in year t, i.e.,
the fraction of the subpopulation of age class x that is in “poor health” in year t. The
fraction in “good health” is then given by 1− πx,t. In our analysis of healthy life ex-




(1− πx+τ,t+τ)× (τ+1px,t + τ px,tqx+τ,t+τax+τ,t+τ) . (3.3)
Similar to life expectancy, we shall calculate healthy life expectancy on the basis of
cohort life tables. Thus, each πx+τ,t+τ is the health status index applying to age class
x + τ at year t + τ.
In these equations qx+τ,t+τ and πx+τ,t+τ, τ ≥ 1, refer to future one year death proba-
bilities and future health status indices from the perspective of year t. We shall consider
these quantities to be random at time t. As a consequence, both life expectancy LEx,t
and healthy life expectancy HLEx,t will be random variables at year t. In the sequel,
we shall present “best estimates” of these quantities at time t, with corresponding con-
fidence intervals.
3.2.2 Modeling and jointly forecasting mortality and health
A cohort life table method requires a very long data period, a large part of which typ-
ically has to be forecasted. When determining life expectancy, existing studies have
taken into account the uncertain development of future mortality. However, few stud-
ies concentrate on forecasting both life expectancy and healthy life expectancy, while
accounting for the uncertainty in the health development and the uncertainty in the
joint evolution of mortality and health. We apply a methodology that allows to incor-
porate the joint movement of mortality and health, based on Yang, De Waegenaere,
and Melenberg (2013b), who study the development of health, also including the joint
development with real GDP per capita and the unemployment rate. In this section,
we first describe the model used to capture the development of mortality and health,
then introduce a prediction approach which allows to capture the joint developments
of mortality, health, GDP, and the unemployment rate.
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In the mortality literature, the approach proposed by Lee and Carter (1992) is well
documented and widely used. Recently, Yang, De Waegenaere, and Melenberg (2013b)
applied the Lee-Carter framework to model the trend in health. They also extended
this model by incorporating economic variables. They found that the macroeconomic
variables included, namely real GDP per capita and the unemployment rate, are able to
capture a large part of the health trend instead of the single latent variable in the orig-
inal Lee-Carter model. In this paper, we adopt Yang, De Waegenaere, and Melenberg
(2013b) to model the trends in both mortality and health.
To describe the Lee-Carter model (for either males or females) with observed vari-
ables included, let ycx,t denote either the mortality rate mx,t, if c = m, or the health
prevalence ratio πx,t, if c = π, at age x and year t of a cohort born in year t− x, and let
Zt be an m-dimensional vector containing the components of observed macroeconomic
variables. In our case, m = 2 and the included macroeconomic variables are logarithm
of real GDP per capita and the unemployment rate. In the Lee-Carter framework, we










′Zt + εcx,t. (3.4)
In this decomposition, αcx describes the time-independent level of mortality or health
as a function of age x, κct is a time-dependent univariate latent variable and repre-




over time, βcx describes the age group-




ρcx,1, · · · , ρcx,m
)′
is an
m-dimensional age group-specific parameter vector, containing the coefficients corre-
sponding to the components in Zt, and εcx,t is the error term, reflecting idiosyncratic
time- and group-specific influences, with mean 0 and (possibly group-specific) vari-
ance σ2x,c(εcx,t).
As discussed by Yang, De Waegenaere, and Melenberg (2013b), certain constraints





κct = 0, ∑
x
βcx = 1, ∑
x
ρcx,i = 1, for each i = 1, . . . , m. (3.5)





over time. The second one implies that βcx represents which fraction (over all
groups) of the change in κct is captured by group x.
1
We choose the logarithm transformation as the functional form F for both the cen-
1As argued by Cairns, Blake, Dowd, Coughlan, Epstein, Ong, and Balevich (2007) and Pitacco, De-
nuit, Haberman, and Olivieri (2009a), the first constraint is a natural choice, whereas other choices of the
second constraint have no impact on the quality of the fit, nor the model forecasts. Other constraints can
be found in the literature, for instance, Wilmoth (1993) employs ∑x (βcx)2 = 1. For uniquely identifying
ρcx, Yang, De Waegenaere, and Melenberg (2013b) propose to include the third constraint and normalize
the components of the vector Zt such that they have mean 0 and variance 1.
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tral mortality death rate (mx,t), as Lee and Carter (1992) suggested, and for the health
prevalence ratio (πx,t), namely F (yc) = log (yc). Based on a sensitivity analysis Yang,
De Waegenaere, and Melenberg (2013b) show that other investigated functional forms
for πx,t do not provide better estimations and forecasts than the log-transformation.
The Lee-Carter model with observed variables included can be estimated under the
Newton-Raphson procedure, generalized by Renshaw and Haberman (2006). For de-
tails we refer to Yang, De Waegenaere, and Melenberg (2013b).
To predict mortality and health, we first need to predict all the time components
associated with mortality and health in the described Lee-Carter framework with ob-
served variables, namely κm, κπ, and the observed variables. Including Lee and Carter
(1992), most studies, see for instance Tuljapurkar, Li, and Boe (2000), use time series ap-
proaches to model and predict the future dynamics of κmt . In this paper, we adopt the
Vector Autocorrelation (VAR) model to fit and predict the interdependence of the four
time components of interest, namely κm, κπ, and the observed variables. Then, based
on the forecasts of these independent variables from the VAR model, future values of
the dependent variables m and π can be forecasted using the Lee-Carter model ex-
tended with the macroeconomic variables, see equation (3.4). Finally, we can construct
a cohort life table from the observed and predicted mortalities. Moreover, (healthy) life
expectancy can be derived following the process presented in section 3.2.1.
Because components in the VAR model need to be stationary, before applying a VAR
model, we first have to test whether or not these variables, or their dth order differences
if these are going to be included, are stationary processes. Let Kt denote a vector with
components κmt and κ
π
t , then Dd(Kt) and Dd(Zt) represent the d
th order difference of
the vectors Kt and Zt, respectively. The subscript d will be omitted when d = 1. If
our four variables of interest are stationary processes after taking the dth differences, a










ΘiYt−p + νt, (3.6)
where p is the number of lags included, C in our case is a (4× 1) parameter vector of
constant, Θi in our case is a 4× 4 coefficient matrix, and νt in our case is a 4-dimensional
vector of white noise terms with means zero and covariance matrix Σν. The lag length p
can be determined by the three most common information criteria, namely the Akaike
(AIC), Bayesian (BIC) and Hannan-Quinn (HQIC) information criteria. The values can
be calculated as follows,
AIC(p) = −2LLF + 2N, (3.7)
BIC(p) = −2LLF + 2N log(T), (3.8)
HQIC(p) = −2LLF + 2N log(log(T)), (3.9)
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where LLF is the value of the loglikelihood function with in our case N = 4 + p42 +
4(4+1)
2 as the number of parameters. The process is to estimate VAR(p) models with
orders p = 0, . . . , pmax accordingly, the value of p with the lowest AIC, BIC, or HQIC
will be selected. A detailed discussion on the application of model selection criteria in
VAR models is provided in chapter four in Lutkepohl (1991).
Once the parameters in the VAR(p) model are estimated, we are able to derive the
point predictions for the four time series of interests s period ahead, conditional on Yt
at time t, that is Ŷt+s = (Dd(K̂t+s), Dd(Ẑt+s))′. In turn, the forecasts of log(ŷcx,t+s) can













, c = m, π. (3.10)
Cohort life tables can be constructed at this point, from which “best estimates” of
(healthy) life expectancy (and corresponding confidence intervals) can be computed.
We construct confidence intervals around LEx,t and HLEx,t, by taking into account
two common uncertainties created from the VAR model. One is associated with ran-
domness of νt in equation (5.2), to which we shall refer as process risk. The other un-
certainty is so-called parameter risk, which is present due to the inaccuracy of estimated
model parameters in equation (5.2). In addition, we take into account measurement risk,
i.e., the risk due to εcx,t in (3.4) for both mortality (c = m) and health (c = π).
2.
3.3 Data description
In this section, we describe the data, namely the development of U.S. mortality, self-
assessed health status, real GDP per capita, and the unemployment rate. For self-
assesssed health and for the two macroeconomic variables, we use the same data as in
Yang, De Waegenaere, and Melenberg (2013b). For completeness, we include a brief
description of these data.
3.3.1 Mortality
This study obtains the consecutive annual cross-sectional mortality rate from 1972 to
2010 for the U.S. population from the Human Mortality Database (HMD)3. HMD is
a collaborative project, involving research teams of the Department of Demography
at the University of California, Berkeley, and of the Max Planck Institute for Demo-
graphic Research. It contains detailed annual age-specific mortality rates (mx,t), which
are defined as the ratios of the number of deaths to the total number of person-years
2Contrary to Yang, De Waegenaere, and Melenberg (2013b) we do not include parameter risk gener-
ated by the parameters in (3.4)
3The website of Human Mortality Database is http://www.mortality.org/.
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where Dx,t is the number of deaths and Ex,t is the corresponding exposure (number of
person-years).
In our study, the mortality rate consists of all males or all females in the U.S., at age
x, with x ∈ {0, 1, · · · , 110+}, where 110+ stands for the age category of age 110 and
higher. Figure 3.1 shows the time pattern of the log central mortality rates for three
age classes (age 25, 55, 85) in the examined period, for males (left panel) and females
(right panel). The levels of the curves for females are lower than the corresponding
curves for males. Figure 3.2 shows the percentage change in the log central mortality
rates over the years 1972 to 2010 for all ages between 0 and 100 years. The relative
change for males is higher (in absolute values) than the relative change for females for
most age classes up to 90 years. Moreover, for males the relative change (in absolute
values) is highest for the youngest and the elderly in the age range 70–90. For females
the relative increase (in absolute value) is highest for the youngest and around age 90.
Figure 3.1 – Description of the central mortality rate in the U.S.
Data Source: Human Mortality Database (HMD), see http://www.mortality.org/
The log central mortality rate over time (1972–2010) for three ages: 25, 55, 85. Left
panel: males; right panel: females.
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Figure 3.2 – Relative change in log central mortality rate in the U.S.
Data Source: Human Mortality Database (HMD), see http://www.mortality.org/
The relative change in log central mortality rate between 1972 and 2010, as function of
age.
3.3.2 Self-reported health
Self-assessed health is a simple subjective measure of health that provides an ordinal
ranking of perceived health status. As discussed in Yang, De Waegenaere, and Me-
lenberg (2013b) it is a commonly used measure of health. Current research studied the
relationship, for instance, between self-assessed health and social economic status, (see
Smith (1999), Contoyannis, Jones, and Rice (2004), Robine, Romieu, and Michel (2003)),
and the relationship between health and life styles (see Contoyannis and Jones (2004)
and Crimmins, Hayward, and Saito (1994))
The National Health Interview Survey (NHIS) is the principal nationally-representative
source of data on health of the civilian noninstitutionalized population in the United
States. It provides the consecutive annual cross-sectional self-assessed health status of
individuals from newborn to age class 85+ at the national level.4 We use the annual
data from 1972 until 2010. Throughout each year, survey respondents are asked to rate
their health with the conditions of “excellent,” “very good,” “good,” “fair,” or “poor.”
In this paper, the health status index defines the fraction of the population with a par-
ticular health status (“good” or “bad”) at a particular age in a certain year. Following
Yang, De Waegenaere, and Melenberg (2013b), we choose to cluster “poor” and “fair”
health status as “bad” health condition, and the three other categories as “good” health
condition. 5
4Minnesota Population Center and State Health Access Data Assistance Center, Integrated Health
Interview Series: Version 4.0. Minneapolis: University of Minnesota, 2011. The health data were down-
loaded as the variable “Health status” available from the website https://www.ihis.us/ihis-action/
variables/group/health_general.
5See Yang, De Waegenaere, and Melenberg (2013b) for further motivation. Moreover, although such
an aggregation method may remove some potential information, it avoids the problem caused by the
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Let πx,t denote the health status index for a group with age x at time t with a par-
ticular health condition, adjusted for the inverse probability of a person being selected










where Nx,t represents the total number of survey respondents of group x, Hj,x,t is a
zero-one indicator of particular health condition for the jth respondent in this group,
and wj,x,t is the person weight. A more detailed description of the self-assessed health
data, including response rates and person weight can be found in Yang, De Waege-
naere, and Melenberg (2013b), section 3.1. In this study, we define Hj,x,t = 1 when
respondent j reports a “bad” health condition (“poor” or “fair”), and Hj,x,t = 0 oth-
erwise. Therefore, the health status index representing the fraction of the population
who reports a particular condition of health, reflects the overall health level of the age-
specific population in a given year. In our application, the population groups consist
of all males or all females in the U.S., and a group x consists of all individuals in this
population at age x, with x ∈ {0, 1, · · · , 84, 85}, where 85 stands for the age category
85+.
Figure 3.3 describes the health status index averaged over age (π̄.,t, see the left panel)
and averaged over time (π̄x,., see the right panel), distinguished by genders. Moreover,
Figure 3.4 presents the percentage change in the log health status index over the years
1972 to 2010 for all ages (from age 0 to age class 85+ years). As expected, π̄.,x, which
represents people’s “bad” health, has upward trends over age. This indicates that peo-
ple’s health condition is getting worse as people age in general. Over time, health
trends are more volatile than mortality as shown in Figure 3.1. However, the rela-
tive increase (in absolute values) seems to be more evenly spread over the various age
classes (see Figure 3.4). On average, females report a worse health status than males.
This difference seem to be due to the difference between around age 15 and age 55.
small numbers found in the worst category, even in the highest age groups (Bebbington and Shapiro
(2006)).
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Figure 3.3 – Description of the Health Status Index in the U.S.
Data Source: Minnesota Population Center and State Health Access Data Assistance
Center, Integrated Health Interview Series: Version 4.0. Minneapolis: University of
Minnesota, 2011.
The fraction in the population, who are in bad health condition averaged over age (π̄.,t,
see the left panel) is calculated based on the total number of respondents at each age
group x.
The fraction in the population, who are in bad health condition averaged over time
(π̄x,., see the right panel) is calculated based on the total number of respondents in each
survey year.
Figure 3.4 – Relative change in log health status index in the U.S.
Data Source: Minnesota Population Center and State Health Access Data Assistance
Center, Integrated Health Interview Series: Version 4.0. Minneapolis: University of
Minnesota, 2011.
The relative change in log central health status index between 1972 and 2010, as func-
tion of age.
3.3.3 Observed variables
As in Yang, De Waegenaere, and Melenberg (2013b), economic variables are taken into
account when modeling health and mortality changes. We employ two macroeco-
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nomic variables, namely gross domestic product per capita (GDP) corrected by infla-
tion and the total unemployment rate in the United States. These are obtained from the
Organization for Economic Cooperation and Development (OECD) Statistics Extracts
(the Country Statistical Profiles, 2010).
Figure 3.5 describes the in sample evolution from 1972 to 2010 of the two macroe-
conomic variables, with the left panel for GDP per capita and the right panel for the
unemployment rate (in %). GDP per capita, measured in U.S. dollar at constant prices
(with OECD base year 2005), is trending upward over the examined years. OECD
Statistics defines the total unemployment rate as the ratio of people out of work and
actively seeking it to the population of working age either in work or actively seek-
ing it. In the United States, the minimum age for employment set by the Fair Labor
Standards Act (FLSA) is 14 years old. The OECD, therefore, provides the total unem-
ployment rate for the U.S. working age population aged 15 years and over, all raw and
seasonally adjusted. The right panel of Figure 3.5 shows the in-sample development of
the total unemployment rate from 1972 to 2010 with an average 6.32% over years, the
minimum 4% in 2000, and the maximum 9.7% in 1982.
Figure 3.5 – Description of macroeconomic variables.
Note: Data Source: OECD.Stat Extracts, see http://stats.oecd.org/
The left graph describes the GDP per capita in US dollars in base year 2005. The right
graph describes the total unemployment rate for working age group 15 years and older.
3.4 Empirical Results
This section presents the empirical results in terms of the remaining (healthy) life ex-
pectancy for the newborns and 65 year olds from 1972 to 2020. We first present the
estimates related to modeling mortality and health, based on which future mortal-
ity and health are predicted. We then show the developments of life expectancy and
healthy life expectancy for males and females from several aspects. In the next section,
we also compare the results from the presented model with other alternative models,
which either do not take into account the macroeconomic variables, or do not model
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time components jointly.
3.4.1 Estimation results for mortality and health
Following the methodology described in section 3.2.2, we estimate both the Lee-Carter
model with observed variables for mortality and for health, including real GDP per
capita and the unemployment rate as observed variables, and using in both cases for F
the log-transformation. Figure 4.8 and Figure 4.9 (see Appendix) present the estimates
for male and female mortality and health respectively. We show the original estimates
of the parameters, as well as their smoothed variants. Following Yang, De Waegenaere,
and Melenberg (2013b), we present the transformed estimates of κct (and ρ
c
x), c = m, π,
such that the transformed κct is orthogonal to Zt, the observed variables the logarithm
of real GDP per capita and the unemployment rate. See equations (7)–(9) in Yang,
De Waegenaere, and Melenberg (2013b). The transformed κct for both c = m and c = π
do not show a clear trend anymore, suggesting that real GDP per capita and the unem-
ployment rate are able to capture most (if not all) of the trend in mortality and health.
The coefficients ρcx of the log real GDP per capita are negative for most age classes for
both c = m and c = π, meaning that an increase in real GDP per capita has a positive
correlation with “survival” and “good health.” The coefficients ρcx of unemployment
rate are also negative for most age classes for mortality (c = m), but the smoothed ρcx
of unemployment rate for health (c = π) are negative for the very young and very
old, and positive other age classes (in terms of signs). This means that an increase in
unemployment has a positive correlation with “survival”, a positive correlation with
“good health” for the very young and very old, but a negative correlation with “good
health” for people at other age groups.
The (non-transformed) time variables κmt for mortality and κ
π
t for health are com-
bined with log real GDP per capita and the unemployment rate in a Vector Autore-
gression (VAR) to model and forecast their joint developments. First, as indicated by
the Augmented Dickey-Fuller (ADF) tests, κmt , κ
π
t , and log real GDP per capita are I(1)
processes. We therefore choose the first differences (d = 1) of these three variables to
achieve a stationary VAR(p) process in equation (5.2). We also include the difference
(instead of the level) of the unemployment rate. Thus, we consider D(Kt) = Kt − Kt−1
and D(Zt) ≡ Zt − Zt−1. To determine p, models with p = 0 up to and including
pmax = 4 are estimated and their values in terms of three information criteria are com-
pared. Our results show that for both genders, both AIC and HQIC suggest p = 3,
whereas BIC suggests p = 0. In the sequel, we consider a VAR(3) specification. A






= C + Θ1Yt−1 + Θ2Yt−2 + Θ3Yt−3 + νt, (3.13)
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Table 3.1 and Table 4.1 (see Appendix) present the estimates of the VAR(3) models for
males and females. We further use these estimates to forecast in the next section.
3.4.2 “Best estimates” life expectancy and healthy life expectancy
To compute the “best estimates” of life expectancy and healthy life expectancy until
2020, we need to construct “best estimates” of the cohort life tables with the first one
starting in the earliest sample year 1972 and the final one starting in 2020. The data
is available for mortality and health from 1972 to 2010, therefore, we need to employ
forecasts from 2011 onwards.
Following the method described in section 3.2, we first forecast κm, κh, log real GDP
per capita, and the unemployment rate based on the estimated VAR(3) model, see
equation (4.12). These values can then be adopted as independent variables in equa-
tion (3.4) to forecast future mortality and health, see equation (3.10). The estimates
α̂x, β̂x, and ρ̂x in equation (3.10) are smoothed in order to avoid an erratic progres-
sion when predicting. In addition, when forecasting the mortality rate, we correct for
the jump off bias. The one year death probabilities qx,t are calculated from observed
(t ≤ 2010) and forecasted (t ≥ 2011) mortality rates, see equation (3.1). Here, we as-
sume that ax,t = 0.5 for cohorts at all single-year ages except at birth and at age 110.
For age 110 (an open age interval) we set a110,t = 1m110,t and q110,t = 1. For infants,
following the calculation of a0 in Coale, Demeny, and Vaughan (1983) and Preston,
Heuveline, and Guillot (2001), we adopt the following formulas. For males,
a0,t = 0.35, if m0,t ≥ 0.107. (3.14)
a0,t = 0.045 + 2.684×m0,t, if m0,t < 0.107.
And for females,
a0,t = 0.33, if m0,t ≥ 0.107. (3.15)
a0,t = 0.053 + 2.800×m0,t, if m0,t < 0.107.
Once qx,t is calculated for all x and t (including the relevant future time periods), we
can construct a cohort life table, from which the “best estimates’ of life expectancy can
be calculated, using (3.2).
Next, we compute the “best estimates’ of healthy life expectancy for each cohort by
incorporating the (observed or forecasted) health status index into the cohort life table.
we follow a similar procedure as described above for mortality. A major difference is
that the oldest age group in the observed health sample data is the group 85+. We do
have data on separate ages larger than 85, but only for the years 1972–1995. In Figure
3.6 we plot the 10%, 50%, and 90% quantiles of πx,t for both males and females and all
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ages x ∈ {0, · · · , 99+}, using only t = 1972, · · · , 1995. We see that after age 85, there
is no clear trend anymore, but, instead, quite a lot of uncertainty. We shall assume
that πx,t = π85+,t, for x = 85, 86, · · · ,110. In addition, when quantifying the corre-
sponding confidence intervals, we shall explicitly take into account the large variation
in πx,t for high ages. We do this by incorporating measurement risk, i.e., the risk due
to the measurement errors εcx,t, see equation (3.4). For further details, please refer to
the Appendix.
Figure 3.6 – Quantiles (10%, 50%, 90%) of πx,t, x = 0, · · · , 99+ for males and
females for the subperiod 1972–1995.
Figures 3.7 and 3.8 show the comparison of “best estimates” of life expectancy (left
panel) and healthy life expectancy (right panel) by genders for cohorts at birth and age
65, respectively. The best estimate results imply that males’ life expectancy and healthy
life expectancy are lower but increasing faster than females’, both at birth and age 65.
To illustrate, when we compare gender gaps in (healthy) life expectancy for cohorts at
birth in 1972 and 2020, the gap in life expectancy reduces from 3.83 to 0.87 years (i.e.
by 77.2%), and from 2.62 to 0.85 years (i.e., by 67.5%) in healthy life expectancy. The
gender gaps for cohorts at age 65 are larger than at birth, but they are also reducing:
The gap in life expectancy reduces from 4.56 to 1.81 years (60.4%), and reduces from
3.02 to 1.50 years (50.4%) in healthy life expectancy.
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Figure 3.7 – Life expectancy and healthy life expectancy for males and females
at birth
Figure 3.8 – Life expectancy and healthy life expectancy for males and females
at age 65
To further understand how much (healthy) life expectancy increases, we compute
values of relative increases in (healthy) life expectancy compared with the ones in the
first available sample period. Let t1 denote the (first sample) year 1972, the relative
increases in life expectancy (RLEx,t) and healthy life expectancy (RHLEx,t) describe
how much the (healthy) life expectancy of cohorts at age x in year t increases compared








Figure 3.9 presents the relative increases of (healthy) life expectancy of cohorts at birth
and at age 65 in each year relative to the ones in 1972, distinguished by genders. Fig-
ure 3.9 shows that for both males and females, healthy life expectancy of cohorts at
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birth (left panel) and age 65 (right panel) increase faster than life expectancy. Our best
estimates results are in line with findings from Nusselder, Looman, Oyen, Robine, and
Jagger (2010) and Van Oyen, Nusselder, Jagger, Kolip, Cambois, and Robine (2013).
On the one hand, females’ mortality advantage leads to their higher (healthy) life ex-
pectancy compared with males; On the other hand, females’ larger prevalence of bad
health condition reduces this gender gap in the future both at birth and age 65.
Figure 3.9 – Relative increases of life expectancy and healthy life expectancy for
males and females at birth and age 65
3.4.3 Confidence intervals
So far, the discussed results are all based on the “best estimates” without considering
any uncertainties. In this section, we quantify the uncertain development of (healthy)
life expectancy by means of confidence intervals. These confidence intervals are cal-
culated by taking into account two common types of risks when forecasting from the
VAR model, namely process risk and parameter risk, see Section 3.2. In addition, we
incorporate measurement risk, due to the measurement errors in equation (3.4).
Figure 3.10 shows the 95% age-specific confidence intervals of life expectancy and
healthy life expectancy at birth by gender. Figure 3.11 presents these values for the
cohorts at age 65. In both figures, the narrower confidence intervals are the 95% con-
fidence intervals when only taking into account process and measurement risk, and
the wider confidence intervals are the ones when considering next to process and mea-
surement risk also parameter risk. In line with the findings in Van Baal, Peters, Mack-
enbach, and Nusselder (2013) for the Netherlands, our results for the United States
suggest that life expectancy of cohorts at birth and age 65 are very likely to continue
rising in the future. This also applies to healthy life expectancy at age 65 for both males
and females. However, the lowest 95% confidence band for healthy life expectancy at
birth reflects some uncertainty about a continuing increasing trend in these healthy life
expectancies.
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Figure 3.10 – Quantified uncertainties of (healthy)life expectancy of cohorts at
birth for males and females
Note: Two 95% confidence intervals are presented in each graph. The narrower dashed
curves present the 95% confidence interval when considering the process risk in the
VAR model and measurement risk in the Lee-Carter model with observed variables.
The wider dotted curves present the 95% confidence interval when considering both
process and parameter risks in the VAR model, and measurement risk in the Lee-Carter
model with observed variables.
Figure 3.11 – Quantified uncertainties of (healthy)life expectancy of cohorts at
age 65 for males and females
Note: Two 95% confidence intervals are presented in each graph. The narrower dashed
curves present the 95% confidence interval when considering the process risk in the
VAR model and measurement risk in the Lee-Carter model with observed variables.
The wider dotted curves present the 95% confidence interval when considering both
process and parameter risks in the VAR model, and measurement risk in the Lee-Carter
model with observed variables.
Figure 3.12 presents the development of the proportion of healthy life expectancy
over the total expected life years (HLE/LE) at birth and at age 65 by gender. The
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corresponding 95% confidence intervals are based on process risk and measurement
risk. The graphs show that the ratios for males and females for the cohorts at birth
seem to keep rising and at the same time converging to each other. The ratios for the
cohorts at age 65 also seem to keep rising, but the ratio of females seems to be slightly
higher than the ratio of males, although this difference is not significant.
Figure 3.12 – The percentage of life at birth lived in good health
Note: The left panel shows the proportion of remaining lifetime at birth by genders in
good health. The right panel shows the proportion of remaining lifetime at age 65 in
good health. 95% confidence intervals generated from the process risks are presented.
3.4.4 Comparison with other models
In this subsection, we compare our findings with three alternative approaches, which
do not jointly model mortality and health, do not consider the macroeconomic vari-
ables, or both. We shall refer to the model investigated so far as model “JoLCO” (with
“Jo” standing for modeling the joint development of mortality and health, “LC” stand-
ing for Lee-Carter, and “O” for using observed macroeconomic variables). The first al-
ternative method we consider is the Lee-Carter model with macroeconomic variables,
but separately modeling the development of mortality and health. This variant is de-
noted as “SeLCO” (with “Se” standing for modeling the development of mortality and
health separately). The second alternative models mortality and health by the original
Lee-Carter model, without observed variables, but with joint modeling the develop-
ment of mortality and health latent trends, to be denoted by “JoLC”. The last one mod-
els mortality and health by the original Lee-Carter model, with separately modeling
the development of mortality and health, to be denoted by “SeLC”. In case of model
JoLC a VAR(4) model is selected, following the same procedure as for model JoLCO.
In case of models SeLC and SeLCO, we model and forecast mortality and health sepa-
rately using an autoregression of order 4 (AR(4)).
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A comparison of the four models only using the “best estimates” is provided in
Figure 3.13 and Figure 3.14.
Figure 3.13 – Comparison of life expectancy from the four models of interest
Note: Graphs show life expectancy of cohorts at birth (the upper panel) and at age 65
(the lower panel) from four compared models.
‘Model JoLCO’ models mortality and health by Lee-Carter model with macroeconomic
variables, and jointly models and forecasts latent trends of mortality and health in a
VAR(4) model;
“Model SeLCO” models mortality and health by Lee-Carter model with macroeco-
nomic variables, but separately models and forecasts latent trends of mortality and
health in a AR model;
‘Model JoLC’ models mortality and health by Lee-Carter model, and jointly models
and forecasts latent trends of mortality and health in a VAR(4) model;
“Model SeLC” models mortality and health by Lee-Carter model, but separately mod-
els and forecasts latent trends of mortality and health in a AR model.
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Figure 3.14 – Comparison of healthy life expectancy from the four models of
interest
Note: Graphs show life expectancy of cohorts at birth (the upper panel) and at age 65
(the lower panel) from four compared models.
‘Model JoLCO’ models mortality and health by Lee-Carter model with macroeconomic
variables, and jointly models and forecasts latent trends of mortality and health in a
VAR(4) model;
“Model SeLCO” models mortality and health by Lee-Carter model with macroeco-
nomic variables, but separately models and forecasts latent trends of mortality and
health in a AR model;
‘Model JoLC’ models mortality and health by Lee-Carter model, and jointly models
and forecasts latent trends of mortality and health in a VAR(4) model;
“Model SeLC” models mortality and health by Lee-Carter model, but separately mod-
els and forecasts latent trends of mortality and health in a AR model.
Figures 3.15 and 3.16 show the comparisons of life expectancy (the upper panel), and
healthy life expectancy (the lower panel) with their 95% confidence intervals (repre-
senting process risk and measurement risk) of model JoLCO and the model that differs
most from model JoLCO, i.e., model JoLC in case of life expectancy and model SeLC
in case of healthy life expectancy. For males, we only find small differences in case of
life expectancy, with a substantial overlap in terms of the forecast intervals. However,
in case of healthy life expectancy we see some substantial differences, even though the
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forecast intervals still overlap. Compared to model JoLCO that takes the joint devel-
opment of mortality and health into account and that incorporates the development
in observed economic variables, model SeLC, that ignores the joint development and
that does not incorporate the development in observed economic variables, gives much
wider forecast intervals for the newborns and seems to underestimate the future devel-
opment for males at age 65. The wider forecast intervals in case of model SeLC might
be due to the following reason, see also Niu and Melenberg (2014). Model SeLC only
uses latent variables to capture the trend in mortality and health. This might result
in some overfitting of the trend, generating extra volatility in the latent variable. This
extra volatility will then be translated into a wider forecast interval.
In case of females, we also see some differences when comparing life expectancy
at birth. Model JoLC that does not take into account the development in observed
economic variables seems to overestimate the future life expectancy at birth compared
to model JoLCO, that incorporates the development in observed economic variables.
For healthy life expectancy we find similar differences for females as in case of males
when comparing model SeLC and model JoLCO: model SeLC results in wider forecast
intervals for the newborns and seems to underestimate the future development for
females at age 65.
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Figure 3.15 – Life expectancy and healthy life expectancy comparison for males,
Model “JoLCO” versus model “JoLC” and versus model “SeLC.”
Note: The upper panel shows life expectancy (left) and healthy life expectancy (right)
of cohorts at birth with process risk and parameter risk. The lower panel shows life
expectancy (left) and healthy life expectancy (right) of cohorts at age 65 with process
risk and parameter risk.
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Figure 3.16 – Life expectancy and healthy life expectancy comparison for fe-
males, model ‘JoLCO” versus model “JoLC” and versus model “SeLC.”
Note: The upper panel shows life expectancy (left) and healthy life expectancy (right)
of cohorts at birth with process risk and parameter risk. The lower panel shows life
expectancy (left) and healthy life expectancy (right) of cohorts at age 65 with process
risk and parameter risk.
3.5 Conclusion
This paper uses the data in the United States on the age-specific prevalence rates of self-
assessed health from the National Health Interview Survey and the mortality preva-
lence from Human Mortality Database from 1972 to 2010 to jointly model and predict
time trends in mortality, health, and macroeconomic variables. We compute the life ex-
pectancy and healthy life expectancy from cohort life tables using Sullivan’s method.
In addition to the point prediction, we also quantify two corresponding uncertainties,
namely “process risk” and “parameter risk.” Furthermore, measurement risk in the
Lee-Carter framework is taken into account as well.
Our findings suggest that, between 1972 and 2010, there has been an improvement
in the quality of life at age 65 in both absolute terms (number of years) and relative
66
DO AMERICANS LIVE LONGER AND HEALTHIER? FORECASTING HEALTHY LIFE
EXPECTANCY BY INCLUDING DYNAMIC EVOLUTIONS OF MORTALITY, HEALTH, AND
MACROECONOMIC VARIABLES
terms (the proportion of life). Our point forecasts up to 2020 show a further increase.
However, when also taking into account the forecast uncertainty, our forecast intervals
become so wide that a decrease in (healthy) life expectancy cannot be excluded.
We also compare our model with alternative models that do not include observed
macroeconomic variables or that do not take the joint development in mortality and
health into account. These are the standard Lee and Carter (1992) models, with or
without taking the joint development in mortality and health into account. Our results
show that our approach might help to get more precise model-based forecasts. The
included macroeconomic variables seem to capture the time variation in mortality and
health in a smoother way than happens in the standard Lee and Carter (1992) model.
In this paper we considered males and females separately. While studying the as-
sociation between the increase in life expectancy and the changes in the prevailing
patterns of health, researchers realize that understanding the gender disparities is very
important for improving efficiency of government policies, such as allocation of health
care resources. Two similar patterns are found in many aging countries. First, both fe-
males and males show rapid increases in life expectancy. However, many researchers,
including Waldron (1993), Trovato and Heyen (2006) Glei and Horiuchi (2007), and
Thorslund, Wastesson, Agahi, Lagergren, and Parker (2013), have shown that the fe-
male advantage in life expectancy at older age has been narrowing since the 1970s in
the U.S. Second, in a country like the United States, although females at most ages still
have a remarkable lower mortality than males, they tend to report a worse health status
than males (Case and Paxson (2005)). This is the so called male-female health-survival
paradox. An interesting topic of future research would be to extend our model to also
take into account the joint development in male and female mortality and health. This
would allow to test whether the gender gap has narrowed, taking into account the
uncertainty in the development of mortality and health.
Appendix
We quantify the accuracy of the estimates in the VAR model as follows,




and obtain the estimates Ĉ and Θ̂. Residuals ν̂t are computed as ν̂t = Yt − Ŷt,
where Ŷt = (Ĉ + Θ̂Yt−1), and its variance covariance matrix is derived as Σ̂ν =
Ĉov(ν̂t).
2. To ensure that the bootstrapped residuals ν̂bt have the same variance covariance
matrix Σ̂ν, we first decompose Σ̂ν = ADA′, where D is a unique diagonal matrix
with positive entries along the principal diagonal and A is a unique lower trian-
gular matrix with 1-s along the principal diagonal. We then construct ût = A−1ν̂t.
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Next, ûbt are generated by sampling with replacement of ût. The bootstrapped
residuals are in turn computed as ν̂bt = Aû
b
t .
3. The bootstrapped series Ybt are obtained by Y
b
t = Ŷt + ν̂
b
t . This yields the compu-
tation of the estimated parameters Ĉb and Θ̂b.
4. Then, we generate a projection Ŷbt+s based on bootstrapped estimates Ĉ
b and Θ̂b.
When quantifying the process risk in the VAR model together, we use the future
errors ν̂bt+s, which are the 2000 simulated innovations in the process risk.
5. With the estimates of αcx, βcx, ρcx, projected κct+h, and Ẑ
b
t+h, we can generate pro-
jections of ycx,t+h for both males and females, and for c = m and c = π. The
future errors εcx,t+h are sampled from the estimated ε
c
x,t. The future errors ε
π
x,t+h
for x = 86, 87, · · · are drawn from the estimated επ85,t, inflated by a factor in line
with the increase in the corresponding standard deviations of πx,t+h. For males
we use as inflation factor 106.5030− 2.6167x + 1.6150x2/100, and for females we
use 267.7101− 6.2266x + 3.6344x2/100, for x = 86, 87, · · · .
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−0.16(0.15) 0.06(0.08) 13.75(8.53) 1.69(1.41)
−0.05(0.35) −0.02(0.18) −32.66(19.77) −4.48(3.28)
0.01(0.01) −0.01(0.00) 0.43(0.41) 0.04(0.07)









0.04(0.15) −0.09(0.07) 2.47(6.58) 0.75(1.15)
−0.72(0.34) 0.08(0.16) 35.00(15.24) 6.20(2.68)
−0.01(0.01) 0.00(0.00) −0.13(0.32) 0.02(0.06)









0.48(0.18) −0.11(0.07) 3.73(7.28) 2.02(0.88)
−0.33(0.42) −0.12(0.16) 41.45(16.87) 3.06(2.04)
0.01(0.01) 0.00(0.00) 0.36(0.35) 0.10(0.04)




1.93 −0.23 0.03 −0.23
−0.23 10.38 0.03 −0.46
0.03 0.03 0.00 −0.03
−0.23 −0.46 −0.03 0.22

Note: The table presents estimates of VAR(3) model for males with κm, κh, loga-
rithm of GDP, and unemployment rate.
∆Kt = (∆κmt , ∆κ
h
t )
′, ∆Zt = (∆ log(GDP)t, ∆UnEmpt)′, where UnEmp denotes
unemployment rate.
Standard errors are provided in parentheses.
Σ̂ is the estimated variance covariance matrix of ν.
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−0.27(0.15) 0.08(0.08) 5.55(9.59) 0.64(1.56)
−0.21(0.35) 0.08(0.18) −16.39(21.92) −1.14(3.57)
0.01(0.01) −0.005(0.003) 0.51(0.37) 0.04(0.06)









0.16(0.14) −0.08(0.08) −8.12(8.35) −0.96(1.37)
−0.22(0.31) 0.04(0.18) 27.40(19.09) 5.39(3.13)
−0.01(0.01) −0.005(0.003) −0.29(0.33) −0.01(0.05)









0.36(0.15) −0.14(0.08) 0.62(8.40) 1.02(1.11)
0.14(0.35) −0.07(0.17) 44.71(19.18) 4.55(2.54)
0.01(0.01) −0.001(0.003) 0.49(0.33) 0.13(0.04)




2.87 −0.60 0.02 −0.22
−0.60 15.20 0.04 −0.60
0.02 0.04 0.00 −0.03
−0.22 −0.60 −0.03 0.22

Note: The table presents estimates of VAR(3) model for females with κm, κh, loga-
rithm of GDP, and unemployment rate.
∆Kt = (∆κmt , ∆κ
h
t )
′, ∆Zt = (∆ log(GDP)t, ∆UnEmpt)′, where UnEmp denotes un-
employment rate.
Standard errors are provided in parentheses.
Σ̂ is the estimated variance covariance matrix of ν.

CHAPTER 4
LINKING RETIREMENT AGE TO LIFE EXPECTANCY
EFFECTS ON HEALTHY LIFE EXPECTANCY BEFORE AND
AFTER RETIREMENT
This Chapter is based on De Waegenaere, Melenberg, and Yang (2014)
This chapter considers the effects of a policy that links retirement age to life ex-
pectancy. We focus on the effects on healthy life expectancy before and after retire-
ment, and on the likelihood of being in good health at retirement age. To investigate
these effects, we use a stochastic projection model that allows to jointly model and
forecast health and mortality, and to quantify the corresponding uncertainties. In the
best-estimate projection, linking retirement age to life expectancy would lead to an in-
crease in retirement age of about 9 months per decade. Even though younger cohorts
face significantly higher retirement ages than older cohorts, the likelihood of being in
good health at retirement age is higher for younger cohorts. The effects of the policy
on healthy life expectancy before and after retirement, however, are somewhat more
mixed. Whereas best estimate projections suggest that healthy life expectancy before
and after retirement would increase or remain constant over time, there is considerable
uncertainty regarding the actual development. The bounds of the forecast intervals
correspond to significant increases in time spent in poor health before retirement age,
and decreases in time spent in good health after retirement age.
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4.1 Introduction
The well-documented ongoing increases in life expectancy and the accompanying ag-
ing of the population raise significant challenges for pension providers such as gov-
ernments, company or private sector pension funds, and insurance companies offering
life annuities (see, e.g., Bloom, Canning, Mansfield, and Moore, 2007; Hári, De Waege-
naere, Melenberg, and Nijman, 2008; Pitacco, Denuit, Haberman, and Olivieri, 2009b).
Moreover, a social concern of possible increasing imbalance between the growing age-
ing population who consume goods and services and the amount of workers who have
to produce has been raised, see (see, e.g., Bloom, Canning, and Fink, 2008, 2009; Maes-
tas and Zissimopoulos, 2010). In response to these concerns, several countries con-
sider changes in their pension systems. A policy change that is often considered is an
increase in retirement age. Several countries have already implemented (gradual) in-
creases in retirement age, while others plan to do so in the near future. In the United
States, for example, the 1983 Social Security Amendments included a provision for a
gradual increase in the full retirement age for cohorts born after 1937. Specifically, re-
tirement age has gradually increased from 65 years in 2002 to 66 years in 2008. It will
stay at 66 years until 2020, and will then further increase by 2 months every year until
it reaches 67 in 2026.1 For an overview of retirement age policies in different countries,
we refer to OECD (2013) and Schwan and Sail (2013).2
Determining a trajectory for the development of retirement age for some period in
advance, however, has some potentially important drawbacks. A problem associated
with this approach is that there is a considerable degree of uncertainty regarding the
development of life expectancy. This has two important implications. First, there is
no guarantee that the (predetermined) increase in retirement age will keep pace will
the actual development of life expectancy, and so the policy might in the long run
again lead to a “mismatch” between retirement age and life expectancy. Second, even
though the expected level of pension payments decreases due to the policy, the degree
of uncertainty in these pension payments can remain high. This uncertainty is referred
to as longevity risk, and poses significant risk management challenges for governments
and pension providers (see, e.g., Hári, De Waegenaere, Melenberg, and Nijman, 2008;
Pitacco, Denuit, Haberman, and Olivieri, 2009b).
Because of the drawbacks associated with (long-term) deterministic retirement age
policies, several countries (including Italy, Denmark, Greece, the Netherlands, Slo-
vakia, and Cyprus) have implemented policies in which the development of retire-
ment age is directly linked to the development of life expectancy (see, e.g., Schwan
and Sail, 2013). There is some literature that investigates the benefits of such policies.




age and pension benefits to life expectancy, and find that public expenditures in the EU
could almost be halved when retirement age is fully linked to life expectancy. Prettner
and Canning (2013) consider a life-cycle optimization perspective to optimal retire-
ment planning. They identify sufficient conditions under which optimal retirement
age increases when life expectancy increases, and show that these conditions are satis-
fied for the U.S. An aspect that is ignored in these studies, however, is whether trends
in health of the elderly support the raise in retirement age. Several potential concerns
have been raised. First, when healthy life expectancy does not grow at the same pace as
life expectancy, the policy might significantly impact the number of years that retirees
can enjoy retirement in good health (see, e.g., Cutler, Meara, and Richards-Shubik,
2011). Second, concerns have been raised regarding whether people will be healthy
enough to work longer (see, e.g., Munnell, Meme, Jivan, and Cahill, 2004; Munnell
and Libby, 2007; Unger and Schulze, 2013). If the fraction of individuals that is not
sufficiently healthy to work until retirement would increase significantly, the benefits
of the policy in terms of reduced pension payments can, at least to some extent, be
outweighed by increases in unemployment or other social security benefits (see, e.g.,
Munnell, Meme, Jivan, and Cahill, 2004). Several studies have identified such spillover
effects from retirement benefits to disability benefits due to the increase in retirement
age in the U.S.(see, e.g., Duggan, Singleton, and Song, 2007; Li and Maestas, 2008; Coe
and Haverstick, 2010). Third, it is unclear how the policy would affect wealth transfers
between males and females. Because males and females have the same retirement age
even though female life expectancy is currently higher than male life expectancy, there
can be significant transfers of pension between males and females. However, recent
evidence suggests that female life expectancy increases at a slower rate than male life
expectancy (see, e.g., Thorslund, Wastesson, Agahi, Lagergren, and Parker, 2013; Yang,
De Waegenaere, and Melenberg, 2013a, and references therein). Hence, linking retire-
ment age to gender-neutral life expectancy could non-trivially affect the gender gap,
and, hence, the degree of wealth transfers.
Our focus in this paper is on the effects of a policy in which, roughly speaking, an
increase in life expectancy of one month is accompanied by an increase in retirement
age of one month. We investigate the effects of such a policy on life expectancy and
healthy life expectancy before and after retirement, as well as the likelihood of being
in good health at retirement age. We do these analyses for men and women separately.
To generate projections for future mortality and health, we use a stochastic projection
model based on the model developed in Yang, De Waegenaere, and Melenberg (2013a).
In that paper, health and mortality are modeled using a generalization of the approach
proposed by Lee and Carter (1992), and projected jointly using a Vector AutoRegres-
sive approach. An important advantage of this method is that it not only generates
point forecasts but also the corresponding forecast uncertainty. Moreover, it allows to
take into account dependence between the developments of mortality and health. Be-
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cause for our purpose also dependence between the developments of gender-neutral
mortality rates (which form the basis of the retirement age decision) and the gender-
specific male and female mortality rates (which determine how the policy affects males
and females) is important, we slightly extend the model in Yang, De Waegenaere and
Melenberg (2013) by jointly modeling mortality and health rates of both genders. The
model is estimated on mortality and self-assessed health data for the U.S. male and
female population in the period 1972-2010.
Our results suggest that linking retirement age to life expectancy would lead to sig-
nificant increases in retirement age; best-estimate projections suggest an increase of on
average 9 months per decade. Even though retirement age increases quite sharply, the
probability of being in good health at retirement age increases significantly. These re-
sults suggest that improvements in health indeed support the increase in retirement
age. The results regarding the number of years spent in good health before and af-
ter retirement are a bit mixed. In the best-estimate scenario, linking retirement age
to gender-neutral life expectancy would lead to relatively constant levels of both life
expectancy and healthy life expectancy after retirement, for both males and females.
However, there is a considerable degree of uncertainty. Whereas the best-estimate pro-
jections suggest that all future cohorts would enjoy an almost equal number of healthy
years in retirement, the bounds of the forecast intervals present a more pessimistic
view. At these bounds, the time spent in good health during retirement would de-
crease by a little bit less than five months per decade, for both males and females.
Moreover, the bounds of the forecast intervals that we generate correspond to an in-
crease in the time spent in poor health between age 60 and retirement age by 2 months
per decade for males, and by 1.4 months per decade for females. Overall, these results
suggest that focusing on best-estimate projections, as is often done by policy makers,
might provide a too optimistic view regarding the feasibility of retirement age policies
that link retirement age to life expectancy.
The rest of this paper is organized as follows. Section 4.2 defines the retirement age
policy that is considered in this paper, and presents the model that is used to generate
forecasts for mortality and health. Section 4.3 presents the empirical results on the
development of retirement age, life expectancy and healthy life expectancy before and
after retirement, and the probability of being in good health at retirement age. We
conclude in Section 5.5.
4.2 Model and methods
Our goal in this paper is to investigate the effect of a policy that links retirement age to
life expectancy on healthy life expectancy before and after retirement, and on the like-
lihood of being in good health at retirement age. In this section, we present the model
and methods used throughout the paper. In Section 4.2.1, we define the retirement age
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policy that will be investigated in this paper. In Section 4.2.2, we briefly discuss the
method used to forecast mortality and health. More details regarding this method can
be found in Yang, De Waegenaere, and Melenberg (2013a).
4.2.1 Retirement age policy
We consider a policy in which retirement age is directly linked to the development of
life expectancy. The goal of the policy is to adjust retirement age in such a way that
all future cohorts face approximately the same expected number of years lived after
retirement.
There are some practical complications associated with linking retirement age to
remaining life expectancy. First, remaining life expectancy for an individual with a
given age x depends on death rates at ages higher than x. Unless one is consider-
ing a cohort for which all individuals have died (e.g., the cohort born in 1880), death
rates for future years are needed in order to determine the individual’s remaining life
expectancy. There is, however, a significant degree of uncertainty regarding the de-
velopment of mortality rates, and projections for future mortality rates are sensitive to
model risk. To avoid this model risk, policies that link retirement age to life expectancy
are typically based on changes in period life expectancy rather than based on changes
in cohort life expectancy. Period life expectancy in a given year is determined under the
assumption that death rates for all future years are identical to the death rates in the
last observed year. Using period life expectancy to adjust retirement age therefore has
the important advantage that the determination of life expectancy is not sensitive to
model risk, since it is based on observed mortality rates only. A potential drawback of
linking retirement age to changes in period life expectancy is that the policy might not
lead to constant life expectancy at retirement age, if changes over time in period life
expectancy deviate significantly from changes over time in cohort life expectancy. We
discuss this issue in detail in Section 4.3.2. A second practical complication associated
with linking retirement age to life expectancy is that life expectancy depends signifi-
cantly on gender. In many countries, however, it is prohibited to differentiate between
men and women in terms of retirement age. Therefore, we consider a policy in which
the adjustment of retirement age is based on gender neutral period life expectancy. This
implies that life expectancy is determined based on population mortality rates, rather
than gender-specific mortality rates.
To formally define the retirement age policy that will be investigated in this paper,
we introduce the following notation:
• LEperiod(x, t): gender-neutral period life expectancy of an x-year old in year t; the
expression for LEperiod(x, t) is presented in Appendix 4.A (in (4.26));
• t0: the year in which the policy is first implemented;
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• RetAge(t): the retirement age in year t, where we consider only retirement ages
that are multiples of years and whole months.
If the goal is to adjust retirement age in such a way that (gender-neutral period)
life expectancy after retirement is constant, then retirement age in year t should be
determined such that:
LEperiod(RetAge(t), t) = LEperiod(RetAge(t0), t0). (4.1)
This, however, implies that determining retirement age requires solving an equation
(i.e., (4.1)). For that reason, most countries choose for a somewhat simpler policy that
yields an explicit rather than implicit expression for retirement age. In this paper, we
focus on a policy similar to the policy implemented in the Netherlands in 2013. The
policy determines as benchmark age the retirement age at the start of the implemen-
tation of the policy, i.e., RetAge(t0). In any future year, one determines by how many
months remaining (gender neutral period) life expectancy in year t at the benchmark
age has increased as compared to year t0. We denote this increase by ∆LEperiod(t) , i.e.,
∆LEperiod(t) =
⌊




where for any x, bxcmonths means that x is rounded below to a multiple of 1/12. Because
decreases in retirement age over time are ruled out, retirement in year t = t0 + 1, · · · , T,
retirement age is determined as:
RetAge(t) = max
{
RetAge(t− 1), RetAge(t0) + ∆LEperiod(t)
}
. (4.3)
For any given scenario for the development over time of gender neutral life ex-
pectancy, the corresponding development over time of retirement age can be deter-
mined from (4.2) and (4.3). In the next section, we discuss how scenarios for gender-
neutral death rates are generated.
4.2.2 Projecting mortality and health
Our focus is on the effects of the retirement age policy defined in Section 4.2.1 on
(healthy) life expectancy before and after retirement, and on the likelihood of being in
good health at retirement age. To determine life expectancy and healthy life expectancy
before and after retirement age, we need projections of death rates and health status
as a function of age, for both males and females. Moreover, for the determination of
retirement age, we need projections of gender neutral death rates. In Sections 4.2.2
and 4.2.2, we first discuss how we measure mortality and health. The model that we
use to forecast the future developments of health and mortality is presented in Section
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4.2.2. In Section 4.2.2, we discuss the data. The parameter estimates of the model are
presented in Appendix 4.B.
Mortality measurement
In this section, we discuss the measures that we use for mortality, as a function of age
and gender. We use the following notation:
• g ∈ {m, f , n}: an indicator for the gender specification, where g = m refers to
males, g = f refers to females, and g = n refers to the gender neutral case;
• ω: the maximum attainable age; we assume that any individual who reaches age
ω dies within the next month;
• A = {0, 1, . . . , ω− 1}: the set of integer ages, except for the maximum attainable
age ω.
For mortality, we model the development of the central death rate, which is defined
as the ratio of the number of deaths at age x in year t for gender g, denoted D(g)x,t , to the




, for x ∈ A and g ∈ {m, f }. (4.4)
(see, e.g., Chapter 3 in Pitacco, Denuit, Haberman, and Olivieri (2009b)). For any given
scenario for the development of the central death rates m(g)x,t for males and females, the
corresponding one-year death probabilities can be determined from (see, e.g., Molla,





for all ages x ∈ A, and for both genders g ∈ {m, f }.
Because retirement age can be expressed as multiples of months, we transform the
one-year death probabilities into monthly death probabilities. To transform one-year
probabilities to monthly death probabilities, we assume that for any given x ∈ A,
the probability of dying in the age interval [x + s, x + s + 1) is independent of s for
s ∈ {0, 112 , . . . ,
11
12}. Hence, the gender-specific probability of dying within the next
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for all ages x ∈ A, all s ∈ {0, 112 , . . . ,
11
12}, and both genders g ∈ {m, f }. Moreover, be-
cause retirement age is based on gender-neutral life expectancy, we need gender-neutral
monthly death probabilities. Gender-neutral monthly death probabilities are deter-















To measure health, we use self-assessed health information. The Integrated Health In-
terview Series (IHIS) integrates survey data collected by the National Health Interview
Survey (NHIS), and provides consecutive annual cross-sectional self-assessed health
status at the national level , distinguishing “excellent”, “good”, “fair”, and “poor”
before 1982, and “excellent”, “very good”, “good”, “fair”, and “poor”after 1982. The
NHIS considers individuals in the age groups x ∈ {0, 1, . . . , 85+}, where the age group
85+ consists of all individuals aged 85 or higher.
As in Yang, De Waegenaere, and Melenberg (2013a), survey respondents who report
their health status as “poor” and “fair” are clustered in the “unhealthy” group, and
survey respondents who report the other three better health categories are clustered
in the “healthy” group. Hence, we define the health status index of x-year olds in year
















j,x,t, for x ∈ {0, 1 . . . , 84, 85+} and g ∈ {m, f }, (4.8)
where N(g)x,t represents the total number of survey respondents in age group x in
year t, H(g)j,x,t is a zero-one indicator, with H
(g)
j,x,t = 1 if the self-assessed health of the j
th
respondent with age x was either fair or poor, and H(g)j,x,t = 0 otherwise, and w
(g)
j,x,t is the
person weight, representing the inverse probability of the jth respondent in the pop-
ulation selected into the sample. Section 3.1 in Yang, De Waegenaere, and Melenberg
(2013b) provides a more detailed description of the self-assessed health data, including
3This way of determining gender neutral probabilities corresponds to how these probabilities are
often determined in practice. From a theoretical perspective, however, one would instead determine the
gender neutral probabilities by determining mx,t based on death numbers, Dx,t, and exposures to death,
Ex,t, of males and females together. Given the focus of our analysis, however, we use the approach that
is most often used in practice.
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response rates and person weight.
To compute the healthy life expectancy, we need values of the health status indicator
π
(g)
x,t for each individual age x ∈ {85, . . . , ω} in the age group 85+. Following Yang,





85+,t, for x = 85, 86, . . . , ω.
As was the case for mortality rates, we need to transform the yearly health status
index to a monthly health status index in order to determine healthy life expectancy at
non-integer ages. To do so, we assume that the health status index in the age interval
[x, x + 1) increases linearly from π(g)x,t to π
(g)














for all ages x ∈ A, all s ∈ {0, 112 , . . . ,
11
12}, and both genders g ∈ {m, f }.
Forecast model
The forecast model that we use, models the development over time of the yearly central
death rates m(g)x,t , and yearly health status indices π
(g)
x,t , for both genders. For any given
scenario for m(g)x,t and π
(g)
x,t , monthly death probabilities and health status indices can
be determined from (4.5)-(4.9).
In order to take into account the likely dependence between mortality and health,
we use the forecast method proposed in Yang, De Waegenaere, and Melenberg (2013a),
in which mortality rates and health prevalence rates are modeled and projected jointly.
Because for our purpose also dependence between the developments of gender-neutral
mortality rates and gender-specific male and female mortality rates is important, we
slightly extend the model in Yang, De Waegenaere and Melenberg (2013) by jointly
modeling mortality and health rates of both genders. In this section, we briefly sum-
marize the approach. For a more detailed discussion, we refer to Yang, De Waegenaere,
and Melenberg (2013a).
In the first step, the developments of mortality and health are modeled separately,
using a generalization of the approach proposed by Lee and Carter (1992) for mortality.
Whereas Lee and Carter (1992) models mortality rates as a function of latent variables
only, Yang, De Waegenaere, and Melenberg (2013a) model both mortality and health,
and include in addition to the latent variables also GDP and unemployment rate as ex-
planatory variables. They find that including these two macroeconomic variables leads
4When quantifying the corresponding confidence intervals, we explicitly take into account that there
is more uncertainty in the value of πx,t for higher ages than for lower ages. This higher uncertainty is
reflected by a higher variance in the measurement errors εhx,g,t, in equation (4.11). For further details, we
refer to Yang, De Waegenaere, and Melenberg (2013a)
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to significant improvements in both the model fit (as measured by mean square error)
and the forecast accuracy of the model (as measured by the mean squared forecasting
error). For each gender specification g ∈ {m, f } separately, the dynamics of m(g)x,t and
π
(g)





= αmx,g + β
m











= αhx,g + β
h
x,g · κht,g + (ρhx,g)′ · Zt + εhx,g,t. (4.11)
For both the mortality model (c = m) and the health model (c = h), and for both gen-
ders, αcx,g describes the age-specific time-independent level of mortality (health); κct,g
is a time-dependent univariate latent variable that reflects the change in the overall
level of mortality (health) over time; βcx,g reflects the age-specific sensitivity of mor-
tality (health) to changes in κct,g; Zt is a 2-dimensional vector containing log GDP and
unemployment rate in year t; ρcx,g is a 2-dimensional age-specific parameter vector that
reflects the effect of changes in log GDP and unemployment rate on the overall level of
mortality (health), and εcx,g,t is the error term, reflecting idiosyncratic time- and gender-
specific influences, with mean 0 and (possibly age-specific) variance σ2ε,x.
In the second step, the joint dynamics of the latent time trends for mortality and
health of both genders (κmt,g and κ
h
t,g, for g ∈ {m, f }), as well as the two observed
variables (log GDP and unemployment rate), are modeled and projected using Vector
AutoRegression (VAR). The approach that we use in this paper deviates from that in
Yang, De Waegenaere, and Melenberg (2013a) in one aspect. Yang, De Waegenaere,
and Melenberg (2013a) estimate a separate VAR model for males and females. For
our purpose, however, joint modeling of male and female mortality and health (tak-
ing into account correlations between males and females) is important for two reasons.
First, ignoring the correlation between male and female mortality will likely lead to
biased forecasts of the gender-neutral measure of life expectancy that is used to de-
termine retirement age (see (4.3)). Second, biases in the correlation between male and
female health and/or mortality lead to biases in the correlation between retirement
age (which is based on gender-neutral measure of life expectancy) and gender-specific
life expectancy and healthy life expectancy before and after retirement. To avoid these
biases, we extend the model in Yang, De Waegenaere, and Melenberg (2013a) to al-
low for joint modeling and projecting of male and female mortality and health. We
choose the lag length in the VAR model according to the Akaike (AIC), Bayesian (BIC),
and Hannan-Quinn (HQIC) information criteria. These information criteria provide a
trade-off between goodness-of-fit and the parsimony of the model. Because we have a
relatively small sample size (i.e., 39 years), and the number of variables included in the
VAR model is 6, we set the maximum tested lag length equal to 3. Both AIC and HQIC
suggest a lag length of 3, whereas BIC suggests a lag length of 0. Lütkepohl (2007)
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compares these information criteria when selecting the lag length in a VAR model, and
finds that in settings with moderate or small sample sizes, AIC is preferred over BIC.







= C + Θ1Yt−1 + Θ2Yt−2 + Θ3Yt−3 + νt, (4.12)
where Kt is a vector with components (κmt,m, κ
m




t, f ), ∆Kt and ∆Zt are the first
order differences of Kt and Zt, i.e., ∆Kt ≡ Kt − Kt−1, and ∆Zt ≡ Zt − Zt−1, and νt is a
six-dimensional vector of white noise terms with covariance matrix Σν.
In our forecasts, we consider two sources of risk. First, we include process risk that
arises due to uncertainty in νt in (4.12), as well as εcx,t in (4.10) and (4.11) for both mor-
tality (c = m) and health (c = π). In addition to this, we consider parameter risk,
which arises due to uncertainty is the estimated parameters in (4.12). A standard boot-
strap procedure is used to generate scenarios for these parameters. Readers can refer to
Yang, De Waegenaere, and Melenberg (2013a) for a detailed discussion on the method
of predicting mortality and health prevalence and quantifying their uncertainties.
Data and parameter estimates
As in Yang, De Waegenaere, and Melenberg (2013a), we use the following data, for the
period 1972 to 2010:5
• consecutive annual cross-sectional gender-specific death numbers, D(g)x,t , and gender-
specific exposures to death, E(g)x,t , for the U.S. population, for males and females,
obtained from the Human Mortality Database (HMD);6
• consecutive annual cross-sectional self-assessed health for the noninstitutional-
ized population in the U.S., for males and females, obtained from the NHIS;7
• Gross Domestic Product (GDP) per capita, measured in U.S. dollar constant prices
(OECD base year 2005). Data is obtained from the Organisation for Economic Co-
operation and Development (OECD) website.8
• total unemployment rate, obtained from the OECD website (Statistics Extracts,
Country Statistical Profiles, 2010).9




9OECD Statistics defines the total unemployment rate as the ratio of people aged 15 years and over
that are out of work and actively seeking it to the population of working age either in work or actively
seeking it, all raw and seasonally adjusted.
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For a more detailed description of the data, we refer to Yang, De Waegenaere, and
Melenberg (2013a). Estimates of the parameters of the mortality and health models in
(4.10) and (4.11), and of the parameters of the VAR(3) model in (4.12) are presented in
Appendix 4.B.
4.3 Effects of the retirement age policy
In this section, we analyze the effects of the retirement age policy as defined in (4.13)
on (healthy) life expectancy before and after retirement, and on the probability of being
in good health at retirement date. If the policy would imply that the expected number
of years in poor health before retirement increases significantly, or that the fraction of
individuals that is in good health at retirement age decreases significantly, this could
be an indication that fewer people will be willing to, or able to, work until retirement
age when retirement age is linked to life expectancy. This, in turn, could imply that the
policy would have adverse effects on unemployment benefits or disability benefits.
Moreover, if the policy would imply that the expected number of years lived in good
health after retirement decreases significantly, this could decrease the support for the
policy, as it could be perceived as unfair.
Throughout the paper, we use the following notation:
• LEcohort(x, y, g, t): the gender-specific expected number of years lived between
ages x and y, for x-year olds in year t with gender g ∈ {m, f , n}, conditional on
being alive at age x;
• HLEcohort(x, y, g, t): the gender-specific expected number of years lived in good
health between ages x and y, for x-year olds in year t with gender g ∈ {m, f , n},
conditional on being alive at age x.
The (healthy) life expectancy measures LEcohort(x, y, g, t) and HLEcohort(x, y, g, t) are
based on projected gender-specific cohort monthly life tables. In contrast to the period
life tables used to determine retirement age, cohort life tables take into account pro-
jected future changes in mortality rates. Expressions for LEcohort(x, y, g, t) and HLEcohort(x, y, g, t)
are given in (4.27) and (4.28) in Appendix 4.A.
This section is organized as follows. In Section 4.3.1, we illustrate the effect of the
policy on the development of retirement age as a function of time, as well as a function
of the birth cohort. We also compare the corresponding retirement age policy to the
policy implemented under the 1983 Social Security Amendments. In Section 4.3.2, we
show the effect on (healthy) life expectancy after retirement for males and females. In
Section 4.3.3, we analyze the effect of the policy on the likelihood of being in good
health at retirement age, as well as on the expected number of years lived in poor
health between age 60 and retirement age. All results are based on 2000 scenarios for
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the developments of m(g)x,t and π
(g)
x,t , for males and females, generated with the model
described in Section 4.2.2.
4.3.1 Retirement age
In this section we show the effect of the policy defined in Section 4.2.1 on the develop-
ment of retirement age over time. We first determine the development of retirement
age as a function of time, as well as a function of the birth cohort. Then, we compare
the retirement ages according to the 1983 Social Security Amendments to the retire-
ment age suggested by the policy that we consider.
Because retirement age in 2010 in the United States is 66 years, we let t0 = 2010 and
RetAge(t0) = 66. Moreover, remaining life expectancy of a 66 year old in 2010, based
on the period life table in 2010, equals 18.58 years. Hence, according to the policy
defined in (4.3), retirement age in year t would be determined by:
RetAge(t) = max
{







for t = 2011, . . . , 2060. To determine retirement age for different cohorts, we introduce
the following notation:
• t(x): the year in which an x-year old in year t0 will retire;
• R(x): the age at which an x-year old in year t0 will retire.
Now consider an individual belonging to the cohort aged x-years old in year t0 who
is not yet retired at the beginning of year t. This individual will reach retirement age
during year t if RetAge(t)− (x + t− t0) < 1. Hence, the year in which (s)he retires,
t(x), is given by:
t(x) = min {t ∈ {t0, t0 + 1, · · · , T} : RetAge(t)− (t− t0 + x) < 1} , (4.14)
and the corresponding retirement age is given by
R(x) = RetAge(t(x)). (4.15)
For each of the 2000 scenarios for the development over time of the central death
rates m(g)x,t for males and females, (using the model described in Section 4.2.2), the cor-
responding retirement age in a future year t in that scenario is determined from (4.13),
using (4.5), (4.7), and (4.26). We determine both the best-estimate projection, as well
as the 95% forecast interval, where for the latter we distinguish the case where only
process risk is taken into account, and the case where both process risk and parameter
risk are taken into account.
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Figure 4.1 – Retirement age as a function of time (RetAge(t), left panel) for
t = 2010, . . . , 2060, and as a function of age in 2010 for x = 25, . . . , 66 (R(x),
right panel). In each figure, the solid line represents the best-estimate forecast;
the dashed and the dotted lines represent the 95% forecast intervals, where the
smaller intervals reflect process risk only while the wider intervals reflect both
process risk and parameter risk.
Figure 4.2 – Retirement age according to the U.S. 1983 Social Security Amend-
ments (solid line), and according to the retirement age policy in (4.13) (dashed
lines and dotted lines), for t = 2010, . . . , 2026.
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The left panel in Figure 4.1 displays the expected value of retirement age in year t,
i.e., RetAge(t) for t = 2011, 2012, . . .,2060. The right panel shows the retirement age as
a function of the birth cohort, i.e., R(x) for cohorts aged x = 25, . . . , 66, in 2010. In each
figure, the solid line represents the best-estimate forecast; the dashed lines represent
the 95% forecast intervals, where the smaller intervals reflect process risk only while
the wider intervals reflect both process risk and parameter risk. The best-estimate is
determined by setting εmx,g,t = 0 in (4.10) and ε
h
x,g,t = 0 in (4.11), and νt = 0 in (4.12).
The figure shows an increase in the best-estimate projected retirement age from 66
in 2010 to 69 years and 8 months in 2060. However, there is a significant degree of
uncertainty regarding the development of retirement age. When both process risk and
parameter risk are taken into account, the upper bound of the 95% forecast interval in
2060 is 71 years and 4 months; the lower bound is 67 years and 11 months.
We conclude this section by comparing the retirement age according to the 1983
Social Security Amendments to the retirement age according to the policy that we in-
vestigate. The 1983 Social Security Amendments implies that retirement age gradually
increases from 65 for individuals born in 1937 or earlier to 67 for individuals born after
1960 and later. Figure 4.2 shows both the retirement age according to the 1983 Social
Security Amendments and the best-estimate retirement age according to the policy that
we investigate, as a function of the year in which the individual retires. Because the
1983 Social Security Amendments defines retirement age until t = 2026, we consider
only these years in our comparison.
The figure shows that linking retirement age to life expectancy according to (4.13)
yields a significantly higher retirement age in t = 2013, . . . , 2021 than the one that is
implemented in the 1983 Social Security Amendments. Because the policy that we
consider aims at adjusting retirement age in such a way that remaining life expectancy
after retirement stays constant, this suggests that under the current U.S. policy, remain-
ing life expectancy after retirement age will continue to increase over time. In later
years, the 95% forecast interval contains both scenarios in which the retirement age
according to (4.13) is higher and scenarios in which it is lower than under the current
policy.
4.3.2 Life expectancy and healthy life expectancy after retirement
In this section we show the effect of the policy defined in (4.3) on life expectancy and
healthy life expectancy after retirement, for different cohorts. Although the general
idea behind linking retirement age to life expectancy as in (4.3) is to keep the number
of years spent in retirement stable over time, there are several reasons why this is not
guaranteed. First, keeping retirement age constant over time would require retirement
age to be determined from (4.1), which is slightly different from how retirement age is
determined under the policy, i.e., via (4.3). Second, as discussed in Section 4.2.1, the
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policy is based on period life tables, which implies that changes in mortality rates af-
ter the date at which life expectancy is determined are not taken into account. Hence,
when mortality rates decline over time, period life expectancy is an underestimate of
the cohort’s “true” life expectancy. This implies that period life expectancy might not
accurately capture the actual change in life expectancy of different cohorts. Third, to
avoid gender “discrimination”, the measure of life expectancy used to determine retire-
ment age is based on gender-neutral mortality rates. It is well-documented, however,
that males and females not only have significantly different life expectancies, but that
the trends in these life expectancies over time are also different (see, e.g., Thorslund,
Wastesson, Agahi, Lagergren, and Parker (2013); Yang, De Waegenaere, and Melenberg
(2013a), and references therein). Because retirement age is based on gender neutral life
expectancy, there is no guarantee that gender-specific life expectancy remains constant
even if it were stable at population level. In order to investigate the potential differ-
ential effect of the policy on men and women, we consider gender-neutral as well as
gender-specific (healthy) life expectancies.
Because retirement age in year t equals RetAge(t), and because the maximum at-
tainable age in our model is 110, the remaining life expectancy of an individual with
gender g who retires in year t equals
LEretiree(t, g) = LEcohort(RetAge(t), 110, g, t), (4.16)
and the remaining healthy life expectancy of an individual with gender g who retires
in year t equals
HLEretiree(t, g) = HLEcohort(RetAge(t), 110, g, t), (4.17)
where LEcohort and HLEcohort are as defined in (4.27) and (4.28). For each of the 2000
scenarios for the development over time of the central death rates (m(g)x,t ) and health
status index (π(g)x,t ) for males and females, the corresponding retirement age in a fu-
ture year t in that scenario is determined from (4.13), using (4.5), (4.7), and (4.26), and
(healthy) life expectancy at retirement age can be determined from (4.16) and (4.17),
using (4.9), (4.25), (4.27), and (4.28).
The left panel in Figure 4.3 shows the best-estimate projections of LEretiree(t, g), for
all population (solid lines, g = n), for males (dashed lines, g = m) and for females
(dotted lines, g = f ).
The best-estimate projections provide an optimistic view for policymakers. First, re-
maining life expectancy at retirement is relatively stable over time for both males and
females, with a very slight decreasing trend for females and a somewhat stronger but
still small increasing trend for males. This occurs because life expectancy for females
increases at a slower rate than gender-neutral life expectancy, and, hence, the opposite
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Figure 4.3 – Best estimate projections of life expectancy after retirement (left
panel), and healthy life expectancy after retirement (right panel), for individ-
uals who retire in year t = 2010, . . . , 2060. The solid lines represent gender-
neutral (healthy) life expectancy, the dotted lines represent female (healthy) life
expectancy, and the dashed lines represent male (healthy) life expectancy.
Figure 4.4 – Best estimate projections and 95% forecast interval of life ex-
pectancy and healthy life expectancy after retirement for males (left panel) and
for females (right panel), for individuals who retire in year t = 2010, . . . , 2060.
In each figure, the solid line represents the best-estimate forecast; the dashed
lines and dotted lines represent the 95% forecast intervals, where the smaller
intervals reflect process risk only while the wider intervals reflect both process
risk and parameter risk.
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occurs for males. Because retirement age is based on the trend in gender-neutral life ex-
pectancy, this implies that the expected number of years spent in retirement decreases
slightly over time for females, and increases slightly over time for males. Even though
these effects are small, they do suggest that in the long run the gender disparity at re-
tirement will decrease. While the best-estimate of the difference in remaining lifetime
after retirement between males and females is almost 2.27 years in 2010, it is projected
to decrease to 0.73 years in 2060. Second, best-estimate projections for healthy life ex-
pectancy at retirement for both males and females are relatively stable over time. This
suggests that the increase in healthy life expectancy keeps pace with the increase in life
expectancy, so that the policy would not adversely affect the number of years spent
in good health after retirement. However, these conclusions are based exclusively on
best-estimates, i.e., they do not account for the relatively large uncertainty in the devel-
opments of mortality and health. While linking retirement age to life expectancy yields
a significant reduction in the degree of uncertainty in remaining life expectancy after
retirement, the uncertainty is not fully “hedged”, for two reasons. First, as discussed
above, the measure of life expectancy used by the policy deviates from the cohort’s true
life expectancy. Second, after retirement age is set, there can still be developments in
life expectancy. To quantify this remaining uncertainty, we generated forecast intervals
for (healthy) life expectancy, taking into account both process risk and parameter risk,
as discussed in Section 4.2. Figure 4.4 displays the developments of remaining lifetime
and remaining lifetime in good health at retirement for males and females, including
the 95% forecast intervals. In each graph, the narrower forecast intervals reflect only
process risk, whereas the wider forecast intervals reflect both process and parameter
risks.
Figure 4.4 shows that the degree of uncertainty in remaining life expectancy after
retirement is relatively small. The degree of uncertainty regarding the development
of healthy life expectancy after retirement is much larger. For males, the remaining
healthy life expectancy at retirement for the cohort that retires in 2060 has a lower
bound of 10.30 years and an upper bound of 17.00 years, whereas the best estimate of
healthy life expectancy in 2010 is 13.48 years. This implies that there is a significant
probability that the number of years in retirement spent in good health will decrease
substantially if retirement age is linked to life expectancy. For females, there is a similar
degree of uncertainty.
4.3.3 Healthy enough to work until retirement?
As mentioned in the introduction, a potential concern associated with policies that
link retirement age to life expectancy is that they might have a significant impact on
the fraction of individuals that remain in relatively good health until retirement. If that
fraction decreases significantly, this could be an indication that the policy could ad-
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versely affect unemployment or disability payments (see, e.g., Munnell, Meme, Jivan,
and Cahill, 2004; Duggan, Singleton, and Song, 2007; Li and Maestas, 2008; Coe and
Haverstick, 2010).
In this section, we focus on the effect of the retirement age policy on the number of
years lived in poor health between age 60 and retirement age (Section 4.3.3), and on
the likelihood of being in good health at retirement age (Section 4.3.3). Because empir-
ical literature suggests that individuals who report poor self-assessed health are more
likely to retire early (see, e.g., McGarry, 2004; Jones, Rice, and Roberts, 2010), a higher
value of the expected number of years lived in poor health or a lower likelihood of
being in good health at retirement age can be indicators that the fraction of individ-
uals that may not be able to, or willing to, work until extended retirement age could
increase due to the policy.
Time spent in poor health before retirement age
In this section we show the effect of the retirement age policy defined in (4.3) on the
expected number of years spent in poor health between age 60 and retirement age, as
this could be an indicator of the extent to which individuals will be able (or willing) to
work until the extended retirment age.
Because retirement age of an individual aged 60 in year t equals R(2010− t + 60),
the expected years lived between age 60 and retirement for that individual equals
LEactive(t, g) = LEcohort(60, R(60− (t− 2010)), g, t), (4.18)
and the expected number of years lived in good health between age 60 and retirement
equals
HLEactive(t, g) = HLEcohort(60, R(60− (t− 2010)), g, t). (4.19)
For each of the 2000 scenarios for the development over time of the central death
rates (m(g)x,t ) and health status index (π
(g)
x,t ) for males and females, the corresponding
retirement age in a future year t in that scenario is determined from (4.13), using (4.5),
(4.7), and (4.26), and (healthy) life expectancy at retirement age can be determined from
(4.16) and (4.17), using (4.9), (4.25, (4.27), and (4.28).
Figure 4.5 displays the expected number of years in poor health between age 60 and
retirement age, i.e.,
LEactive(t, g)− HLEactive(t, g),
for males (left panel) and females (right panel) of cohorts aged 60 in year t = 2010, . . . , 2045.
The figure shows that the best-estimate expected number of years in poor health be-
tween age 60 and retirement age decreases slightly over time. There is, however, a sig-
nificant degree of uncertainty. The upper bounds of the forecast intervals correspond
to an increase in the expected number of years in poor health between age 60 and re-
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Figure 4.5 – Expected number of years in poor health between age 60 and re-
tirement age, as a function of the year in which the individual reaches age 60,
for males (left panel) and for females (right panel). In each figure, the solid line
represents the best-estimate forecast; the dashed lines and the dotted lines rep-
resent the 95% forecast intervals, where the smaller intervals reflect process risk
only while the wider intervals reflect both process risk and parameter risk.
tirement age from 1.4 years in 2010 to 2.0 years in 2045 for males. The corresponding
numbers for females are 1.4 and 1.8. These results suggest that linking retirement age
to life expectancy may lead to significant reductions in the fraction of individuals that
remains sufficiently healthy to work until extended retirement age.
Health status at retirement age
In this section, we investigate the effect of the retirement age policy on health status at
retirement age. We introduce the following notation:10
• ϕy,s: the probability of being alive at age y in year 2010 + s, conditional on being
alive at age 30; the expression for ϕy,s is presented in Appendix 4.A;11
• ξy,s: the probability of being in good health at age y in year 2010 + s, conditional
on being alive at age y, i.e., ξy,s = 1− π(g)y,2010+s.
Because retirement age of an individual with gender g belonging to the cohort aged
x in 2010 is R(x), the fraction of these individuals who survive until their retirement
10To avoid overloaded notation, we omit the gender index in some of our notation in this section.
11We condition on being alive at age 30 because of data availability. The cumulative survival prob-
ability between age x0 and age R(x) for the cohort aged x in 2010 depends on the one-year survival
probability in years 2010− x + x0 (the year in which they are x0 years old) till 2010− x + R(x) (the year
in which they retire). Because we use data as off 1972, we need 2010− x + x0 ≥ 1972 for all x ≤ 66, and,
hence, x0 ≥ 28.
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age, conditional on having been alive at age 30, is given by
Palive(x, g) := ϕR(x),R(x)−x,
and the corresponding fraction who is in good health is
Phealthy(x, g) = ϕR(x),R(x)−x · ξR(x),R(x)−x.
Figure 4.6 displays Palive(x, g) and Phealthy(x, g) for males (left panel) and females
(right panel), respectively, as a function of the age x in 2010.12 The results suggest
that even though younger cohorts will retire at later ages than older cohorts, their
probability to survive until retirement is higher. The effect is even stronger for the
fraction that survives and is in good health at retirement age. This holds true for both
males and females, although the effects for males are stronger than for females. For
example, conditional on being alive at age 30, the fraction of individuals that survives
until retirement age increases from 0.80 to 0.86 for male cohorts aged 66 till 25 in 2010;
the fraction in good health at retirement age for these cohorts increases from 0.61 to
0.75. In general, mortality and health improve over time, but depreciate as people age.
Our results suggest that the positive effects on mortality and health of improvements
over time are stronger than the negative effects on mortality and health of delayed
retirement.
Furthermore, Figure 4.6 also shows that, as was the case for (healthy) life expectancy
after retirement, the difference in the likelihood of being in good health at retirement
age between males and females is also projected to decrease. Whereas females are
more likely to survive until retirement than males, and are also more likely to be in
good health at retirement, these differences are projected to become smaller.
We conclude this section by investigating the effect of the policy on the likelihood
of reaching retirement age in good health. Specifically, we let ∆healthy(x, g) denote the
difference between the fraction of people that is in good health at retirement when the
policy is implemented, and what that fraction would be if retirement age would stay
at 66 for all future cohorts, which we denote Phealthy|R(x)=66(x, g). Then,
∆healthy(x, g) = Phealthy(x, g)− Phealthy|R(x)=66(x, g) (4.20)
= ϕR(x),R(x)−x · ξR(x),R(x)−x − ϕ66,66−x · ξ66,66−x. (4.21)
Moreover, to gain insight into which factors contribute most to differences in survival
in good health due to the policy, we decompose ∆healthy(x, g) into a health effect (which
12Expected probabilities for cohorts who are between 60 and 66 years old are somewhat non-smooth
over age. This occurs because for these cohorts, most of the data used to derive the cumulative survival
probability as off age 30 are observed, rather than predicated.
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Figure 4.6 – Probability of being alive (upper lines) and probability of being
alive and in good health (lower lines) at retirement age, conditional on being
alive at age 30 for males (left figure) and females (right figure). In each figure,
the darker solid lines and dahsed lines represent the best-estimate forecasts; the
dashed lines and dottend lines represent the 95% forecast intervals, where the
smaller intervals reflect process risk only while the wider intervals reflect both
process risk and parameter risk.
we denote H(x, g)), and a mortality effect (which we denote M(x, g)), i.e.,












The mortality effect M(x, g) reflects the effect of changes in mortality on ∆healthy(x, g)
in case health prevalence at retirement age is the same as the health prevalence at age
66 (π66,66−x). The health effect can be interpreted as the residual effect due to changes
in health between age 66 and R(x).
Figure 4.7 shows ∆healthy(x, g) as well as the decomposition of the total effect into a
mortality effect (M(x, g)) and a health effect (H(x, g)), see (4.21), (4.22), and (4.23), for
males and females. As expected, as compared to the situation which the retirement age
would stay at 66, the increase in retirement age leads to a smaller fraction that survives
and is in good health at retirement age i.e., ∆healthy(x, g) is negative for all cohorts
and for both genders. However, the effect is very small. The best estimate projection
suggests that over a period of 50 years, the fraction that survives and is in good health
at retirement age would be less than 3 percentage points lower than when retirment
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Figure 4.7 – Decomposition of the effect of the retirement age policy on the
probability of being in good health at retirement age, for individuals aged
x = 25, . . . , 66 in 2010. The left panel corresponds to males; the right panel
corresponds to females. The solid lines represent the total effect; the dashed
lines represent the effect of increased mortality; the dotted lines represent the
effect of decreased health.
age would not increase. Moreover, this effect is mainly driven by increased mortality
due to the delay in retirement age. The effect of worsened health is negligible.
4.4 Conclusion
In this paper, we consider a policy in which, roughly speaking, an increase in gender-
neutral life expectancy of one month is accompanied by an increase in retirement age of
one month. In addition to avoiding that the number of years spent in retirement contin-
ues to increase as life expectancy increases, such policies have the important advantage
that they can significantly reduce the longevity risk born by pension providers.
Our study investigates the effect of this policy on remaining (healthy) life expectancy
before and after retirement, as well as on the likelihood of being in good health at
retirement age. In addition to best-estimate projections, we quantify the degree of
uncertainty using a stochastic forecast model that incorporates dependence between
the developments of health and mortality over time. Based on best-estimate projec-
tions alone, one would be inclined to conclude that improvements in health of the
elderly are sufficiently strong to justify linking retirement age to developments in life
expectancy. However, the bounds of the forecast intervals that we generate correspond
to an increase in the time spent in poor health between age 60 and retirement age by 2.5
months per decade for males, and by 1.6 months per decade for females. The bounds
of the forecast intervals for the time spent in good health after retirement correspond
to decreases by a little bit less than 5 months per decade for both males and females.
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The extent to which our results allow to draw conclusions regarding the effect of the
policy for work force participation depends on whether self-reported health helps to
predict people’s willingness and/or ability to work. Identifying a causal effect of self-
reported health on retirement decisions is complicated due to potential endogeneity
and justification biases in self-reported health (see, e.g., Bound, 1991; Bound, Schoen-
baum, Stinebrickner, and Waidmann, 1999; McGarry, 2004; Lindeboom and Kerkhofs,
2009, to name just a few). Nevertheless, several studies provide evidence that indi-
viduals that report poor self-assessed health are more likely to retire early (see, e.g.,
McGarry, 2004; Jones, Rice, and Roberts, 2010; Au, Crossley, and Schellhorn, 2005).
We conclude by discussing potential directions for future reserach. First, it is well
documented that, in addition to gender, (healthy) life expectancy and health status de-
pend significantly on social status. This suggests that the effects of the policy that we
have investigated can be significantly different for different social status groups (see,
e.g., Cutler, Meara, and Richards-Shubik (2011) and Munnell, Meme, Jivan, and Cahill
(2004)). Based on our current results, a preliminary conclusion could be that for in-
dividuals belonging to groups with weaker improvements in health and/or mortality
than the overall population, a policy that links retirement age to population life ex-
pectancy could have rather strong adverse effects on their life expectancy and healthy
life expectancy after retirement, and on the likelihood of being in good health at retire-
ment age. Quantification of these effects is left for future research.
Second, a potential limitation of this study is that it ignores potential causal effects
of retirement on mortality and health. Regarding the effects of retirement on health,
it has often been argued that retirement negatively affects health due to, for example,
declines in physical activity (see, e.g., Dhaval, Rashad, and Spasojevic, 2006). On the
other hand, factors such as stress relief or more time to engage in healthy behavior af-
ter retirement could have the opposite effect (e.g., McGarry, 2004). While some studies
find a negative effect of retirement on health (Dhaval, Rashad, and Spasojevic, 2006;
Behncke, 2012), others find either no effect or a small positive effect (Bound and Waid-
mann, 2007; Neuman, 2008; Coe and Lindeboom, 2008; Pedersen and Bingley, 2011), or
a significant but temporary positive effect (Coe and Zamarro, 2011). Moreover, some
studies find different effects for different dimensions of health. van der Heide, van
Rijn, Robroek, Burdorf, and Proper (2013) find a positive effect of retirement on mental
health, and contradictory evidence of the effect of retirement on self-assessed health
and physical health. Eibich (2013) finds a positive effect of retirement on subjective
health and mental health. Regarding the effect of retirement on mortality, Hernaes,
Markussen, Piggott, and Vestad (2013) find no effect. Given the inconclusive evidence
regarding a causal effect of retirement on mortality and health, we have analyzed the
effects of the retirement policy on healthy life expectancy before and after retirement,
assuming no effect of retirement on mortality and health.
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4.A Notation and formulas
In this appendix, we first introduce some notation, and give the expressions for period
and cohort (healthy) life expectancy used in Section 4.3.2, as well as the cumulative
survival probability used in Section 4.3.3.
4.A.1 Notation
We use the following notation:
• M = { i12 : i = 0, . . . , 12 ∗ω}: the set of ages (expressed as multiples of months);
• 1
12
q(g)x,t : the probability of death within the age interval [x, x +
1
12), conditional
on being alive at age x at time t, for ages x ∈ M\{ω} and gender group g ∈
{m, f , n}; we discuss the details of the estimation of these gender neutral death
probabilities in Section 4.2.2; individuals who have reached age ω − 1/12 are
assumed to die within the age interval (ω− 1/12, ω];
• s p
period,(n)
x,t : the probability that an individual aged x in year t survives to age
x + s, based on the gender neutral period monthly lifetable in year t. This survival
probability is determined under the assumption that death rates for future years














x,t : the gender-specific probability that an x-year old in year t survives












4.A.2 (Healthy) life expectancy
Gender neutral monthly period life expectancy of an x-year old in year t, which we












The expected number of years lived between age x and age y for an x-year old in
year t with gender g ∈ {m, f }, based on gender-specific monthly cohort probabilities can




qy,t for all i ≥ 0.
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be determined as:











Moreover, following Imai and Soneji (2007b), the expected number of years lived in
good health between age x and age y for an x-year old in year t with gender g ∈ {m, f },
based on gender-specific monthly cohort probabilities can be determined as:











4.A.3 Survival until retirement
Because an individual aged y in year 2010 + s belongs to the cohort that was born in
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0.01(0.52) −0.08(0.43) 0.06(0.17) 0.02(0.16) 15.04(10.53) 2.27(1.66)
−0.16(0.58) 0.02(0.49) 0.18(0.19) −0.03(0.18) 12.16(11.84) 1.86(1.87)
2.25(1.17) −2.17(0.97) 0.12(0.37) −0.25(0.36) −66.57(23.62) −9.39(3.73)
2.97(1.27) −2.84(1.06) 0.90(0.40) −0.94(0.39) −76.33(25.74) −10.43(4.06)
−0.06(0.02) 0.05(0.02) −0.02(0.01) 0.01(0.01) 1.02(0.47) 0.09(0.07)













−0.30(0.48) 0.28(0.38) 0.01(0.17) −0.16(0.15) 0.17(8.86) −0.36(1.29)
−1.11(0.54) 1.05(0.43) 0.16(0.19) −0.29(0.17) 2.10(9.96) −1.09(1.45)
−0.72(1.08) −0.04(0.85) 0.09(0.38) 0.13(0.34) 26.71(19.88) 7.42(2.89)
0.52(1.17) −0.57(0.93) 0.71(0.41) −0.31(0.37) 11.91(21.66) 8.66(3.15)
0.06(0.02) −0.05(0.02) −0.01(0.01) 0.002(0.01) −0.42(0.40) 0.0002(0.06)













1.23(0.49) −0.57(0.38) 0.16(0.16) −0.25(0.13) −5.37(8.03) 1.8097(0.93)
1.83(0.55) −0.95(0.43) 0.31(0.18) −0.35(0.15) −12.79(9.03) 1.1903(1.05)
−2.69(1.09) 2.04(0.85) −0.34(0.36) 0.19(0.30) 58.71(18.01) 2.2562(2.10)
−3.03(1.19) 2.82(0.93) −0.15(0.39) 0.01(0.33) 73.32(19.63) 3.9927(2.29)
−0.02(0.02) 0.02(0.02) −0.02(0.01) 0.01(0.01) 0.74(0.36) 0.1497(0.04)




1.61 1.69 0.32 0.72 0.04 −0.28
1.69 2.03 0.49 0.72 0.04 −0.29
0.32 0.49 8.09 7.90 0.03 −0.46
0.72 0.72 7.90 9.60 0.06 −0.68
0.04 0.04 0.03 0.06 0.00 −0.02
−0.28 −0.29 −0.46 −0.68 −0.02 0.18

Note: The table presents estimates of VAR(3) model for females with κmm , κmf , κ
h
m, κ f , log GDP, and unem-
ployment rate.
∆Kt = (∆κmt,m, ∆κ
m





′, ∆Zt = (∆ log(GDP)t, ∆UnEmpt)′, where UnEmp denotes unemploy-
ment rate.
Standard errors are provided in parentheses.
Σ̂ is the estimated variance covariance matrix of ν.

CHAPTER 5
AN ANALYSIS OF THE INTERACTION BETWEEN HEALTH
EXPENDITURE AND ITS DETERMINANTS IN THE U.S.
This Chapter is based on Yang and Melenberg (2014)
This chapter investigates the dynamic economic relationship between healthcare ex-
penditure, macroeconomic determinants, the age structure of the population, and the
elderly’s self-assessed health status. We investigate the dynamic relationship between
health expenditure and its determinants after transformations to stationarity. We find
that an improvement in the elderly’s health status slows down the rising healthcare
cost. The increase of the proportion of the elderly people in the population has a posi-
tive effect on the rising healthcare cost. Healthcare is found to be a necessity good after
controlling for the other determinants. Moreover, relative healthcare price and public
financing are significant factors affecting the increase of the healthcare cost. An out-of-
sample prediction analysis shows that accounting for the elderly’s health status helps
to improve the accuracy of the health expenditure forecasts, compared to ignoring the
relationship and to official (CMS) forecasts.
5.1 Introduction
In the United States, healthcare as a share of the country’s GDP dramatically increased
over the past half-century from 5.2% in 1960 to 17.9% in 20111. This share as well as
1Source: "NHE summary including share of GDP, CY 1960-2011" provided by National Health Ex-
penditure Data at Center of Medicare and Medicaid
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the per capita spending on healthcare in the United Status are both much higher than
in other countries. As is well documented by the current health economics literature,
factors such as national income, economic growth, public financing of the healthcare,
relative price of healthcare services, and age structure are main determinants of the
rising health expenditure. In light of these findings, this paper proposes to investigate
the dynamic relationship between health expenditure and a set of determinants in the
United States, including additionally the elderly’s health status, a potentially impor-
tant determinant of the demand for healthcare.
Health expenditure and the determinants that we consider all show a clear trending
behavior. However, our test results suggest that these variables show different nonsta-
tionary behavior, including trend stationarity, first difference stationarity, and second
difference stationarity processes. These different forms of nonstationarity complicate
the econometric analysis considerably, because their presence prevents the straightfor-
ward use of many standard econometric models. In this paper we proceed as follows
to deal with these various forms of nonstationarity. First, we apply variable-specific
transformations so that after applying these transformations the transformed variables
are (close to) stationary. In particular, we find that the logarithm of health expenditure
is integrated of order one, so that its corresponding first difference (the growth rate
in health expenditure) is stationary. Then we apply a Vector Auto Regression (VAR)
model to capture the joint dynamic relationships between these stationarized variables.
This means that we model the growth rate in health expenditure jointly with the other
stationarized variables, allowing the other variables to influence health expenditure
but also the other way around. By including a relatively large number of variables, we
might be able to reduce a potential bias due to omitted variables. The VAR model can
straightforwardly be used to make forecasts for all variables included, in particular,
the growth rate in health expenditure. We investigate the out-of-sample forecasting
performance of our VAR model and make a comparison with “official forecasts.”
As discussed in the next section, there is some controversy in the literature whether
health care is a luxury or a necessity good and whether the relative healthcare service
price and the public financing of the healthcare sector have a positive or negative effect
of healthcare spending. We find that the income elasticity is less than one, so that ac-
cording to our estimates healthcare is a necessity good and our results show that both
the stationarized relative healthcare service price and the stationarized ratio of public
to total financing of the healthcare sector have a positive effect on healthcare spending.
We also investigate the importance of “Baumol’s cost disease,” and find that the sta-
tionarized variable to quantify this “disease” turns out to have only a small impact. On
the other hand, productivity growth shows a clear positive effect. Furthermore, both
the proportion of the younger and the older elderly have a positive effect on health
expenditure (after stationarization). Finally, we find that an improvement in the (sta-
tionarized) elderly’s health status implies a slower growth of the per capita healthcare
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spending. Our out-of-sample forecasts show that, although forecasting during the fi-
nancial crisis is hard, the forecasts based on the VAR-model might be useful to help to
improve the official forecasts.
The remainder of this paper first discusses the current health economics literature on
explaining the main factors account for the increase in the healthcare spending and the
literature on the methodology of analyzing this growth. We then describe the variables
used in this analysis and the available data in Section 5.3. The Appendix contains fur-
ther information which transformations we used to stationarize our variables. Section
5.4 describes the VAR model applied in this analysis and presents the corresponding
estimation results. We especially focus on the effect of the elderly’s health status on
the growth of the health expenditure. Forecasts of future health expenditure are also
presented. We conclude in Section 5.5.
5.2 Overview of the literature
The analysis of drivers behind the evolution in healthcare spending is far from straight-
forward. It should take account of a complex network of interactions between fac-
tors from the demand side and the supply side. This section first is going to summa-
rize findings from various studies for a number of possible variables on determining
healthcare expenditure from both the demand and the supply sides. Then we pro-
vide a brief overview of the current methodology applied in studying the rising health
expenditure.
5.2.1 Drivers of healthcare spending - factors that affect demand
Income—The growth of the national income has been recognized as an important de-
terminant in the growth of healthcare expenditure by many studies, including both
cross-country studies and single-country studies. In an early study, Newhouse (1977)
has proposed that national income can explain much of the increased health expendi-
ture. Hall and Jones (2007) also suggest that the growth of health spending is a rational
response to the growth of income per person. Similar conclusions are derived by other
researchers, such as Gerdtham, Jonsson, MacFarlan, and Oxley (1998), Roberts (1999),
Oliveria Martins, De la Maisonneuve, and Bjornerud (2006), Christiansen, Bech, and
Lauridsen (2007), and Amiri and Ventelou (2012).
Many studies have been focusing on the estimation of the income elasticity of health
expenditure, questioning whether healthcare is a luxury or a necessity good (see Hansen
and King (1996), Blomqvist and Carter (1997), Gerdtham and Lothgren (2000), Dreger
and Reimers (2005), Baltagi and Moscone (2010), and Moscone and Tosetti (2010), etc.).
However, the complexity of estimating the income elasticity can be attributed to at least
two reasons. First, the estimation might be biased due to an omitted variable bias, see
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Roberts (1999) and Gerdtham and Jonsson (2000). For example, omitting the influence
of healthcare service price or population ageing may overestimate the income elastic-
ity. Second, there might exist a simultaneous relationship between income and health
expenditure. Failure to take into account the impact of the healthcare spending on na-
tional income may also lead to a biased estimation of income elasticity, see Xu, Saksena,
and Holly (2011).
Demographic structure—Population ageing is increasingly identified as an important
factor affecting the rising healthcare spending. The importance of ageing on the ris-
ing health expenditure are both examined by studies concerning the United States (see
for example Murthy and Ukpolo (1994) and Murthy and Okunade (2000)), and con-
cerning other OECD countries (see for example Dreger and Reimers (2005) and Oku-
nade, Karakus, and Okeke (2004)). However, researchers including Zweifel, Felder,
and Meiers (1999) and Yang, Norton, and Stearns (2003) point out that because the
largest healthcare expenditure typically happens during the last years of one’s life, the
impact of population ageing on healthcare expenditure may be estimated with a bias
if the time remaining to death is not taken into account. For this reason, Okunade,
Karakus, and Okeke (2004) suggest that “healthcare costs are better off shifting demo-
graphic paradigms from measurements based on simple population aging to that of
‘time to death’” (Page 175). Researchers such as Zweifel, Felder, and Werblow (2004)
and Werblow, Felder, and Zweifel (2007) empirically tested the positive effect of the
variable “time to death” on the rising healthcare cost. When analyzing the effect of
the population ageing on the growth of the healthcare cost, instead of including the
“time to death” variable, some researchers also separate the elderly age group into the
younger elderly and the older elderly. For example, Christiansen, Bech, and Lauridsen
(2007) separately estimate the effects of the population groups aged 65-74 and aged 75+
on the health expenditure. They find that these two groups have different effects. van
Elk, Mot, and Franses (2009) apply a panel data approach and find that both the ratio
of population aged 65-74 and aged above 75 to the total population have a significant
positive effect on the rising health expenditure.
Health status of the elderly— The increase in the share of the older people in the
population has an obvious impact on the demand for healthcare. However, as the
demand for healthcare is ultimately derived from being in good health or not, age itself
may not be a sufficient factor to explain the rising health expenditure. For this reason,
the elderly’s health status has been considered in analyzing healthcare spending. In
many studies, researchers usually use the “elderly’s health” and the “demographic
structure” interchangeably. For example, Leu (1986), Cutler and Sheiner (1998), and
Colombier (2012) use the percentage of people over 65 in the population as a proxy for
population health. Lee and Miller (2002) adopt “time to death” as a rough indicator
for the elderly’s health status and project the future health expenditure by assuming a
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fixed schedule relating health expenditure to “time to death.” Other proxies, such as
life expectancy, death rate, and disability, are also commonly applied as representing
the health status, see, for example, Dormont, Grignon, and Huber (2006), Manton,
Lamb, and Gu (2007) and Colombier (2012). Recently, Solakoglu and Civan (2012) use
the population self-reported health as an indicator of healthcare need and find that the
increased need for healthcare can explain the rising share of healthcare expenditure in
GDP for the studied OECD countries.2
Relative price of the health service to the GDP deflator— The relevance of includ-
ing the relative price of healthcare is addressed in van Elk, Mot, and Franses (2009).
In studies of OECD countries, they obtain large positive effects of the relative price in
the short run. Okunade, Karakus, and Okeke (2004) find that the increase in health-
care price significantly drives up the healthcare costs during different periods. Roberts
(1999) finds that, in the long run, the effect of the relative price falls from positive to
negative, during the examined period 1960 to 1993. Murthy and Ukpolo (1994) con-
duct a cointegration study for the aggregated health expenditure for the United States,
obtaining a long-run negative effect.
5.2.2 Drivers of healthcare spending - factors that affect supply
In addition of factors on the demand side of the healthcare, factors on the supply side
also affect the level of healthcare spending.
Baumol’s cost disease—Baumol (1967) proposes the so called “Baumol’s cost disease”
to explain the growth of healthcare spending. In his study, he distinguishes two eco-
nomic sectors, namely a “progressive” and a “nonprogressive” sector. Baumol (1967)
characterizes the progressive sector, such as manufacturing sector, as being more cap-
ital intensive with a high level of productivity growth. Contrarily, nonprogressive in-
dustries, such as medical care and education, are seen as being more labor intensive
with a relatively slow productivity growth. Because of higher productivity growth, the
wage rate in the progressive sector tends to increase. If the ratio of the outputs of the
two sectors is held constant, there has to be shifts of employment from the progressive
sector to the nonprogressive sector. To do so, the nonprogressive sector has to increase
the wage rate to attract more workers. As a result, the labor costs in the nonprogressive
industries tend to increase because of an increase in wage rates in the progressive sec-
tor. In turn, the total costs in the nonprogressive sector, such as the healthcare sector,
rises.
2In support of using self-reported health as a proxy for the health status, it is worth mentioning
that McGee, Liao, Cao, and Cooper (1999), Hillen, Schaub, Hiestermann, Kirschner, and Robra (2000),
and Burstrom and Fredlund (2001) find a positive relationship between self-reported and actual health
outcomes, and empirically provide evidence of self-reported health to be a reasonable indicator for
health.
108
AN ANALYSIS OF THE INTERACTION BETWEEN HEALTH EXPENDITURE AND ITS
DETERMINANTS IN THE U.S.
One problem when estimating the effect of “Baumol’s cost disease” is the complex-
ity of measuring output and price deflators (Hartwig (2011) and Colombier (2012)).
Without a proper measurement, testing whether “Baumol’s cost disease” applies to
the healthcare sector might be problematic. Recently, Hartwig (2008) proposed a new
“Baumol’s variable” to avoid the drawback of using medical-price indices. It is defined
as the excess wage growth above the productivity growth, and equals the growth in
unit costs in the Baumol sector. Applying this “Baumol’s variable”, helps to avoid
a possible bias due to the use of an incorrect medical price deflator. Hartwig (2008)
still obtained the conclusion that the healthcare costs’ growth over the past 40 years
in OECD countries can be attributed to the “Baumol’s cost disease”. In recent stud-
ies, Colombier (2012) and Bates and Santerre (2013) adjust “Baumol’s variable” by
the proportion of the labor force in the healthcare sector (or Baumol’s sector) in the
total economy. They show that after correcting the proportion of the labor participa-
tion, “Baumol’s cost disease” is still valid in the healthcare. However, they obtained a
smaller effect than the one provided by Hartwig (2008).
Public financing of the healthcare— A large part of the healthcare is financed by
public funding. Therefore, the ratio of the public healthcare expenditure to the to-
tal healthcare expenditure (public financing of the healthcare) may be correlated with
changes in the health expenditure. Researchers hold two different views on the role of
public funding on the rising healthcare cost. Leu (1986) and his proponents, such as
Gerdtham, Sogaard, Andersson, and Jonsson (1992), Murthy and Ukpolo (1994), and
Murthy and Okunade (2000), support the view that public financing of the healthcare
increases the total health expenditure. Leu (1986) explains this positive effect from two
aspects. First, compared with the private sector, because of less competition in the
public sector, the incentives to minimize costs might be lower. Moreover, bureaucrats
might have incentives to maximize the government budget. Second, health insurance
provided by the government reduces the healthcare price to consumers. Therefore,
individuals tend to overuse healthcare services. On the contrary, Culyer (1989), Oku-
nade, Karakus, and Okeke (2004), and others hold an opposite opinion. Okunade,
Karakus, and Okeke (2004) find that “systems with greater government involvements
in healthcare provision and financing can moderate spending growth” (page 179) for
different periods among OECD countries. Gerdtham and Jonsson (2000) summarize a
few reasons for this. Those are higher selling and advertising cost, less reliable market
pressure, and higher production cost in the private sector.
Medical technology— Technology advance is considered to have a complicated im-
pact on changes in healthcare costs. In general, it affects health expenditure from two
directions. On the one hand, it increases the healthcare spending because of the in-
vention of new and expensive medical technologies, see Zweifel (1984), Berndt, Cutler,
Frank, Griliches, Newhouse, and Triplett (2000), Gerdtham and Lothgren (2000), and
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Okunade (2001). Moreover, better technology prolongs the length of ill lives, but may
result in higher spending on curing chronic diseases for a longer period, see van Elk,
Mot, and Franses (2009). On the other hand, it reduces the healthcare costs because
of several reasons. First, the availability of more advanced and better technology may
induce more outpatients and, in turn, reduce cost for inpatient hospital stays. Sec-
ond, new treatments may improve people’s health status. As a result, the demand for
healthcare will decline, see Hall and Jones (2007).
Measuring technology progress is a challenging issue in the current literature. Prox-
ies are typically used, for example, health related R&D or total R&D (Okunade and
Murthy (2002)), life expectancy, infant mortality, the share of the elderly (Dreger and
Reimers (2005)), and diagnosis procedures such as MRI (Chandra and Skinner (2011)).
Moreover, some researchers implicitly quantify the medical technology as a residual ef-
fect, after taking into account other factors in the equation for healthcare costs, see, for
example, Newhouse (1992) and Oliveria Martins, De la Maisonneuve, and Bjornerud
(2006). Others include a constant or a simple linear trend to capture in general terms
technology progress, see for example Di Matteo (2005).
5.2.3 Overview of approaches studying healthcare expenditure
Different models have been used to study the link between healthcare spending and its
determinants. Gerdtham and Jonsson (2000), Moscone and Tosetti (2010), and Xu, Sak-
sena, and Holly (2011) provide reviews of current approaches applied to OECD coun-
tries and the United States. Depending on the type of data used, the main methods
used in analyzing the determinants of health expenditure are cross-section analyses
(Newhouse (1977), Leu (1986), Gerdtham, Sogaard, Andersson, and Jonsson (1992)),
panel data analyses(Gerdtham (1992), Roberts (1999), Gerdtham and Lothgren (2000),
and Xu, Saksena, and Holly (2011)), and unit root and cointegration analyses in a time
series context (Murthy and Ukpolo (1994), Hansen and King (1996), King and Hansen
(1996), and Blomqvist and Carter (1997)). Moreover, the unit root and cointegration
methods are applied in analyzing not only single country aggregate healthcare expen-
diture (see Murthy and Ukpolo (1994), King and Hansen (1996), Murthy and Okunade
(2000), Okunade and Murthy (2002), and Murthy (2012) for the studies in the U.S.,
see Hansen and King (1996), and Blomqvist and Carter (1997) for country-by-country
studies for OECD countries), but also cross countries/states’ health changes in a panel
data framework (see Wang and Rettenmaier (2007) and Moscone and Tosetti (2010) for
U.S. studies, and see MacDonald and Hopkins (2002), Dreger and Reimers (2005), and
Baltagi and Moscone (2010) for OECD countries’ studies).
If the time series are all integrated of the same order, and a linear combination of
them is stationary, we say that these time series are cointegrated. Therefore, testing the
stationarity of the studied time series has been addressed as a very important issue, be-
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fore applying regression methods, when looking at the link between healthcare spend-
ing and its determinants at the aggregate level, see Gerdtham and Lothgren (2000),
Moscone and Tosetti (2010), and Xu, Saksena, and Holly (2011). It is well known that
the violation of the assumption that all time series are stationary might lead to spu-
rious statistical results using OLS estimation (Engle and Granger (1987)). Appropri-
ately choosing a model specification (whether to include a time trend or a constant)
is an empirically difficult task for researchers when testing the existence of the unit
root in the time series. Therefore, we observe conflicting conclusions regarding the
stationarity/non-stationarity of health expenditure and its determinants, and possible
cointegration relationships between them, see also reviews provided by Gerdtham and
Lothgren (2000) and Moscone and Tosetti (2010).
Alternatively, if health expenditure and its determinants are not all integrated of
the same order, a vector autoregression (VAR) model can be estimated, applied to the
stationarized variables, to investigate the simultaneous relationship. In the area of
health expenditure analysis, Erdil and Yetkiner (2009), Hartwig (2010), and Amiri and
Ventelou (2012) are examples of cross-country studies. One potential weakness of the
current research applying VAR models is that typically only the relationship between
health expenditure, economic growth, and GDP is studied, while other potentially im-
portant determinants are omitted.
5.3 Data
In this section we first present the variables to be used in this paper. We then describe
the data sources to obtain our time series data, which consists of the years 1972 to 2010
at an annual frequency. All our variables show a trending behaviour over this sample
period. Therefore, we conclude this section by selecting appropriate data transforma-
tions to transform our variables into more stationary ones.
This study aims to consider a comprehensive set of determinants when analyzing
the rising healthcare expenditure in real term. We consider eight variables as sug-
gested by previous studies which may determine the increasing healthcare cost. The
combined nine variables of interest will be denoted as follows,
• PHE = Total health expenditure per capita.
• INCOME = Personal income per capita.
• RPHC = The ratio of healthcare service price index to GDP deflator with base
year 2005.
• AdjBV = Adjusted Baumol’s variable.
• PF = The ratio of public health expenditure to total health expenditure.
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• PROD = Labor productivity per person employed.
• AGE65−84 = The ratio of population 65 to 84 years old to total population.
• AGE85+ = The ratio of population 85 years and over to total population.
• HSG65+ = The share of the population who report good health within the age
group 65 and older to the total population.
The National Health Expenditures Accounts (NHEA) released in 20113 provides an-
nual total health spending per capita (PHE) in the United States. These are the official
estimates of the Center of Medicare and Medicaid (CMS) database. The OECD (Or-
ganization for Economic Cooperation and Development) Statistics4 provide the ratio
of public healthcare expenditure to total healthcare expenditure (PF), the labour pro-
ductivity per person employed (PROD), and the labour compensation per employee
(WAGE), where the latter will be used to construct Baumol’s variable. The OECD
statistics define PROD as real output (gross value added) divided by total employed
persons, and define WAGE as compensation of employees5 divided by total employ-
ees6. The Bureau of Economic Analysis (BEA)7 produces economic accounts statistics
for personal income (INCOME). It is defined as the income received (including com-
pensation and interest and dividend income) by persons from participation in produc-
tion and from transfers from government and businesses. Personal income is closely
monitored both as an indicator of economic activity and as a predictor of future spend-
ing. BEA also provides the price index of GDP, and the price index of healthcare ser-
vices, from which we can derive the relative price of healthcare (RPHC). Total health
expenditure per capita is deflated by the price index of healthcare services (base year
2005). All other economic variables are measured in U.S. dollar constant prices (OECD
base year 2005).
The adjusted Baumol’s variable (AdjBV) is calculated by the method provided and





3See http://www.cms.gov; go to “Research, Statistics, Data & Systems,” then go to “National Health
Expenditure Data,” and finally go to “Historical.”
4See http://stats.oecd.org/.
5Compensation of employees in the OCED dataset is defined as the sum of wage rates, earnings, em-
ployer contribution to statutory social security schemes or to private funded social insurance schemes,
and unfunded employee social benefits paid by employers.
6The total number of employment and the total number of employees documented by the OECD
dataset are classified from the United Nations International Standard Industrial Classification (ISIC) of
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where lH is the ratio of the employment in the healthcare sector to the total economy.
To construct the adjusted Baumol’s variable (AdjBV), we obtain detailed employment
information from the Bureau of Economic Analysis (BEA). On October 5, 2006, BEA
released estimates of full-time and part-time employment by industry for 1948-1997,
based on the 1997 North American Industry Classification System (NAICS). Together
with the data released for the years 1998-2012, we obtain the total number of employ-
ment in the economy and the total number of employment in the healthcare service.
The ratio of the employment in the healthcare sector to the total economy (lH) in turn
can be derived. The variable AdjBV can then be computed from equation (5.1).
Since the largest share of the health expenditure happens at the end of one’s lifetime,
the increased life expectancy has two effects. First, it means that a smaller share of the
younger elderly will be in the last year of life. Furthermore, more of the elderly will
be dying at older ages and the share of elderly’s death shifts from the younger to the
oldest old. The end-of-life expenditure will get pushed into the future. So, Stearns
and Norton (2004) conclude that omitting the factor “time to death” will result in a
biased estimation of the future health expenditure. Therefore, we separate the elderly
age structure of the population into two age groups, namely the younger elderly who
are between age 65 and 84 (AGE65−84), and the oldest old whose age are 85 and over
(AGE85+). In this way, we approximately take into consideration the effect of “time
to death” by the oldest old age group. The age-specific population data, which can be
used to construct the age structure are obtained from the Human Mortality Database
(HMD)8.
Finally, we focus on the health status of the people 65 and over. This variable is
different from Solakoglu and Civan (2012), who use the health status of the total pop-
ulation to indicate the healthcare demand. Because the elderly is the group which
requires the majority of the healthcare, we use the elderly’s health condition instead
of the health status of the total population. The elderly’s health status is obtained
from the Integrated Health Interview Series (IHIS).9 The National Health Interview
Survey (NHIS) conducts annual surveys for civilian, non-institutionalized U.S. pop-
ulation. One of the survey questions asks respondents to rate their health with four
categories (“excellent”, “good”, “fair”, or “poor”) before 1982 and five categories (“ex-
cellent”, “very good”, “good”, “fair”, or “poor”) after 1982. The IHIS documents the
integrated self-assessed health from survey results and provides annual data to track
health status at the national level. Following Yang, De Waegenaere, and Melenberg
(2013b), the health status variable of age 65 and over (HSG65+) in this paper is mea-
sured as the proportion of the population of age 65 and over who report their health
8See http://www.mortality.org/
9For general information see http://www.ihis.us/ihis/. The health data was downloaded via the
variable “Health status”, available from the website https://www.ihis.us/ihis-action/variables/
group/health_general.
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status with “excellent”, “very good,” or “good” to the total surveyed population. Due
to the data availability of the health status, this paper uses data from 1972 to 2010.
In Figure 5.1 we present the time series characteristics of our variables. All our
variables show a clear trending behaviour over the sample period. Therefore, we se-
lect for each of our variables an appropriate transformation, so that after transforming
the variable it becomes stationary. The details of this analysis are presented in the ap-
pendix. It turns out that different variables require different transformations. We start
from the logarithmic form for all variables except for the adjusted Baumol’s variable.
We find that log(PHEt), log(INCOMEt), log(PFt), and log(PRODt) are I(1), requir-
ing time differencing to make these variables stationary. We find that log(RPHCt) and
log(Age65−84,t) are I(2), requiring double time differencing to make these variables sta-
tionary. Finally, we find that the remaining variables (AdjBVt, Age85+,t, and HSG65+,t)
are trend stationary, requiring detrending to make these variables stationary. The sta-
tionarized variables will be denoted by adding a superscript s. Thus, for example,
PHEst stands for ∆ log(PHEt).
5.4 VAR models and empirical results
In the analysis of health expenditure and its determinants, it is very likely that there are
bilateral relationships. For example, there is possibly a bilateral relationship between
health expenditure and the elderly’s health condition. On the one hand, an increase in
the fraction of elderly in good health may slow down the increase in healthcare cost; on
the other hand, an increase in healthcare expenditure may be devoted to provide a bet-
ter medical treatment, improving the quality of life and, in turn, might help to improve
people’s health. Next, income is likely to affect the health expenditure, but a reverse ef-
fect may exist as well. Erdil and Yetkiner (2009) explained this reverse causation using
two arguments. First, a higher health expenditure might positively affect human capi-
tal through the enhancement of education, which may lead to productivity growth and
ultimately an increase in national income. Second, a better health condition of people
may be achieved because of higher health expenditure. This may improve the labor
participation and productivity growth10. In addition, it also seems reasonable to ex-
pect that even if causality exists in both directions, it does not occur instantaneously,
but with some time lag. For these reasons, a VAR model is used in this analysis.11
10Weil (2007) quantitatively calculate the income gain because of health improvement. The paper
states that “healthier people are better workers. They can work harder and longer and also think more
clearly” (Page 1266). Bloom and Canning (2005) also find a positive relationship between health and
productivity.
11The vector autoregressive (VAR) model has been very popularized by Sims (1980).
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Figure 5.1 – Time series plots of the variables used in the analysis. The main
text contains the definitions of these variables as well as the data sources.
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A VAR model with p lags for the K-dimensional vector Yt is specified as




ΘiYt−p + νt, (5.2)
where Θi is a K × K coefficient matrix, C is a (K × 1) vector of intercepts allowing for
possibility of a nonzero mean of E(Yt). Finally, νt is a K-dimensional vector of white
noise terms with zero mean and covariance matrix Σν. In this study, Yt is a vector
containing the stationarized health expenditure and its stationarized determinants, i.e.,
Yt is given by

















The number of lags p in the VAR model can be selected by different information
criteria, such as the Akaike’s Information Criterion (AIC) and the Bayesian Information
Criterion (BIC). The information criteria select a model which has an optimal trade-off
between model fit and parsimony, quantified in terms of number of parameters. Based
on the loglikelihood function values (LLF) and the number of parameters (Np), AIC
and BIC are computed as follows
AIC(p) = (−2LLF + 2Np) (5.4)
BIC(p) = (−2LLF + 2Np log T) (5.5)
For more information on the use of model selection criteria in VAR models, see chapter
four in Lutkepohl (2007). Both AIC and BIC indicate a lag length of 1 (p = 1) in (5.2).
Therefore, we estimate a VAR(1).12
As the elderly’s health status can be an important indicator for healthcare spending,
and the adjustment of health expenditure to the changes of elderly’s health might even
have lagged effect, we further examine the effect of elderly’s health status up to the
previous five years, i.e., we consider the VARX model








ΦiHSGs65+,t−i + νt, (5.6)
where HSGs65+,t−i are the extra “X”-variables, with corresponding vectors of regres-
sion coefficients Φi, i = 2, · · · , 5. By assumption, these exogenous variables collected
in X have a unidirectional effect on Y . Both AIC and BIC also in this case indicate a
12To check the stability of this VAR(1), we check the inverse roots of the estimated characteristic AR
polynomial (see Lutkepohl (2007)). The estimated VAR is stable if all roots have modulus less than one
and lie inside the unit circle. The estimated VAR has as largest modulus 0.87, and all roots lie inside the
unit circle. Therefore, our estimated VAR satisfies the conditions for stability.
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lag length of 1 (p = 1).13 To see the joint significance of the lagged elderly’s health
status included, F-tests are performed, suggesting that only the longest lag seems to
be significant.14 Therefore, we also investigate a VARX model with only HSGs65+,t−5 as
extra “X”-variable. Both AIC and BIC again indicate a lag length of 1.15
Estimation Results—As the purpose of this study is investigating how health expen-
diture is affected by its determinants, we focus on the equation in the VAR model with
PHEst as the dependent variable. The corresponding estimation results, reflecting the
short term effects, are shown in Table 5.1. The full estimation results are presented
in Tables 5.12–5.14. We also look at the medium term cumulative effect on the health
expenditure. Figure 5.2 shows 10 years cumulative impulse responses due to one unit
change in each one of the error terms (νt). For example, assume that the error term
in the equation of INCOMEst increases by one unit, the upper left graph shows the
cumulative changes in log(PHEt) (not stationarized) after 1, 2, and so on, up to 10
years.
We obtain an income elasticity less than one, thus supporting the hypothesis that
healthcare is a necessity good. Our estimated income elasticity is around 0.29 to 0.32
after three to four years. This is slightly less than Moscone and Tosetti (2010) who
report an income elasticity of 0.36, which is at the lower end typically found in the
literature.16 Our relatively low income elasticity may due to the fact that we consider a
relatively large set of determinants besides income, such as, for example, productivity,
public finance, age structure, or the health status. Without these variables, income
would capture their effects.
Furthermore, we find that the (stationarized) relative healthcare price has a clear
positive effect on the health expenditure. Also public financing (after stationarization)
has a clear positive effect on healthcare spending. This finding is in line with findings
in Leu (1986), Murthy and Ukpolo (1994), and Murthy and Okunade (2000), support-
ing the view that provision of health care is less efficient in the public than in private
sector. For the (stationarized) adjusted Baumol’s variable we find a significant nega-
tive, but very small, short term effect, which is turned into a small positive effect in
the medium term (after two to five years). Productivity per employment (after station-
arization) does not seem to have a significant short term effect on the healthcare costs
in the models with higher order terms of the lagged health status included. How-
ever, when turning to the medium term, also in the VARX-models the productivity
per employment shows a clear positive effect on healthcare costs. Productivity growth
13By checking inverse roots of the characteristic AR polynomial, we find this VARX model stable.
14F-statistics are 4.225 with a p-value of 0.006 for H0 : φ21 = φ31 = φ41 = φ51 = 0, and 0.678 with a
p-value of 0.576 for H0 : φ21 = φ31 = φ41 = 0.
15Tests on the inverse roots of the characteristic AR polynomial indicates that the VARX model is
stable.
16For example, Wang and Rettenmaier (2007) obtain as lowest income elasticity among 48 studied
states a value of 0.514.
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Table 5.1 – Estimates of equations with PHEst as the dependent variables in
the VAR model
VAR Model VARX Model 1 VARX Model 2
PHEst−1 0.6602**(0.1900) 0.9578**(0.1903) 0.9953**(0.1774)
INCOMEst−1 0.2171**(0.0912) 0.2044**(0.0770) 0.2108**(0.0741)
RPHCst−1 0.5878**(0.1971) 0.4737**(0.1834) 0.4665**(0.1684)
AdjBVst−1 -0.0034 (0.0039) -0.0098**(0.0044) -0.0087**(0.0035)
PFst−1 0.3489**(0.1643) 0.3910**(0.1512) 0.4388**(0.1356)
PRODst−1 0.4148* (0.2157) 0.1296 (0.2378) 0.2053 (0.1924)
Ages65−84,t−1 1.2532**(0.6252) 0.7730 (0.5487) 0.8150 (0.5187)
Ages85+,t−1 0.0602 (0.1548) 0.2351* (0.1424) 0.2423* (0.1329)
HSGs65+,t−1 -0.0196 (0.0977) -0.2796**(0.1063) -0.2894**(0.1032)




HSGs65+,t−5 -0.1466* (0.0787) -0.1378* (0.0707)
R2 0.6753 0.8164 0.7994
AIC -53.579 -53.993 -54.125
BIC -49.621 -48.336 -49.681
Notes: standard errors are in the parentheses
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may reflect the cost increasing effect of technology progress on healthcare spending.
Higher level of productivity indicates the possibility of providing more advanced and
more expensive medical techniques.
The two (stationarized) demographic variables Ages65−84 and Age
s
85+ have a positive
effect, both in the short and medium term. When controlling for higher orders of the
lagged elderly’s health status, the short term effect of Ages85+ becomes significant at
the 90% significance level. This suggests that the increase in the number of the elderly,
especially the oldest old, means a larger demand for healthcare. Moreover, we find that
the (stationarized) elderly’s health status has a clear negative effect. Especially when
the higher lagged health status is included, the short term negative effect of the first
lagged health status is significant at the 95% confidence level. This suggests that an
improved health status of the elderly slows down the growth of per capita healthcare
expenditure, indicating that the elderly’s health status is an effective indicator of the
demand for healthcare.
A Forecasting Study—We forecast health expenditure based on the dynamic relation-
ship between health expenditure and the other eight variables modeled by the VAR
framework. We then compare the forecasts of healthcare spending per capita from the
three VAR models. Once the VAR has been estimated, we can forecast the future en-
dogenous variables Y for h periods ahead, conditional on time t. For example, h year








The VAR model with exogenous variables (VARX, see (5.6)) also can be forecasted
when one can predict future paths of the exogenous variables X. For example, when
two to five year lagged elderly’s health status are considered, forecasts of Ŷt+h from a


















To test the forecasting accuracy, we perform an out-of-sample analysis. This means
that the total sample period is cut into a fitting period and a forecasting period. We
choose the fitting period from 1972 to 2005, and predict 5 years ahead until the last
available sample year 2010. In this way, forecasts of health expenditure in level (PHEt)
can be compared with the realized values from 2006 to 2010. The forecasting accuracy
is measured by using the mean square forecasting error (MSFE), in terms of PHEt,
which is the mean square differences between the realized values of PHEt and the
corresponding forecasts. We further compare the VAR(X) forecasts with using a simple
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Figure 5.2 – Cumulative Impulse Responses.
This figure shows the cumulative impulse responses on log(PHEt) for each of the other
eight variables. The main text contains the details.
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linear regression. We regress PHEst on the other eight stationarized variables at time t.
One difficulty to generate forecasts in this simple linear regression is that it requires to
generate first forecasts of the independent variables. Since we focus on investigating
the forecasting performance of the VAR(X) for the future healthcare cost, we use the
“best” forecasts for the independent variables in the linear regression by using their
observed values from 2006 to 2010. In addition, to further investigate the role of the
elderly’s health status in forecasting the future health expenditure, we also compare
our VAR(X) forecasts with forecasts when using a VAR model without including the
elderly’s health status.
Figure 5.3 presents the in-sample and out-of-sample forecasts for the health expendi-
ture per capita. The in-sample MSFE and out-of-sample MSFE are shown in Table 5.2.
The results first suggest that all considered models provide reasonable in-sample fore-
casts. The out-of-sample foreasts include the period of the financial crisis, starting
in 2007. All models have difficulty in forecasting the development of the healthcare
spending during this period, including the linear regression model with observed vari-
ables. Forecasts based on this appproach seem to overreact to changes in the indepen-
dent variables. Nevertheless, the VAR model with the higher lagged elderly’s health
status as observed variables outperforms the other models, both in-sample and out-
of-sample. Moreover, including the lagged health status of the elderly provides better
in-sample and out-of-sample forecasts than ignoring the previous health status. It is
also superior to using a simple linear regression, even when the independent variables
take their actual values in the out-of-sample forecasts.
Furthermore, the healthcare spending forecasts based on the VAR system also out-
perform forecasts provided by the Center for Medicare and Medicaid Services (CMS).
We compare our forecasts with forecasts reported in the “National Health Expendi-
tures Projections: 2006 - 2016”17 and “National Health Expenditures Projections: 2007
- 2017”.18 These reports present the forecasted nominal health expenditure per capita,
calculated by CMS as the forecasted real health expenditure times the forecasted price
deflator. Using the forecasted nominal health expenditure per capita and the fore-
casted price deflator from both reports, we find as forecasted real health expenditure
per capita in 2010 $7,477.5 (according to the 2006 - 2016 projections) and $7,480.2 (ac-
cording to the 2007 - 2017 projections), using in both cases 2005 as base year. Our
predictions are $7,416.5, $7,379.6, and $7,400 based on the three considered VAR sys-
tems. These are closer to the actual spending $7,302.7 in 2010. As most studies on
health expenditure projections do, the CMS actuaries assume that healthcare needs are
constant across age groups. This assumption means that medical needs change only
17Data obtained via private communication, available on request. Poisal, Truffer, Smith, Sisko, Cowan,
Keehan, Dickensheets, and the National Health Expenditure Accounts Projections Team (2007) report
part of the health expenditure projections based on the “National Health Expenditures Projections: 2006
- 2016”.
18See Table 1 from http://amcp.org/WorkArea/DownloadAsset.aspx?id=12771
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as the age and sex distributions of the population change (Cutler and Sheiner (1998)).
One shortcoming of this assumption is that the health condition, which ultimately af-
fects the demand for healthcare, is assumed to be the same as age changes, which is
unlikely to be true. Our model relaxes this assumption, by both including the elderly’s
age structure and the (lagged) elderly’s health status, yielding a possible explanation
why we obtain a smaller bias in our forecasts.
We conclude that the out-of-sample forecasts based on the dynamic relationship
between the variables of interest outperform forecasts without taking into account this
relationship, though the in-sample forecasts from the different models are quite similar.
Moreover, when taking into account the higher order of the lagged elderly’s health
status, less biased forecasts are obtained than when ignoring them.
Table 5.2 – Comparison of the mean square forecasting errors among models with different vari-
ables
VAR without HSG VAR VARX Model 1 VARX Model 2 Linear Regression
In-sample fit 0.0010 0.0010 0.0007 0.0007 0.0015
Out-of-sample test 0.0051 0.0049 0.0016 0.0028 0.0030





65+,t−5. VARX Model 2 is the VAR model including the exogenous variables Xt =
HSGs65+,t−5.
Figure 5.3 – In-sample and out-of-sample forecasts of the per capita healthcare
spending
5.5 Conclusion
In this paper we applied a Vector Auto Regression (VAR) model to quantify the dy-
namic relationship between health expenditure and its determinants. We include a
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rather comprehensive set of determinants for healthcare spending, with the aim to re-
duce a possible bias due to omitted variables. Before applying the VAR model, we first
stationarized the variables, using variable specific stationarizing transformations. In
terms of the stationarized variables, we find that healthcare is a necessity good as the
income elasticity is lower than one. Furthermore, we find that an increase in the rel-
ative price of the healthcare service or more public financing both contribute to rising
health expenditure. We separate the elderly’s age group into the younger elderly and
the oldest old, to take into account that most healthcare expenditure seems to happen
during the last years of one’s life and the share of the people who are approaching
death shifts into the oldest old age group. We find that both elderly groups have pos-
itive effects on the per capita healthcare spending. Finally, the improvement in the
elderly’s health status has a clear negative effect on the per capita healthcare spending
both in the short and medium term, especially when we control for the higher order
of the lagged health status. Our findings confirm the statement by Stearns and Norton
(2004) that health expenditure will be affected by a number of factors, including health
status trends. Forecasts of the health spending based on the dynamic relationship are
superior to forecasts derived from the Center of Medicare and Medicaid. Forecasts
based on a model including the elderly’s health status are also better than ignoring it.
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Appendix: Transformations to Stationarity
We use the Augmented Dickey Fuller test (ADF) to test the existence of the unit root in
the examined time series. In this type of test, Dickey and Fuller (1979) actually consider
three model specifications, namely a model without time trend and constant (“AR”),
a model with a constant (“ARD”), and a model with both a constant and a time trend
(“TS”). These specifications can be written as follows,




βi∆yt−i + εt, (AR)




βi∆yt−i + εt, (ADR)




βi∆yt−i + εt. (TS)
To test whether the time series has a unit root or not, the parameter of interest in all the
regression equations is γ. γ = 0 means the presence of a unit root, and the time series
is possibly non-stationary. We can estimate the above equations using OLS, and check
the t-statistic for the null hypothesis H0 : γ = 0. However, the appropriate critical
value compared with the t-statistic is different as the usual critical value, and provided
in the Dickey-Fuller tables.
In models “TS” and “ARD”, we can further perform the F-test to assess the signifi-
cance of a joint restriction of the parameters. The null hypothesis in model “TS” is that
there is a unit root and there is no time trend (γ = 0 and b = 0). The null in model
“ARD” is that there is a unit root and there is no constant (γ = 0 and a = 0). Dickey
and Fuller (1981) provide the critical values for these additional F-test. If the F-statistic
cannot reject the null hypothesis, then {yt} is possibly I(1) with a drift if the model is
“TS”, and is possibly I(1) without drift if the model is “ARD”.
To select a proper model specification, we follow the Pantula principle and start with
the least restrictive model, which includes both a constant and a time trend (“TS”). If
a unit root is rejected, the time series can be viewed as stationary under this model
specification. Otherwise, we continue to the more restrictive model only with a con-
stant (“ARD”). Again, if a unit root is rejected, we can possibly conclude that the time
series is stationary under “ARD”. Otherwise, the most restrictive model specification
without the constant (“AR”) will be further tested. However, “AR” may not be a good
choice in practice if a clear trend can be observed in the variable.
An important practical issue for the implementation of the ADF test is the specifica-
tion of the lag length p. An inappropriate choice of p may bias the test. Ng and Perron
(1995) proposed the procedure to start with a relatively long lag length. Each time,
by applying the usual t-test and/or F-test for the highest lag order, one can decide
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whether to reduce the number of lag by one. Enders (2009) suggest that Ng-Perron
procedure results in stable size of the test and minimal test power loss. A detailed pro-
cedure is described in chapter 4 of book Enders (2009). First, we set an upper bound
pmax for p. Next, we estimate the ADF test regression with p = pmax. If the abso-
lute value of the t-statistic for testing the significance of the last lagged difference is
greater than 1.6 then we set p = pmax and perform the unit root test. Otherwise, we re-
duce the lag length by one and repeat the process. Enders (2009) illustrates that in the
above ADF model specification we can further perform a test for the null hypothesis
βi = βi+1 = . . . = βp = 0 using the standard F-tests to determine the lag length.
In addition to use the t-test and F-test, it is also possible to determine the lag length
following the information criteria, such as Akaike information criterion (Akaike (1974))
and Bayesian information criterion or Schwarz criterion (Schwert (1989)). In this anal-
ysis, we follow both the Ng-Perron “general to specific" procedure and information
criteria (AIC and BIC) to determine the lag length of each model.
Furthermore, since residuals in an appropriately specified model should not have
any strong serial correlation, we shall apply a diagnostic check on the residuals in the
proposed model specification and lag length. To do so, we perform the Ljung-Box
Q-statistic to check if there is any significant autocorrelation among the residuals.
As shown by Figure 5.1, all variables in levels seems to be trended upward. There-
fore, we test the unit root for variables in level starting from the model specification
“TS”, and continue with “ARD” if trend stationary is rejected. We do not apply “AR”
specification when analyzing variables in level, since all variables seems to have clear
trends. The testing results for each variable are now discussed in detail. In the subse-
quent analysis, the maximum lag length of 10 is examined, i.e., pmax = 10.
The logarithm of health expenditure per capita—When analyzing the log(PHE) in
levels, with the model specification “TS”, AIC and BIC select the lag length of 1 (p = 1).
Whereas following the Ng-Perron procedure, the lag length of 3 (p = 3) is suggested.
As Ljung-Box Q-statistics cannot reject the null that there is no autocorrelation in resid-
uals when p = 1 and p = 3, we further perform the F-test to check whether the co-
efficients in front of the lagged first difference variables are jointly significant or not.
For this purpose, the equation with the lag length p = 4 is estimated. The F-statistics
are 1.5585 with a p-value of 0.2138 for the null hypothesis β3 = β4 = 0, 1.6924 with a
p-value of 0.1808 for H0 : β2 = β3 = β4 = 0, and 12.4182 with a p-value of 0.0000 for
H0 : β1 = β2 = β3 = β4 = 0. This indicates that the F-test also selects a model with 1
lag at the 5% significance level.
Therefore, we perform the ADF test for the series in level with p = 1 in model
specification “TS”. Results are presented by the first panel in Table 5.3. Results show
that log(PHE) in level has a unit root if choosing p = 1. It is not trend stationary.
The F-statistics in the ADF test cannot reject the null hypothesis that a = b = γ = 0,
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suggesting that log(PHE) is possibly a I(1) process with drift. Following the Pantula
principle, we continue to the less restrictive model “ARD”, the ADF test still cannot
reject the unit root in time series.
Next, we test for a unit root in the first difference. The ADF test results are presented
in the second panel of Table 5.3. We again start from the least restrictive model “TS”.
AIC and BIC, and the Ng-Perron procedure all suggest lag length of 0 (p = 0). The
ADF-statistic cannot reject the null hypothesis of a unit root. We continue to model
only with a constant (“ARD”). In this case, p = 0 is again suggested. The ADF-statistic
rejects the null. Therefore, we shall proceed under the assumption that the first differ-
ence of log(PHE) is stationary. That is log(PHE) is a I(1) process.
Table 5.3 – Unit root test for log(PHE)
“TS” “ARD”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0
Level
p = 1 2.308(0.680) -2.148(0.513) 2.489(0.356) -0.387(0.901)
First Difference
p = 0 4.723(0.178) -3.045(0.135) 5.247(0.041) -3.118**(0.034)
Notes: p-values in parentheses. “**" represents that it is significant at the 5%
significant level.
The logarithm of income per capita—For log(INCOME) in levels, in model “TS”,
AIC and BIC select the lag length of 0 (p = 0), whereas the t-tests suggest a lag length
of 10 (p = 10). The Ljung-Box Q-statistics cannot reject the null that there is no auto-
correlation in residuals of both lag choices. We further use F-tests in model “TS” with
maximum 11 lags, and test the joint restriction of the parameters in front the lagged
first differences, starting with testing the last two lagged coefficients until testing all
the lagged coefficients. The F-tests suggest a lag length of 0 (p = 0) at the 5% signifi-
cance level. Therefore, we proceed to test the unit root of log(INCOME) with p = 0.
Results are shown in Table 5.4. At the 5% significance level, the null hypothesis of a
unit root cannot be rejected.
Next, we test for a unit root in the first difference of log(INCOME). Under “TS”,
AIC and BIC suggest lag length of 0 (p = 0). The t-tests and F-tests following the
Ng-Perron procedure also suggest a lag length 0 (p = 0). We find that ADF-statistics
reject the null of a unit root. Therefore, log(INCOME) is assumed to be integrated
with order 1.
126
AN ANALYSIS OF THE INTERACTION BETWEEN HEALTH EXPENDITURE AND ITS
DETERMINANTS IN THE U.S.
Table 5.4 – Unit root test for log(INCOME)
“TS” “ARD”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0
Level
p = 0 1.504(0.865) -0.917(0.943) 16.105**(0.001) -1.576(0.479)
First Difference
p = 0 14.567**(0.001) -5.384**(0.001)
Notes: p-values in parentheses. “**" represents that it is significant at the 5% signifi-
cant level.
The logarithm of relative healthcare price—The AIC and BIC select the lag length of
1 (p = 1), and the t-tests suggest a lag length of 10 (p = 10) when testing log(RPHC)
in levels with model “TS”. F-tests further suggest a lag length of 1 (p = 1) at the 5%
significance level. The Ljung-Box Q-statistics cannot reject the null that there is no
autocorrelation in residuals when p = 1. Therefore, we proceed to test the unit root of
log(RPHC) with p = 1. The results are presented in Table 5.5. At the 5% significance
level, the null hypothesis of a unit root cannot be rejected. When checking the model
specification “ARD”, the ADF test again cannot reject the null hypothesis of a unit root.
Next, we test for a unit root in the first difference of log(RPHC) with p = 0 in the
model specification “TS”, which is suggested by AIC, BIC, and t-tests and F-tests. We
find that ADF-statistics cannot reject the null of a unit root. When continuing with the
model specifications “ARD" and “AR”, the ADF test statistics still suggest that there
exists a unit root. Therefore, we further test its second difference.
In the analysis of log(RPHC) in its second difference, AIC, BIC, and the t-tests and
F-tests all select a lag length of 0 (p = 0) in the model specification “TS”. ADF-statistics
now reject the null hypothesis that there is a unit root. Therefore, we conclude here
that log(RPHC) is a I(2) process.
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Table 5.5 – Unit root test for log(RPHC)
“TS” “ARD” “AR”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0 γ = 0
Level
p = 1 3.686(0.381) -1.533(0.799) 5.996**(0.025) -2.5563(0.112)
First Difference
p = 0 5.645(0.104) -3.052(0.133) 3.041(0.200) -2.413(0.146) -1.115(0.238)
Second Difference
p = 0 13.493**(0.002) -5.194**(0.001)
Notes: p-values in parentheses. “**" represents that it is significant at the 5% significant level.
The Adjusted Baumol’s Variable—For the adjusted Baumol’s variable in levels, in
model “TS”, the AIC selects the lag length of 7 (p = 7), the BIC selects the lag length
of 5 (p = 5), and the t-tests suggest a lag length of 10 (p = 10). Again, we use the
F-tests to further determine the lag length together with the t tests. The lag length of
0 (p = 0) at 5% significance level is suggested. Ljung-Box Q-statistics cannot reject the
null that there is no autocorrelation in residuals of all the above lag choices. Therefore,
we further proceed to test the unit root of AdjBV for scenarios that p = 0, p = 5,
and p = 7. Table 5.6 shows the test results. The lag length does not seem to make a
difference: At the 5% significance level, the null hypothesis of a unit root is rejected
with all three possible choices of lag length. Therefore, we proceed by assuming that
AdjBV is a trend stationary process.
Table 5.6 – Unit root test for AdjBV
“TS”
H0 b = γ = 0 γ = 0
Level
p = 0 73.97**(0.001) -4.797**(0.003)
p = 5 22.89**(0.001) -6.708**(0.001)
p = 7 11.18**(0.006) -4.326**(0.009)
Notes: p-values in parentheses. “**" repre-
sents that it is significant at the 5% signifi-
cant level.
The logarithm of ratio of public health expenditure to total health expenditure—For
log(PF) in levels, in model “TS”, AIC, BIC, t-tests, and F-tests all suggest a lag length
of 1 (p = 1). Results are shown in Table 5.7. At the 5% significance level, ADF-statistics
cannot reject the null hypothesis of a unit root. Therefore, we further check the model
specification “ARD”. Now, AIC, and the t-tests and F-tests choose the lag length of
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1, whereas BIC chooses the lag length of 0. However, when p = 0, the Ljung-Box
Q-statistics reject the null that there is no autocorrelation in residuals. Therefore, we
choose p = 1 in model “ARD” to perform the ADF test. The ADF tests again cannot
reject the null hypothesis of a unit root.
Next, we test for a unit root in the first difference of log(PF). p = 0 is selected in
model “TS”. We find that ADF-statistics reject the null of a unit root. Therefore, log(PF)
is assumed to be a I(1) process.
Table 5.7 – Unit root test for log(PF)
“TS”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0
Level
p = 1 4.908(0.160) -3.110(0.119) 1.390(0.668) -0.872(0.780)
First Difference
p = 0 6.708(0.056) -3.636**(0.040)
Notes: p-values in parentheses. “**" represents that it is significant at the 5%
significant level.
The logarithm of productivity per capita— For log(PROD) in levels, in model “TS”,
AIC and BIC select the lag length of 1 (p = 1). The t-tests suggest a lag length of 9
(p = 9). The F-tests suggest a lag length of 0 (p = 0) at the 5% significance level.
Furthermore, the Ljung-Box Q-statistics cannot reject the null that there is no autocor-
relation in the residuals of all the above lag choices. Therefore, we further proceed
to test the unit root of log(PROD) for the scenarios that p = 0 and p = 1. Results
are shown in Table 5.8. At the 5% significance level, the null hypothesis of a unit root
cannot be rejected with both possible lag length.
Next, we test for a unit root in the first difference of log(PROD). We again start
from the least restrictive model “TS”. AIC and BIC suggest lag length of 1 (p = 1).
The t-tests and F-tests suggest a lag length of 0 (p = 0). Regardless of the lag length,
we find that the ADF-statistics reject the null of a unit root. Therefore, log(PROD) is
assumed to be integrated with order 1.
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Table 5.8 – Unit root test for log(PROD)
“TS” “ARD”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0
Level
p = 0 4.954(0.155) -2.098(0.536) 17.191**(0.001) 0.825(0.993)
p = 1 8.031**(0.026) -3.203(0.100)
p = 2 5.747**(0.030) 1.606(0.999)
First Difference
p = 0 11.087**(0.005) -4.650**(0.004)
p = 1 8.097**(0.025) -3.991**(0.018)
Notes: p-values in parentheses. “**" represents that it is significant at the 5% significant
level.
The logarithm of ratio of population 65 to 84 years old to total population—For
log(Age65−84) in levels, in model “TS”, AIC, BIC, and the t-tests and F-tests select
the lag length of 1 (p = 1) at the 5% significance level. The Ljung-Box Q-statistics
cannot reject the null that there is no autocorrelation in the residuals. Therefore, we
further proceed to test the unit root of log(Age65−84) with p = 1. Results are shown
in Table 5.9. At the 5% significance level, the null hypothesis of a unit root cannot be
rejected.
Next, we test for a unit root in the first differences of log(Age65−84). All lag selection
criteria suggest a lag length of 0 (p = 0). We find that ADF-statistics cannot reject the
null of a unit root with model specification “TS”. By further performing the test with
specification “ARD” and “AR”, we still cannot reject the null of a unit root. Therefore,
the first difference of log(Age65−84) is not stationary, we need to continue testing its
second difference.
In the analysis of the second differences of log(Age65−84), AIC, BIC, and the t-tests
and F-tests all select a lag length of 0 (p = 0) in the model specification “TS”. The ADF-
statistics reject the null hypothesis that there is a unit root. Therefore, we conclude here
that log(Age65−84) is a I(2) process.
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Table 5.9 – Unit root test for log(Age65−84)
“TS” “ARD” “AR”
H0 b = γ = 0 γ = 0 a = γ = 0 γ = 0 γ = 0
Level
p = 1 6.505(0.063) -3.484(0.056) 2.809(0.265) -2.288(0.181)
First Difference
p = 0 0.844(0.983) -0.230(0.990) 0.521(0.942) -1.021(0.716) -0.845(0.336)
Second Difference
p = 0 15.546**(0.001) -5.573**(0.001)
Notes: p-values in parentheses. “**" represents that it is significant at the 5% significant level.
The logarithm of ratio of population 85 years and over to total population—The
lag selection criteria suggest a lag length of 2 (p = 2) at the 5% significance level for
log(Age85+) in levels, in model “TS”. The Ljung-Box Q-statistics indicate no autocor-
relation in residuals. Test restuls are shown in Table 5.10. At the 5% significance level,
the null hypothesis of a unit root is rejected. Therefore, we proceed here under the
assumption that log(Age85+) is a trend stationary process.
Table 5.10 – Unit root test for log(Age85+)
“TS”
H0 b = γ = 0 γ = 0
Level
p = 2 7.105**(0.045) -3.664**(0.039)
Notes: p-values in parentheses. “**" repre-
sents that it is significant at the 5% signifi-
cant level.
The logarithm of share of the elderly population in good health—Finally, we test
log(HSG65+) in levels. Under the model specification “TS”, the lag length of 0 (p = 0)
at the 5% significance level is selected. The Ljung-Box Q-statistics cannot reject the null
that there is no autocorrelation in the residuals. At the 5% significance level, the null
hypothesis of a unit root is rejected. Therefore, we proceed here under the assumption
that log(HSG65+) is a trend stationary process. See the results in Table 5.11.
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Table 5.11 – Unit root test for log(HSG65+)
“TS”
H0 b = γ = 0 γ = 0
Level
p = 0 10.313**(0.007) -4.519**(0.005)
Notes: p-values in parentheses. “**" represents
that it is significant at the 5% significant level.
Detrending—Finally, we detrend variables which are found to be trend stationary by
fitting a linear or quadratic function to the trend and substract the fitted values from
each observation. We detrend AdjBV and log(Age85+) with a quadratic trend and
log(HSG65+) with a linear trend, and in this way obtain stationary deviations of the
trends νAdjBV , νAge85+ , and νHSG65+ , based on the following estimation results:
AdjBVt = 0.2427 + 1.2251t− 0.0188t2 + νAdjBV,t
(0.4622) (0.0533) (0.0013)
log(HSG65+,t) = −4.9503 + 0.0339t− 0.0003t2 + νHSG65+,t
(0.0111) (0.0013) (0.0000)
log(Age85+,t) = −0.4011 + 0.0030t + νAge85+,t
(0.0059) (0.0003)
132
AN ANALYSIS OF THE INTERACTION BETWEEN HEALTH EXPENDITURE AND ITS



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































AN ANALYSIS OF THE INTERACTION BETWEEN HEALTH EXPENDITURE AND ITS


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































AKAIKE, H. (1974): “A New Look at Statistical Model Identification,” IEEE Transactions
on Automatic Control, AC-19, 716.
AMIRI, A., AND B. VENTELOU (2012): “Granger causality between total expenditure on
health and GDP in OECD: Evidence from the Toda-Yamamoto approach,” Economics
Letters, 116(3), 541–544.
AU, D. W. H., T. F. CROSSLEY, AND M. SCHELLHORN (2005): “The Effect of Health
Changes and Long-term Health on the Work Activity of Older Canadians,” Health
Economics, 14, 999–1018.
BAIRD, S., J. FRIEDMAN, AND N. SCHADY (2011): “Aggregate Income Shocks and
Infant Mortality in the Developing World,” The Review of Economics and Statistics,
93(3), 847–856.
BALTAGI, B. H., AND F. MOSCONE (2010): “Health care expenditure and income in the
{OECD} reconsidered: Evidence from panel data,” Economic Modelling, 27(4), 804 –
811, Special Issue on Health Econometrics.
BATES, L. J., AND R. E. SANTERRE (2013): “Does the U.S. health care sector suffer from
Baumol’s cost disease? Evidence from the 50 states,” Journal of Health Economics,
32(2), 386–391.
BAUMOL, W. J. (1967): “Macroeconomics of Unbalanced Growth: The Anatomy of
Urban Crisis,” The American Economic Review, 57(3), 415–426.
BEBBINGTON, A., AND J. SHAPIRO (2006): “Incidence of Poor Health and Long-Term
Care: Health Transitions in Europe - Results from the European Community House-




BEHNCKE, S. (2012): “Does retirement trigger ill health?,” Health Economics, 21(3), 282–
300.
BERNDT, E. R., D. M. CUTLER, R. G. FRANK, Z. GRILICHES, J. P. NEWHOUSE, AND
J. E. TRIPLETT (2000): “Medical care prices and output,” in Handbook of Health Eco-
nomics, ed. by A. J. Culyer, and J. P. Newhouse, vol. 1 of Handbook of Health Economics,
chap. 3, pp. 119–180. Elsevier.
BLOMQVIST, A., AND R. A. L. CARTER (1997): “Is health care really a luxury?,” Journal
of Health Economics, 16(2), 207 – 229.
BLOOM, D., D. CANNING, AND G. FINK (2008): “Population Aging and Economic
Growth,” Pgda working papers, Program on the Global Demography of Aging.
BLOOM, D. E., AND D. CANNING (2005): “Health and Economic Growth: Reconciling
the Micro and Macro Evidence,” working paper 42, Center on Democracy, Develop-
ment, and The Rule of Law, Stanford Institute of International Studies.
BLOOM, D. E., D. CANNING, AND G. FINK (2009): “The Graying of Global Population
and Its Macroeconomic Consequences,” PGDA Working Papers 4709, Program on
the Global Demography of Aging.
BLOOM, D. E., D. CANNING, R. K. MANSFIELD, AND M. MOORE (2007): “Demo-
graphic change, social security systems, and savings,” Journal of Monetary Economics,
54(1), 92 – 114, Carnegie-Rochester Conference Series on Public Policy: Economic
Consequences of Demographic Change in a Global Economy April 21-22, 2006.
BOUND, J. (1991): “Self-Reported Versus Objective Measures of Health in Retirement
Models,” Journal of Human Resources, 26(1), 106–138.
BOUND, J., M. SCHOENBAUM, T. R. STINEBRICKNER, AND T. WAIDMANN (1999): “The
dynamic effects of health on the labor force transitions of older workers,” Labour
Economics, 6(2), 179 – 202.
BOUND, J., AND T. WAIDMANN (2007): “Estimating the Health Effects of Retirements,”
Working Papers wp168, University of Michigan, Michigan Retirement Research Cen-
ter.
BOX, G. E. P., AND D. R. COX (1964): “An Analysis of Transformations,” Journal of the
Royal Statistical Society. Series B (Methodological), 26(2), 211–252.
BRANCH, L., A. JETTE, C. EVASHWICK, M. POLANSKY, G. ROWE, AND P. DIEHR
(1981): “Toward understanding elders’ health service utilization,” Journal of Com-
munity Health, 7(2), 80–92.
BIBLIOGRAPHY 137
BURSTROM, B., AND P. FREDLUND (2001): “Self rated health: Is it as good a predictor
of subsequent mortality among adults in lower as well as in higher social classes?,”
Journal of Epidemiology and Community Health, 55(11), 836–840.
CAIRNS, A. J., D. BLAKE, K. DOWD, G. D. COUGHLAN, D. EPSTEIN, AND
M. KHALAF-ALLAH (2011): “Mortality density forecasts: An analysis of six stochas-
tic mortality models,” Insurance: Mathematics and Economics, 48(3), 355 – 367.
CAIRNS, A. J. G., D. P. BLAKE, K. DOWD, G. COUGHLAN, D. EPSTEIN, A. ONG, AND
I. BALEVICH (2007): “A Quantitative Comparison of Stochastic Mortality Models
Using Data from England & Wales and the United States,” Heriot-Watt University,
and Pensions Institute Discussion Paper, (PI-0701), Working Paper.
CASE, A., AND C. PAXSON (2005): “Sex Differences in Morbidity and Mortality,” De-
mography, 42(2), pp. 189–214.
CATALANO, R. A., AND W. A. SATARIANO (1998): “Unemployment and the likelihood
of detecting early-stage breast cancer,” American Journal of Public Health, 88(4), 586–
589.
CAWLEY, J., A. S. MORIYA, AND K. I. SIMON (2011): “The Impact of the Macroecon-
omy on Health Insurance Coverage: Evidence from the Great Recession,” Working
Paper 17600, National Bureau of Economic Research.
CHANDRA, A., AND J. S. SKINNER (2011): “Technology Growth and Expenditure
Growth in Health Care,” NBER Working Papers 16953, National Bureau of Economic
Research, Inc.
CHRISTIANSEN, T., M. BECH, AND J. LAURIDSEN (2007): “Demographic Changes and
Aggregate Healthcare Expenditure in Europe. ENEPRI Policy Briefs No. 4, 18 De-
cember 2007,” .
COALE, A., P. DEMENY, AND B. VAUGHAN (1983): Regional Model Life Tables and Stable
Populations, Second edition. Academic Press, New York.
COE, N., AND M. LINDEBOOM (2008): “Does Retirement Kill You? Evidence from
Early Retirement Windows,” Discussion Paper 2008-93, Tilburg University, Center
for Economic Research.
COE, N. B., AND K. HAVERSTICK (2010): “Measuring the Spillover to Disability Insur-
ance due to the Rise in the Full Retirement Age,” Working Paper 2010-21, Boston
College.
COE, N. B., AND G. ZAMARRO (2011): “Retirement effects on health in Europe,” Journal
of Health Economics, 30(1), 77–86.
138 BIBLIOGRAPHY
COLOMBIER, C. (2012): “Drivers of health care expenditure: Does Baumol’s cost dis-
ease loom large?,” FiFo Discussion Papers - Finanzwissenschaftliche Diskussions-
beiträge 12-5, University of Cologne, FiFo Institute for Public Economics.
CONTOYANNIS, P., AND A. M. JONES (2004): “Socio-economic status, health and
lifestyle,” Journal of Health Economics, 23(5), 965 – 995.
CONTOYANNIS, P., A. M. JONES, AND N. RICE (2004): “The dynamics of health in the
British Household Panel Survey,” Journal of Applied Econometrics, 19(4), 473–503.
CORRAO, G., V. BAGNARDI, A. ZAMBON, AND C. L. VECCHIA (2004): “A meta-
analysis of alcohol consumption and the risk of 15 diseases,” Preventive Medicine,
38(5), 613 – 619.
COSTA, D. L. (2002): “Changing Chronic Disease Rates and Long-term Declines in
Functional Limitation Among Older Men,” Demography, 64(1), 119–137.
CRIMMINS, E., M. HAYWARD, Y. SAITO, AND N. D. J. KENKYŪJO (1996): Differentials
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